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Chapter 1 
Introduction 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
In the field of palladium chemistry and catalysis, a particular focus on intramolecular C-N 
bond formation systems is here elucidated as a suitable method for the synthesis of 
heterocycles.  
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1.1 Palladium in organic synthesis 
 
1.1.1 Introduction 
 
Palladium (Pd), the 46
th
 element on the periodic table uncovered by Wollaston in 1803, is 
arguably the most versatile and ubiquitous metal in modern organic synthesis.
1,2 
Palladium-mediated processes have become essential tools, spanning countless 
applications in the syntheses of natural products, polymers, agrochemicals, and 
pharmaceuticals.  
The wide utility of this transition metal is due to palladium scarcely toxicity and to the 
ability of its complexes to be effective under mild reaction conditions, to tolerate a variety 
of common functional groups and to participate in catalytic transformations yielding high 
chemo-, regio- and stereoselecivity processes. Moreover Pd reagents and catalysts are not 
very sensitive to oxygen and moisture, and even to acids in many reactions catalyzed by 
Pd–phosphine complexes.  
Nearly every area of organic synthesis has been impacted by this versatile transition metal. 
Palladium can be used to conduct myriad of transformations with organic molecules.  
In fact, there are a number of well-known named reactions that feature this metal, just for 
instance, the Heck,
3
 Suzuki,
4
 and Buchwald-Hartwig cross-couplings,
5
 the Wacker 
process;
6
 and the Tsuji-Trost allylation.
1,2
  
                                                 
1
 (a) Muzart, J. J. Mol. Catal. A: Chem. 2007, 276, 62. (b) Zeni, G.; Larock, R. C. Chem. Rev. 2006, 106, 
4644. (c) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873. (d) Muzart, J. Tetrahedron 2005, 61, 5955. (e) 
Muzart, J. Tetrahedron 2005, 61, 9423. (f) Dounay, A. B.; Overman, L. E. Chem. Rev. 2003, 103, 2945. (g) 
Agrofoglio, L. A.; Gillaizeau, I.; Saito, Y. Chem. Rev. 2003, 103, 1875. (h) Negishi, E.-I.; Anastasia, L. 
Chem. Rev. 2003, 103, 1979. (i) Kiss, G. Chem. Rev. 2001, 101, 3435. (j) Beletskaya, I. P.; Cheprakov, A. V. 
Chem. Rev. 2000, 100, 3009. (k) Zimmer, R.; Dinesh, C. U.; Nandanan, E.; Khan, F. A. Chem. Rev. 2000, 
100, 3067. (l) Tsuji, J. Synthesis 1990, 739 and references within this chapter. 
2
 (a) Tsuji, J.; Palladium Reagents and Catalysts: new perspectives for the 21st century; Wiley & Sons: New 
York, 2003. (b) Negishi, E. I.; Handbook of organopalladium chemistry for organic synthesis; Wiley & 
Sons: New York, 2002. (c) Tsuji, J.; Palladium Reagents and Catalysts: Innovations in Organic Synthesis; 
Wiley and Sons: New York, 1995. (d) Tsuji, J.; Palladium in Organic Synthesis; Ed.; Springer: Berlin, 2005. 
(e) Li, J. J.; Gribble, G. W. Palladium in Heterocyclic Chemistry; Pergamon: New York, 2000. 
3
 (a) Mizoroki, T.; Mori, K.; Ozaki, A. Bull. Chem. Soc. Jpn. 1971, 44, 581. (b) Heck, R. F.; Nolley, J. P. J. 
Org. Chem. 1972, 37, 2320. (c) Oestreich, M. The Mizoroki-Heck Reaction, Wiley and Sons: Chichester, 
U.K., 2009.  
4
 Miyaura, N.;. Suzuki A. Chem. Rev., 1995, 95, 2457. 
5
 (a) Buchwald, S. L.; Mauger, C.; Mignani, G.; Scholz, U. Adv. Synth. Catal.2006, 348, 23. (b) Hartwig, J. 
F. Angew. Chem. Int. Ed. 1998, 37, 2046. 
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In addition, Pd also enables hydrogenation, hydrogenolysis, carbonylation, the formation 
of C–C, C–O, C–N, and C–S bonds, cycloisomerizations and even pericyclic reactions.1,2  
Domino catalysis, where multiple Pd-catalyzed transformations are carried out in a single 
operation, is also a powerful extension of this chemistry.
7
  
 
1.1.2 Palladium (0) and Palladium (II) 
 
Oxidation states of Palladium 
Although palladium can exist in a number of different oxidation states, useful organic 
methods are dominated by the use of Pd(0) and Pd(II),
1,2
 and the utility of Pd(IV)
8
 has been 
steadily emerging in its own right. The remaining oxidation states have not found practical 
applications yet and their observation remains rare. The increased stability of the even-
numbered oxidation states (e.g., 0, +2, +4) can be rationalized by the low tendency of 
palladium to undergo one-electron or radical processes; conversely, it readily participates 
in two-electron oxidation or reduction.
2
 
With its 10 electrons in the valence shell, palladium can form stable and isolable 
complexes both with 18 and 16 electrons. Catalytic species can even have 14 electrons 
(Figure 1)  
Figure 1 
 
 
Palladium ability to undergo facile and reversible two-electron operations has contributed 
to its widespread use as a catalyst, since each oxidation state can yield different chemistry. 
Reactions such as cross-couplings and olefin hydrogenation are common to the Pd(0) 
                                                                                                                                                    
6
 Punniyamurthy, T.; Velusamy, S.; Iqbal, J. Chem. Rev.2005, 105, 2329 and references therein. 
7
 Poli, G.; Giambastiani, G.; Heumann, A. Tetrahedron 2000, 56, 5959. 
8
 For examples of Pd(IV) transformations, see the following references and references therein: (a) Desai, L. 
V.; Sanford, M. S. Angew. Chem., Int. Ed. 2007, 46, 5737. (b) Yu, J. Q.; Giri, R.; Chen, X. Org. Biomol. 
Chem. 2006, 4, 4041. (c) Daugulis, O.; Zaitsev, V. G.; Shabasov, D.; Pham, O.-N.; Lazareva, A. Synlett 
2006, 3382. (d) Bressy, C.; Alberico, D.; Lautens, M. J. Am. Chem. Soc. 2005, 127, 13148.  
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platform, while transformations such as alcohol oxidation and cycloisomerization can be 
achieved using Pd(II). 
The bulk of the organopalladium literature is centered on the use of Pd(0) and Pd(II), 
although many reports do not clearly delineate the active catalyst (since Pd(II) precatalysts 
can be used to generate Pd(0) in situ). 
Pd(0) can undergo either oxidation or oxidative addition, which affords a Pd(II) complex.  
Pd(II) complexes can generate new Pd(II) complexes via processes such as β-hydride 
elimination, transmetallation, ligand substitution, insertion, or palladation. Finally, 
reductive elimination converts the Pd(II) complex back to Pd(0). This mechanistic 
understanding, combined with the ability of ligands and reaction parameters to modulate 
the reactivity of palladium, has allowed for a substantial amount of rational design in this 
field. 
 
Pd (0) reactivity 
Palladium(0) catalysis has been the focal point of palladium research over the past several 
decades, although the stabilization of the metal in this oxidation state is not easy to 
accomplish. A popular method of preparing Pd(0) complexes is via an in situ reduction of 
air stable Pd(II) species by reagents such as alkenes, CO, alcohols, amines, phosphines, or 
metal hydrides.  
The principal Pd(0) catalyzed reactions are summarized in Figure 2. 
 
Figure 2 
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In all these reactions the formation of a C-C or C-heteroatom bond is promoted by a 14 
electrons Pd(0) complex, which is easily oxidized to the Pd(II) state.  
Figure 3 
 
 
Most of the catalytic processes using Pd(0) generally begin with oxidative addition of 
palladium(0) to aryl and vinyl halides and triflates leading to a 16 electrons Pd(II) species 
characterized by a -carbon-palladium bond. (Figure 4) 
In general, increasing the electron density on palladium promotes oxidative addition.  
 
Figure 4 
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The Pd-complex thus formed can then evolve in different ways depending on the reaction 
conditions: for example in the presence of an olefin it can undergo coordination and 
insertion followed by β-elimination such as in the Heck reaction.(Scheme 1)  
Scheme 1 
 
 
Another common reaction pathway is transmetallation followed by reductive elimination 
as in the cross coupling reactions.(Scheme 2) 
 
Scheme 2 
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Another frequent mode of reactivity characteristic of Pd(0) involves the complexation of 
an olefin bearing an allylic leaving group, and the subsequent oxidative addition to 
generate a Pd(II) π-allyl complex (Scheme 3). Subsequent nucleophilic attack, which 
occurs predominately at the less-hindered carbon of the palladium π-allyl complex, affords 
the product and regenerates the Pd(0) catalyst.  
Scheme 3 
 
 
Pd (II) reactivity 
Palladium(II) catalysis, in contrast to palladium(0), has received significantly less attention 
from the synthetic community in the past, although there has been a revitalized interest 
within the last several years.
9
 
While Pd(0) complexes are good nucleophiles, Pd(II) complexes are typically electrophilic 
and air stable, and thus usually interact with electron-rich functionalities such as olefins, 
                                                 
9
 (a) Sigman, M. S.; Schultz, M. J. Org. Biomol. Chem. 2004, 2, 2551. (b) Stoltz, B. M. Chem. Lett. 2004, 33, 
362. (c) Tietze, L. F.; Ila, H.; Bell, H. P. Chem. Rev. 2004, 104, 3453. 
Introduction 
_________________________________________________________________________ 
9 
 
alkynes, and arenes promoting the formation of new C-C, C-N and C-O bonds by C-H 
functionalization.
10
 
However, one of the main complications that has been problematic in the development of 
Pd(II) methodology is the difficulty of reoxidizing Pd(0) to Pd(II). The completion of the 
catalytic cycle to regenerate Pd(II) requires the presence of a stoichiometric oxidant, such 
as CuCl2, Cu(OAc)2, benzoquinone, tert-butyl hydroperoxide (TBHP), MnO2, HNO3, and 
most recently O2, found to be the most desirable for its environmental friendliness.
11
 
However, not unexpectedly, the addition of these oxidants to a reaction has often interfered 
with the catalyst/ligand system (or the substrates themselves), and has led to complications 
in maintaining chemo- or stereoselective processes. 
To this aim, the catalytic use of copper salts in the presence of molecular oxygen is 
becoming of great success. (Figure 5) 
12
 
Figure 5 
 
 
A typical reaction with electrophilic Pd(II) commences with the complexation of an olefin 
by Pd(II) (Scheme 4). An intermolecular or intramolecular nucleophilic attack on the 
resulting olefin complex can then occur, generally at the more substituted position of the 
olefin (Wacker-type mechanism). At last, the final product typically results from β-hydride 
elimination. The resultant palladium hydride, HPdX, then undergoes a reductive 
elimination–oxidation sequence to regenerate the active Pd(II) catalyst. Alternatively, a 
pathway involving direct attack of the Pd(II)X2 complex by a nucleophile (e.g, an arene) is 
                                                 
10
 (a) Beccalli, E. M.; Broggini, G.; Martinelli, M.; Sottocornola, S. Chem. Rev. 2007, 107, 5318. (b) Kotov, 
V.; Scarborough, C. C.; Stahl, S. S. Inorg. Chem. 2007, 46, 1910. (c) Jensen, T.; Fristrup, P. Chem. Eur. J. 
2009, 15¸ 9632. 
11
 (a) Stahl, S. S. Angew. Chem., Int. Ed., 2004, 43, 3400. (b) Gligorich, K. M.; Sigman, M. S. Angew. 
Chem., Int. Ed., 2006, 45, 6612. (c) Piera, J.; Bäckvall, J.-E. Angew. Chem., Int. Ed., 2008, 47, 3506. (d) 
Gligorich, K. M.; Sigman, M. S. Chem. Commun., 2009, 3854. 
12
 Campbell, A. N.; Stahl, S. S. Acc. Chem. Res. 2012, 45, 851. 
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also possible. Although different processes may be observed, β-hydride elimination and 
reductive elimination sequences are likely to be the final steps in the cycle prior to 
reoxidation of palladium.  
Scheme 4 
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1.2 Palladium in Heterocycles synthesis 
 
1.2.1 Nitrogen containing heterocycles 
The synthesis of nitrogen-containing heterocycles continues to attract attention by 
synthetic chemists, as these structures are found in the cores of thousands of medicinally 
interesting natural and unnatural products, risulting useful in developing new therapeutics. 
The vast majority of these compounds are five or six-membered heterocycles with one or 
two oxygen or nitrogen atoms.
 
For example, the indole nucleus represents a basic motif with broad occurrence in 
biologically or synthetically relevant molecules endowed with pharmacological and 
agrochemical activities.
13
  
Examples of indole containing molecules of biological interest are the aminoacid 
Tryptophan and the neurotransmitter Serotonin. More complex structures, as natural 
alkaloids usually presenting polyheterocyclic structures, contain the indole nucleus. 
Among them we can find the Yohimbine family of natural products, led by Reserpin
14
 that 
is largely used for its sedative and ipotensive effects. Vincamine
15
 is important for its 
anticancer activity, while the indole moiety can also be found in several psychedelic drugs 
derived from lysergic acid
16
 and in neurotoxins derived from Strychnos nux-vomica such as 
Strychnine.
17
 
 
 
 
                                                 
13
 (a) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical Substances, 4th edn., Thieme, New 
York, 2001; (b) Karapetyan, G.; Chakrabarty, K.; Hein, M.; Langer, P. ChemMedChem 2011, 6, 25; (c) 
Ishikura, M.; Yamada, K.; Abe, T. Nat. Prod. Rep. 2010, 27, 1630; (d) Gilchrist, T. L.; J. Chem. Soc. Perkin 
Trans. 1, 1999, 2849. 
14
 (a) Ooki, Y.; Kanedo, S.; Maeyama, K. J. Pharmacol. Sci., 2008, 106, 197. (b) Gibbons, S.; Udo, E. E. 
Phytother. Res., 2000, 14, 139. 
15
 Erdö, S. L.; Molnár, P.; Lakis, V.; Bence, J. Z.; Tömösköozi, Z. Euro. J. Pharmacol., 1996, 314, 69. 
16
 Fusar-Poli, P.; Borgwardt, S. Neuropsychobiol., 2008, 58, 53 
17
 Zona, S. Economic Botany, 2008, 62, 192. 
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For this reasons great efforts have been devoted to improve the preparation of indole 
derivatives employing innovative synthetic methodologies.
18
 
In the same way benzoimidazole- and benzoxazoles-based compounds can be found in 
several drug and natural compounds.  
 
Although they are not so widely distributed as indoles, there are examples of compounds 
containing these structures employed against Alzheimer and cancer, as reported in recent 
publications
19
 and patents.
20  
                                                 
18
 (a) Gribble, G. W.; J. Chem. Soc. Perkin Trans. 1 2000, 1045; (b) Bandini, M.; Eichholzer, A. Angew. 
Chem. 2009, 121, 9786; Angew. Chem. Int. Ed. 2009, 48, 9608; (c) Bartoli, G.; Bencivenni, G.; Dalpozzo, R. 
Chem. Soc. Rev. 2010, 39, 4449; (d) Cacchi, S.; Fabrizi, G.; Goggiamani, A. Org. Biomol. Chem. 2011, 9,  
41.  
19
 (a) McKee, M. L.; Kerwin, S. M. Bioorg. Med. Chem. 2008, 16, 1775 (anticancer); (b) Kusumi, T.; Ooi, 
T.; Walchli, M. R.; Kakisawa, H. J. Am. Chem. Soc. 1988, 110, 2954 (antibacterial); (c) Rodríguez-
Rodríguez, C.; Sánchez de Groot, N.; Rimola, A.; Álvarez-Larena, A.; Lloveras, V.; Vidal-Gancedo, J.; 
Ventura, S.; Vendrell, J.; Sodupe, M.; González-Duarte, P. J. Am. Chem. Soc. 2009, 131, 1436. (d) 
Takahashi, M. ; Muta, S.; Nakazato, H. Journal of Heterocyclic Chemistry 1997, 34, 1395. 
20
 (a) Sasmal, P. K.; Chintakunta, V. K.; Potluri, V.; Khanna, I. K.; Tehim, A.; Jaleel, M.; Hogberg, T.; Rist, 
O.; Elster, L.; Frimurer, T. M.; Gerlach,L.-O.; PCT Int. Appl. 2012, WO 2012012410 A2 20120126. (b) 
Leblond, B.; Taverne, T.; Beausoleil, E.; Chauvignac, C.; Casagrande, A.-S.; Desire, L.; PCT Int. Appl. 2011, 
WO 2011151423 A1 20111208.(c) Gage, A.; PCT Int. Appl. 2010, WO 2010022300 A1 20100225. (d) 
Kuroita, T.; Oda, T.; Asano, Y.; Taya, N.; Iwanaga, K.; Tokuhara, H.; Fukase, Y.; U.S. Pat. Appl. Publ. 
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For example Gastrazole is used as a lead drug for treatment of pancreatic cancer,
21 
2-[(R)-
2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) is currently 
undergoing clinical trials on humans for treatment of a variety of cancer
22
 and Radiprodil is 
an agent in treatment of neuropathic pain and other cronic pain conditions.
8c 
 
1.2.2 Intramolecular C-N bond formation 
 
The easiest way to synthesize an heterocyclic system is through the intramolecular 
formation of a C-C or a C-heteroatom bond on suitable substrates.  
Figure 6 
 
 
Ring formation is most commonly achieved through intramolecular SN2 reactions, 
halocyclizations, reductive aminations, cycloadditions, or ring closing alkene metathesis 
reactions.
 
 
Among the several methods to build such rings, transition-metal-promoted reactions have 
become one of the most versatile tool a chemist can dispose in his quest,
23
 since a 
transition-metal catalyzed reaction can directly construct complicated molecules from 
readily accessible starting materials under mild conditions.  
                                                                                                                                                    
2009, US 20090227560 A1 20090910. (e) Hauel, N.; Himmelsbach, F.; Langkopf, E.; Eckhardt, M.; Maier, 
R.; Mark, M.; Tadayyon, M.; Kauffmann-Hefner, I.; PCT Int. Appl. 2004, WO 2004050658 A1 20040617.  
21
 Ormerod, D.; Willemsens, B.; Mermans, R.; Langens, J.; Winderickx, G.; Kalindjian, S. B.; Buck, I. M.; 
McDonald, I. M. Org. Process Res. Dev. 2005, 9, 499. 
22
 Penning, T. D.; Zhu, G.-D.; Gandhi, V. B.; Gong, J.; Liu, X.; Shi, Y.; Klinghofer, V.; Johnson, E. F.; 
Donawho, C. K.; Frost, D. J.; Bontcheva-Diaz, V.; J. Bouska, J. J.; Osterling, D. J.; Olson, A. M.; Marsh, K. 
C.; Luo, Y.; Vincent L. Giranda, V. L. J. Med. Chem. 2009, 52, 514. 
23
 (a) Nakamura, I.; Yamamoto,Y. Chem. Rev. 2004, 104, 2127; (b) Chemler, S. R.; Fuller, P.H. Chem. Soc. 
Rev. 2007, 36, 1153; (c) Shen, H.C. Tetrahedron 2008, 64, 3885; (d) Patil, N.T.; Yamamoto Y. Chem. Rev. 
2008, 108, 3395; (e) Majumdar, K. C.; Samanta, S.; Sinha, B. Synthesis 2012, 44, 817; (f) Majumdar, K. C.; 
Chattopadhyay, B.; Maji, P. K.; Chattopadhyay, S. K.; Samanta, S. Heterocycles 2010, 81, 795. 
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The cyclization of alkenes, allenes, and alkynes bearing a pro-nucleophile heteroatom at an 
appropriate position of the carbon chain is therefore a useful methodology for the synthesis 
of four-, five-, six- or seven-membered heterocycles.  
Moreover, the approach to C-N bond formation by late-transition-metal complexes is 
appealing as they often display good functional group compatibility and low air and 
moisture sensitivity, desirable features for potential synthetic applications.  
In this concern, palladium has undoubtedly found a wide utility, since it is effective in mild 
conditions and tolerates a variety of common functional groups, thus avoiding protection 
group chemistry.
23e,f
  
In the last years the general interest in Pd-catalyzed reactions has been shifted towards new 
and more challenging direct C-H functionalization studies on unactivated substrates.
 24,25
  
The non-functionalized carbon–carbon multiple bond systems can be recognized as latent 
functional groups, however, they are generally unreactive towards nucleophiles due to their 
electron rich -orbitals. The development of alternative methodologies for the additions of 
nucleophiles towards such multiple bonds involving transition metal activation can be 
achieved by the complexation of the metal to the alkenes or alkynes, which makes the C–C 
multiple bonds susceptible towards the addition of different nucleophiles. 
In particular the formation of new bonds resulting from the coupling of C-H/N-H bonds, 
with a nitrogen atom acting as nucleophile, is an attractive target, since the only formal by-
product would be hydrogen or water in an oxidative system. Compared to conventional 
cross-coupling reactions of halogenated or metalated reagents, the direct coupling reactions 
of unactivated substrates through C-H bond cleavage have attracted significant attention as 
atom- and step-economical synthetic methods. 
Thus the formal replacing of a C-H bond by a C-N bond through a Pd-catalyzed 
intramolecular processes is of great interest in the formation of a heterocyclic core. 
 
                                                 
24
 (a) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285; (b) Beccalli, E. M.; Broggini, G.; Martinelli, M.; 
Sottocornola, S. Chem. Rev. 2007, 107, 5318; (c) Kotov, V.; Scarborough, C. C.; Stahl, S. S. Inorg. Chem. 
2007, 46, 1910; (d) Minatti, A.; Muñiz, K. Chem. Soc. Rev. 2007, 36, 1142; (e) Thansandote, P.; Lautens, M. 
Chem. Eur. J. 2009, 15, 5874; (f) Chemler, S. R. Org. Biomol. Chem. 2009, 7, 3009; (g) Collet, F.; Dodd, 
R.H.; Dauban, P. Chem. Commun. 2009, 5061; (h) Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010, 110, 
1147. 
25
 Yamamoto, Y.; Radhakrishnan, U.; Chem. Soc. Rev., 1999, 28, 199  
 
Introduction 
_________________________________________________________________________ 
15 
 
Usually the addition of an amine to substituted alkene or alkynes lead to the -addition 
when the unsaturated system is substituted with an electron-withdrawing group, following 
an anti-Markovnikov addition, while the reaction an aryl or alkyl substituted substrate 
gives Markovnikov type additions. 
In the presence of a suitable metal, the electron rich unsaturated bond is activated to 
nucleophilic attack by an umpolung of reactivity due to the coordination of the metal. 
(Figure 7, part A). Then the sigma complex can either undergo a elimination, leading to 
the oxidative amination product, or reductive elimination resulting in the hydroamination 
process.  
A different type of coordination involves the formation of hydride-amido complexes H-
[M]-NR2, olefin insertion and reductive elimination leading to the hydroamination product. 
(Figure 7, Part B) 
Figure 7 
 
 
In this vein, we decided to perform amination reactions such as hydroamination and 
carboamination of different substrates containing allenyl, alkynyl and alkene moieties 
tethered to a nitrogen atom, so as to end up with the formation of new two-heteroatom-
containing cyclic systems.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Hydroamination reactions 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this chapter palladium catalyzed hydroamination reactions are exploited on different 
unsaturated systems in order to obtain new polyheterocyclic systems through a C-N bond 
formation. One of the main feature of this reaction is its environmental friendliness since it 
proceeds following the atom economy principles.  
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2.1 Hydroamination reactions 
 
Among the different synthetic methods to achieve nitrogen-containing heterocycles, 
hydroamination reactions have gained a relevant role since this formal addition of an NH 
group to a C-C multiple bond proceeds in an atom-economical manner.
26
 
Unsaturated moieties (alkenes, alkynes and allenes) tethered to a nucleophilic atom are 
suitable substrates to obtain products arising from exo- or endocyclization depending on 
the length and rigidity of the linking alkyl chain through amination and hydroamination 
reactions. (Figure 1)  
 
Figure 1 
 
 
In particular using allenes the hydroamination can follow different regioselective pathways 
with the addition on position ,  or .  
 
2.1.1 Hydroamination on allenes 
 
Allenes are three-carbon functional group possessing a 1,2-diene moiety and they represent 
versatile precursors that can be utilized as a useful building block in a variety of synthetic 
transformations, leading to complex structures that are useful for constructing natural and 
                                                 
26
 Müller, T. E.; Hultzsch, K. C.; Yus, M.; Foubelo, F.; Tada, M. Chem. Rev., 2008, 108, 3795  
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unnatural products.
27
 Subgroups of allenes are those substituted at the terminal carbon with 
a heteroatom such as oxygen, sulfur or nitrogen. Despite the synthetic potential of allenes, 
heteroatom-substituted allenes and in particular allenamines, have received relatively little 
attention.
27a 
Conceptually, allenamines should be synthetically useful because they are electron-rich 
and can be readily activated in the presence of an electrophile. More significantly, the 
nitrogen atom can donate its lone pair toward the allenic moiety to make transformations 
involving additions of electrophiles and nucleophiles with high regioselectivity, which is a 
general challenge with reactions involving allenes. 
 
 
However allenamines are known to be sensitive to hydrolysis, polymerization and 
isomerization even at low temperatures, thereby creating serious difficulties in their 
preparation and handling. 
 
Electron-deficient allenamines, such as allenamides, have the potential to function as an 
allenamine-equivalent. The electron-withdrawing group on the nitrogen atom should 
decrease its donating ability and lead to improved stability.  
Moreover, since coordination of free amine to the metals is usually irreversible giving 
stabilized complexes which deactivate the aminopalladation catalytic effect, amines 
bearing electron-withdrawing groups are more suitable substrates for palladium-catalyzed 
reactions. 
While among the different transition metals gold and silver were large applied on allene 
substrates, few examples of the Pd-catalyzed hydroamination processes onto allenes are 
reported in the literature remain.
28
 
In particular only two works reported the Pd-catalyzed intramolecular reaction on allenes 
tethered to a pronucleophilic nitrogen.
28c,d
 
                                                 
27
 (a) Saalfrank, R. W.; Lurz, C. J. Heterosubstituierte Allene and Polyallene. In Methoden Der Organischen 
Chemie (Houben- Weyl), Kropf, H., Schaumann, E., Eds.; Georg Thieme Verlag, Stuttgart, 1993, 3093-3102. 
(b) Schuster, H.E.; Coppola, G. M., Allenes in Organic Synthesis, John Wiley and Sons, New York, 1984. (c) 
Krause, N.; Hashmi, A. S. K. Modern Allene Chemistry, Wiley-VCH: Weinheim, 2004. 
28
 (a) Besson, L.; Gorè, J.; Cazes, B. Tetrahedron Lett. 1995, 36, 3857; (b) Al-Masum, M.; Meguro, M.; 
Yamamoto, Y. Tetrahedron Lett. 1997, 38, 6071; (c) Meguro, M.; Yamamoto, Y. Tetrahedron Lett. 1998, 39, 
5421; (d) S. Qiu, Y. Wei, G. Liu Chem. Eur. J. 2009, 15, 2751. 
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2.2 Pd-Catalyzed hydroamination on allenes under microwave 
irradiation 
 
As a part of the study directed to the reactivity of indole derivatives, we decided to focus 
our attention on the reactivity of N-allenyl 2-indolecarboxamides. The interest of these 
substrates is due to the presence of the allenyl group linked to the indole moiety which 
nitrogen atom can act as nucleophile to give intramolecular cyclization. 
Searching conditions to explore the protocols of cyclization, we investigated the behavior 
of the indolyl allenamide 1 under microwave irradiation.  
Using Pd(PPh3)4 8% mol as catalyst in toluene as the best solvent, a 5-exo-allylic 
hydroamination process took place, affording the vinyl derivative 2. 
Scheme 1 
 
 
To reach a better insight about the hydroamination process, we found that the presence of 
both palladium catalyst and microwave irradiation are necessary for the formation of 2. In 
fact, working in the absence of microwave activation only a tarry mixture of degradation 
products was obtained. Conversely, the lack of the palladium catalyst afforded the 
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formation of the hydroxy-substituted pyrazino[1,2-a]indole 3 (41%). This latter arises from 
A by a formal addition of water and the use of microwave activation is not essential, being 
achievable in 38% yield also by conventional heating of a solution of 1 in toluene. 
Scheme 2 
 
 
A similar trend of reactivity was observed when the reaction was carried out on different 
indole allenamides variously substituted on the phenyl ring as well as on the amide 
nitrogen. Thus, the substrates 1b-j afforded the imidazo [1,5-a]indoles 2b-j bearing a 
useful vinyl group in position 2 that allows further functionalizations, in satisfactory to 
high yields (Table 1).  
 
Table 1 
 
 Substrate Product Yield (%) 
1 
  
67 
2 
  
78 
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3 
  
85 
4 
 
 
58 
5 
  
63 
6 
  
89 
7 
  
69 
8 
  
85 
9j 
  
72 
 
In view of its novelty, the observed hydroamination reaction of the allenamides 1a-j 
deserves a mechanistic picture. Similarly to what was previously reported for different NH 
groups (i.e., amines, amides, and pyrrole), an initial coordination of the Pd(0) catalyst with 
the indole nitrogen can give the Pd(II)-hydride complex (Scheme 3). Such an intermediate 
would be susceptible to insertion of the allene group into the Pd-H bond to generate the π-
allyl-Pd(II) complex, which in turn would undergo the intramolecular formation of the new 
carbon-nitrogen bond and the subsequent reductive elimination of a Pd(0) species.  
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Scheme 3 
 
 
As a support for the proposed mechanism, we found that the deuterated hydroamination 
product 2k was formed in the cyclization of the deuterium-substituted allene 1k, prepared 
by treatment of a solution of 1a in CDCl3 with D2O (Scheme 4). 
 
Scheme 4 
 
 
We then decided to prove the new hydroamination protocol on other allenes bearing a 
nitrogen acting as nucleophile. 
To this purpose the O-allenylether of the 2-aminophenol (4) was chosen as suitable 
substrate and several reaction conditions were screened starting with the best found on 
indole derivatives (Table 2, entry 1). By changing different parameters as solvent, catalyst 
and heating source the reaction was optimized finding that the use of PdCl2(CH3CN)2 as 
catalyst in CH3CN as solvent, under microwave activation, achieved the desired vinyl 
derivative 5 in high yield, providing a 5-exo-allylic hydroamination. (Table 2, entry 5) 
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Scheme 5 
 
Table 2 
 
Catalyst Additive Solvent T (°C) Time 
Yield 
(%) 
1 Pd(PPh3
)
4 
8% mol  --- Toluene 120 °C (MW) 40’ 20 
2 Pd(PPh3
)
4  
8% mol --- CH3
CN 120 °C (MW) 40’ 30 
3 Pd(PPh
3
)
4  
8% mol --- THF 120 °C (MW) 40’ 50 
4 Pd(PPh3
)
4  
8% mol --- DMF 120 °C (MW) 40’ 50 
5 PdCl2
(CH
3
CN)
2
 5% mol --- CH3
CN 120 °C (MW) 40’ 70 
6 Pd2
(dba)
3  
5% mol --- THF 120 °C (MW) 40’ 0 
7 Pd(PPh
3
)
4  
15% mol PPh
3
 10%mol Toluene 110°C 120’ 68 
8 Pd(PPh3
)
4
  15% mol PPh
3
 10%mol Toluene 90°C (MW) 40’ 60 
9 Pd(PPh3
)
4
  8% mol PPh
3
 10%mol Toluene 90°C (MW) 40’ 62 
10 Pd(PPh
3
)
4
  5% mol PPh
3
 5%mol Toluene 90°C (MW) 40’ 30 
 
Good results were obtained also under thermal heating, using 15% mol of Pd(PPh3)4 as 
catalyst in the presence of 10% mol of PPh3. (Table 2, entry 7) However the use of the 
same catalytic system under microwave heating gave comparable results. Since a higher 
catalyst loading was employed, we decided to explore whether the catalytic system 
reactivity could be improved: by performing the reaction under microwave heating a lower 
catalyst loading was permitted (entry 9). It has to be pointed out that the presence of 10% 
of PPh3 resulted to be crucial to obtain the product in good yield. (entry 1, 10 vs 9). 
 
The approach to hydroamination by other late-transition-metal complexes is appealing and 
well established. Gold complexes, for example, have been employed as catalysts for a 
number of selective organic transformations and applied to good effect as catalysts for the 
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hydroamination of alkynes, alkenes, allenes, and conjugated dienes.
29
 Though also 
examples of platinum
30 
 and nickel
31
 catalyzed hydroamination reactions are reported in the 
literature, we decided to compare our catalytic system to different reaction conditions 
employing other transition metals that were found to be effective in the literature. 
The results of this screening is reported in the table below and in particular the 
hydroamination product 5 was formed in slightly comparable yields by only a silver-gold 
couple and ruthenium (entry 1 and 5), while in the presence of nickel no product was 
formed at all. 
 
Table 3 
 Catalytic system Solvent T (°C) Time (h) Yield (%) 
1 AuCl3 5% mol; Ag(OTf) 5% mol Dioxane 50 °C 4 60 
2 Ag(OTf) 5% mol Dioxane 50 °C 4 25 
3 
PtCl
2
(CH
3
CN)
2
 5% mol;  
PPh
3 
10% mol 
Dioxane 80 °C 6 40 
4 
Ni(acac)
2
 10% mol  
BINAP 40% mol 
THF 60 °C 6 0 
5 
RuCl
3
 1% mol; dppe 1% mol 
K
2
CO
3
  CuCl
2
  
CH3CN 60 °C 2 62 
 
However, since our catalytic system proved good reactivity and hydroamination reactions 
promoted by palladium catalyst are not widely explored, the scope of the reaction was then 
widened to a range of allenes synthesized starting from different 2-aminophenols (4b-d) 
and to 2-aminoaniline (6), along with O-allenyl-ethanolamine and N-allenyl-
ethylendiamine derivatives (7, 8). Using the best reaction conditions found: 
PdCl2(CH3CN)2 5%, THF, 120°C (MW) (Table 4, conditions I), good results were 
obtained with non aromatic systems. However when aminophenols and aminoaniline 
                                                 
29 
(a) Arcadi, A.; Bianchi, G.; Marinelli, F. Synthesis 2004, 610. (b) Kadzimirsz, D.; Hildebrandt, D.; Merz, 
K.; Dyker, G. Chem. Commun. 2006, 661. (c) Arcadi, A.; Di Giuseppe, S.; Marinelli, F.; Rossi, E. Adv. 
Synth. Catal. 2001, 343, 443; (d) Arcadi, A.; Di Giuseppe, S.; Marinelli, F.; Rossi, E. Tetrahedron Asymm. 
2001, 12, 2715. (e) Zhang, J.; Yang, C.-G.; He, C. J. Am. Chem. Soc. 2006, 128, 1798. (f) Han, X.; 
Widenhoefer, R. A. Angew. Chem. Int. Ed. 2006, 45, 1747. (g) Morita, N.; Krause, N. Org. Lett. 2004, 6, 
4121; (h) Binder, J. T.; Kirsch, S. F. Org. Lett. 2006, 8, 2151. (i) Nishina, N.; Yamamoto, Y. Angew. Chem. 
Int. Ed. 2006, 45, 3314. 
30
 Bender, C. F.; Widenhoefer, R. A.; J. Am. Chem. Soc. 2005, 127, 1070. 
31
 Yoshida, Y.; Kurahashi, T.; Matsubara, S. Chem. Lett., 2011, 40, 1067-1068 
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derivatives were submitted to these reaction conditions a lower amount of the desired 
products were recovered and the formation of the dealkylated side products B was 
detected.  
By using Pd(PPh3)4 in the presence of PPh3 10% mol in toluene at 90 °C (MW or 
conventional heating) (conditions II and III) we found that better results were obtained on 
the substituted aryl derivatives 4b-d, 6. Moreover the presence of additional PPh3 was 
found to be crucial, probably acting as a stabilizing agent for the intermediate thus 
avoiding the dealkylation process (Scheme 6 and Table 4).  
 
Scheme 6 
 
 
Table 4 
 
Substrate Product  
Condition I 
(%) 
Condition II 
(%) 
Condition III 
(%) 
1 
  
76 n.a. n.a. 
2 
 
 
61 n.a. n.a. 
3 
  
Traces 40 35 
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4 
 
 
16 65 91 
5 
 
 
22 42 71 
6 
 
 
16 67 79 
 
The mechanistic pathway is similar to the one described for the indolyl allenylamide 
derivatives. An initial coordination of the Pd(0) catalyst to the nitrogen atom can give the 
Pd(II)-hydride complex able to generate the π-allyl-Pd(II) complex. (Scheme 7) This 
species undergoes the nucleophilic attack of the nitrogen to the inner carbon of the allenyl 
system giving the formation of the new C-N bond with the concomitant reductive 
elimination of a Pd(0) species.  
Scheme 7 
 
 
 
At last, the hydroamination process was applied also to the hydroxylamine derivative 12 to 
confirm the effectiveness of the procedure and the vinyl isoxazolidine 13 was obtained in 
good yield. (Scheme 8) 
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Scheme 8 
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2.3 Palladium and Platinum catalyzed hydroamination on terminal 
alkynes 
 
The hydroamination reaction of alkynes is another attractive route to reach N-containing 
compounds. The literature data reports different hydroamination reactions of alkynes by 
using transition-metal based catalytic systems to promote the hydroamination of carbon-
carbon multiple bonds. 
Since the allenyl moiety arises from the alkynyl group we decided to explore the reactivity 
of palladim catalysis towards these substrates. 
 
Yamamoto reported the intramolecular hydroamination and hydroalkoxylation of alkynes 
in the presence of palladium/benzoic acid or palladium/PPh3 catalysts, producing the five-
membered heterocycles in good yields (Scheme 9).
32
 The described mechanism involves a 
first Pd-mediated formation of the corresponding allene and a second hydropalladation 
leading to a -allyl-palladium intermediate; the intramolecular nucleophilic attack of NH 
to the -allyl-palladium complex and subsequent reductive elimination of Pd(0) forms the 
allylic substituted heterocyclic system. 
Scheme 9 
 
                                                 
32
 (a) Kadota, I.; Shibuya, A.; Lutete, L. M.; Yamamoto, Y. J. Org. Chem. 1999, 64, 4570. (b) Lutete, L. M.; 
Kadota, I.; Shibuya, A.; Yamamoto, Y. Heterocycles 2002, 58, 347. (c) Kadota, I.; Lutete, L. M.; Shibuya, 
A.; Yamamoto, Y. Tetrahedron Lett. 2001, 42, 6207. 
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However, when we tested the same reaction conditions on our substrates 14a-d, 15 the 3-
methylene-dihydrobenzoxazines 16a-d and 2-methylenedihydroquinoxaline 17 were 
obtained instead of the usual dihydrobenzoxazole (imidazole) ring system, then not 
confirming the hypothesis that the propargyl derivative reacts via allene intermediate. 
(Scheme 9)  
Scheme 10 
 
 
 
Substrate Product Yields (%) 
1
 
1 
  
95 (58) 
2 
  
82 (76) 
3 
  
87 (45) 
4 
  
88 (70) 
5 
  
90 (83) 
1.
Yields determined by 
1
H-NMR on the crude reaction mixture; in parenthesis yields 
calculated after chromatography on silica gel column. In some cases the SiO2 column 
resulted in a mixture with the isomerized product C, thus yield can be drastically lower.  
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In searching for new reaction conditions we tested the same propargyl precursor 14a with 
different transition metals (gold, silver, ruthenium, rhodium) which resulted to be 
unreactive. 
On the other hand, in the presence of a copper salt as CuI a Ulmann type reaction took 
place yielding to the alkynyl dimer 18. 
Scheme 11 
 
 
Platinum
33
 was found to be the only effective catalyst by leading to the formation of a new 
product. In fact by performing the reaction with 5% mol PtCl2(CH3CN)2 in toluene as 
solvent a benzoxazepine ring system was obtained in two isomeric forms. (Scheme 11) 
 
Scheme 12 
 
The reaction was then performed on the other alkyne derivatives 14a-d and 15 obtaining 
the seven membered cyclized products 19a-e and 20 as a mixture of the two isomers in 
which the one carrying the double bond in  to the nitrogen always resulted to be the major 
product. 
 
                                                 
33
 (a) Jean-Jacques Brunet, J. J.; Chu, N. C.; Diallo, O.; Vincendeau, S.; J.  Mol. Cat., 2005, 240, 245;  (b) 
Tsukano, C.; Yokouchi, S.; Girard, A.-L.; Kuribayashi, T.; Sakamoto, S.; Enomoto, T.; Takemoto, Y. Org. 
Biomol. Chem., 2012, 10, 6074; (c) Gruit, M.; Pews-Davtyan, A.; Beller, M. Org. Biomol. Chem., 2011, 9, 
1148 
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Scheme 13 
  
Table 5 
 Substrate Catalytic system Solvent T(°C) Time  Product 
Yield 
(%) 
1 
 
PtCl2(CH3CN)2 5%mol Toluene 90 °C 6 h 
 
50 
2 
 
PtCl2(CH3CN)2 5%mol 
PPh3 10% mol 
Dioxane 90 °C 2 h 30 
 
30 
3 
 
PtCl2(CH3CN)2 5%mol Toluene 90 °C 6 h 
 
0 
4 
 
PtCl2(CH3CN)2 5%mol 
PPh3 10%mol 
Dioxane 90 °C 18 h 
 
0 
5 
 
PtCl2(CH3CN)2 5%mol Toluene 90 °C 18 h 
 
0 
6 
 
PtCl2(CH3CN)2 5%mol Toluene 90 °C 24 h 
 
20 
7 
 
PtCl2(CH3CN)2 5%mol Toluene 90 °C 4 h 
 
60 
 
It can be noted that the presence of electron-withdrawing groups on the aryl system affects 
the reactivity of the catalytic system. Thus, while p-methyl substituted benzoxazepine 
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derivative 19d is achieved in good yields, p-chloro-derivative 14c resulted to be less 
reactive. The conversion is only partial although the longer reaction time. 
At last p-nitro-aminophenol an o-aminoaniline derivatives 14b and 15 were found 
completely unreactive. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Domino processes 
 
  
 
 
 
 
 
 
 
 
 
 
 
As a part of the study directed to the development of intramolecular palladium-catalyzed 
procedure in obtaining polyheterocyclic systems, this chapter is focused on the intramolecular 
palladium catalysed carboamination reactions on substrates containing an allenyl moiety.  
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3.1 Domino reactions 
 
The usual procedure for the synthesis of organic compounds is the stepwise formation of the 
individual bond in the target molecule. However, it would be much more efficient if one could 
form several bonds in one sequence without isolating the intermediates, changing the reaction 
conditions, or adding reagents.
35
 It is obvious that this type of reaction would allow the 
minimization of waste and thus making the waste management unnecessary. Compared to 
stepwise reactions the amount of solvents, reagents, adsorbents and energy would be 
dramatically decreased. Thus, these reactions would allow an ecologically and economically 
favorable production. We call this type of transformation a domino reaction.
36
  
The usefulness of a domino reaction is correlated firstly to the number of bonds which are 
formed in one sequence, we call this the bond-forming efficiency (or bond-forming economy), 
secondly, the increase in structural complexity (structure economy) and, thirdly, to its 
suitability for a general application. 
Domino processes such as carboaminations,
37
 aminooxygenations
38
 and aminohalogenations,
39
 
enabling easy access to (poly)functionalized acyclic and cyclic compounds as well as bicyclic 
ring systems, are particularly fascinating and useful in organic synthesis. As a consequence, 
the set-up of selective and tailored procedures based on new combinations of various kinds of 
bonds constitutes a challenge that justifies ongoing efforts in this field. 
                                                 
35
 (a) Tietze, L. F.; Beifuss, U. Angew. Chem. 1993, 105, 137; Angew.Chem., Int. Ed. Engl. 1993, 32, 131. (b) 
Tietze, L. F. Chem.Ind. 1995, 453. Waldmann, H. “Domino Reaction” in Organic Synthesis Highlight II; 
Waldmann, H., Ed.; VCH: Weinheim, 1995; pp 193-202. (c) Hall, N. Science 1994, 266, 32. 
36
 (a) Tietze, L. F. Chem. Rev. 1996, 96, 115; (b) Wolfe, J. P. Eur. J. Org.Chem. 2007, 571. (c) Wolfe, J. P. 
Synlett 2008, 2913. 
37
 (a) Rosewall, C. F.; Sibbald, P. A.; Liskin, D. V.; Michael, F. E. J. Am. Chem. Soc. 2009, 131, 9488; (b) 
Houlden, C. E.; Bailey, C. D.; Gair Ford, J.; Gagn, M. R.; Lloyd-Jones, G. C.; Booker-Milburn, K. I.; J. Am. 
Chem. Soc. 2008, 130, 10066; (c) C. C. Scarborough, S. S. Stahl, Org. Lett. 2006, 8, 3251.  
38
 (a) Alexanian, E. J.; Lee, C.; Sorensen, E. J. J. Am. Chem. Soc. 2005, 127, 7690; (b) Liu, G.; Stahl, S. S. J. Am. 
Chem. Soc. 2006, 128, 7179; (c) Borsini, E.; Broggini, G.; Fasana, A; Galli, S.; Khansaa, M.; Piarulli, U.; 
Rigamonti, M.  Adv. Synth. Catal. 2011, 353, 985. 
39
 (a) Christie, S. D. R. , Warrington, A. D.; Lunniss, C. J. Synthesis 2009, 148; (b) Michael, F. E.; Sibbald, P. 
A.; Cochran, B. M. Org. Lett. 2008, 10, 793; (c) Manzoni, M. R.; Zabawa, T. P.; Kasi, D.; Chemler, S. R. 
Organometallics 2004, 23, 5618; (d) Borsini, E.; Broggini, G.; Colombo, F.; Khansaa, M.; Fasana, A.; Galli, S.; 
Passarella, D.; Riva, E.; Riva, S. Tetrahedron: Asymmetry 2011, 22, 264. 
Domino Reactions 
____________________________________________________________________________ 
37 
 
3.2 Pd-catalyzed carboamination  
 
Among the plethora of Pd-catalyzed domino reactions, carboaminations are an efficient 
method for the synthesis of nitrogen heterocycles.
36a
 In these reactions involving a multiple 
bond (alkenes, alkynes, allenes) bearing a nucleophilic substituent, a new C-N and a new C-C 
bond are formed.  
Pd(0)-catalyzed carboaminations of alkenes tethered to a nucleophilic nitrogen have been 
recently reviewed.
36b,c
 These protocols currently accept a mechanism starting with the 
intervention of an aryl halide to form a Pd(II) complex, which undergoes a nucleophilic attack 
of a nitrogen atom to give the cyclization products. The halide can be furnished by a different 
reactant or can be part of the substrate and a Pd(0) species is always released at the end of the 
cycle. (Figure 1). 
Figure 1 
 
 
Different outcome should be hypothesized widening the reaction to allene derivatives. 
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3.2.1 Carboamination of allenes tethered to a nitrogen nucleophile 
 
Since we were interested to obtain indole-containing polyheterocyclic systems, we decided to 
perform carboamination reactions on the allenylamide of 2-indolecarboxylic acid. 
Thus, exploiting the known reactivity of the -allyl-palladium complex, easily generated by 
carbopalladation of the allene moiety, the reaction of substrate 1 with Pd(PPh3)4 in the 
presence of aryl iodide gave the cyclization product through an intramolecular nucleophilic 
attack of the indolyl nitrogen atom. In the present case, the second step of the domino process 
could have been accomplished by either the nitrogen atom or the C-3 of the indole ring, but 
the reaction proved to be regioselective to the first.  
Under the best conditions typically used to promote this kind of reaction (1.5 equiv of PhI, 5 
% mol of Pd(PPh3)4, 4.0 equiv of K2CO3 in DMF as solvent), the cyclization took place giving 
the -styryl imidazo-[1,5-a]indole derivative 21a (Scheme 1). However, the presence of the 
base gave also the pyrazino [1,2-a]indole side product A, afforded by the nucleophilic attack 
of the nitrogen atom to the central carbon of the 1,2-diene moiety.  
Scheme 1 
 
Other conditions were then tested to avoid the formation of this side product and to maximize 
the formation of the desired compound. Among the array of solvents explored to optimize the 
reaction (DMF, DMA, CH3CN, dioxane), acetonitrile was proven as the most effective.  
The scope of this reaction was then explored with different aryl iodides, thus providing the 
expected products 21 a-e. (Scheme 2, Table1) 
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Scheme 2 
 
Table 1 
 ArI Products %Yield 
1 
 
 
74 
2 
 
 
88 
3 
 
 
68 
4 
 
 
72 
5 
 
 
76 
 
The influence of the electronic availability of the aryl iodide was limited and the expected 
products were afforded in good yields.  
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The formation of 21 constitutes an overall carbopalladation/5-exo-allylic amination process, 
which is doubly selective since the π-allyl-palladium complex is trapped exclusively on its 
internal carbon atom by the only indole nitrogen. 
 
Scheme 3 
 
 
The pathway proceeds with the formation of a PhPd(II)I complex by oxidative addition of 
Pd(0) species to the phenyl iodide, followed by carbopalladation of the allene moiety 
involving its central carbon, generating a -allyl-palladium intermediate. 
Subsequent nucleophilic attack of the indole nitrogen to the inner carbon of the allene and 
protonolysis of the carbon-metal bond would then yield the product and regenerate the 
catalyst. (Scheme 3) 
 
With the aim to study these carboamination processes on different substrates obtaining 
heteropolycyclic systems, other allenes bearing a nitrogen able to act as nucleophile were 
treated with the conditions previously used on indole derivatives.  
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Scheme 4 
 
 
Starting from commercially available o-amino-phenol and o-nitro-aniline, the formed allenyl 
derivatives 4a-d and 6 were treated with aryl- or heteroaryl iodides in the presence of 
Pd(PPh3)4, K2CO3 as base and CH3CN as solvent at reflux, to give the different substituted 
compounds 22a-l and 23a-g in good yields.(Table 2)  
Scheme 5 
 
Table 2 
 Substrate ArI Product % Yield 
1 
 
 
 
70 
2 
 
 
 
62 
3 
 
 
 
54 
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4 
 
 
 
38 
5 
 
 
 
68 
6 
 
 
 
78 
7 
 
 
 
71 
8 
 
 
 
65 
9 
 
 
 
64 
10 
  
 
25 
11 
  
 
67 
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12 
 
 
 
30 
13 
 
 
 
86 
14 
 
 
 
65 
15 
 
 
 
86 
16 
 
 
 
65 
17 
 
 
 
36 
18 
  
 
10 
19 
  
 
7(NBs) 
12(NH) 
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Once again, the reaction mechanism exploits the electrophilic reactivity of a -allyl-palladium 
complex easily accessible by carbopalladation of the allene moiety. The second step of the 
domino process involves the nucleophilic addition of the nitrogen atom to the inner carbon of 
the -allyl-Pd-complex to give the cyclized products, the 2-styryl dihydrobenzoxazoles 22a-l 
and 2-styryl dihydrobenzoimidazoles 23a-g in good yields.  
At last the reaction was also performed on a terminal allene, tethered to an hydroxylamine 
moiety through an alkyl chain, in order to obtain a styryl substituted isoxazolidine. In this case 
the hydroxylamine nitrogen was meant to act as nucleophile, despite of its less electronic 
availability. The allene was submitted to the usual reaction conditions yielding the desired 
compound 24 in good yield. (Scheme 6) 
Scheme 6 
 
 
3.2.1 Carbonylative amination of allenes 
Despite the well-established palladium-catalyzed carbonylations and their applications on 
allene derivatives, this kind of carboamination reactions on allenes under carbonylative 
conditions are rarely reported in the literature.
40
 
Only the Pd(II)-catalyzed cyclization of allenyl-amine derivatives by carbomethoxylation in 
the presence of carbon monoxide and methanol to form pyrrolidine or piperidine carboxylic 
esters is well known. 
 
We thus decided to perform the domino heterocyclization of different allenes derivatives in 
the presence of carbon monoxide.  
                                                 
40
 (a) Kang, S.-K.; Kim, K-J. Org. Lett. 2001, 3, 511; (b) Beccalli, E. M.; Broggini, G.; Clerici, F.; Galli, S.; 
Kammerer, C.; Rigamonti, M.; Sottocornola, S. Org. Lett. 2009, 11, 1563. 
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Scheme 7 
 
By using the same catalyst, base, and solvent as in the carboamination reactions, the 
conversion of the indol-2-allenylamides 1 (Scheme 8, Table 3) and the allenes derived from 2-
aminophenol (4a) and 2-aminoaniline (6) (Scheme 9) in the presence of different aryliodide 
under a CO atmosphere (1 atm) furnished the products 25a-d, 26 and 27, even if in modest 
yield due to the presence of degradation products.  
 
Scheme 8 
 
Table 3 
 Ar Product % Yield 
1 
 
 
45 
2 
 
 
31 
3 
 
 
0 
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4 
 
 
33 
5 
 
 
28 
 
Scheme 9 
 
 
This reaction gave the best results working at room temperature for a prolonged time; in fact, 
by refluxing the mixture for 24 h an increased amount of carboamination product was formed. 
As the previous one, the mechanism of this reaction involves a -allyl-palladium complex 
generated in this case by the interaction of a Ph-CO-Pd-I complex with the allene central 
carbon. 
In particular, the first carbonylation of the PhPd(II)I species to give the PhCOPdI complex is 
followed by the addition of the latter to the central carbon of the 1,2-diene group to form the 
aroyl intermediate, which then undergoes the 5-exo-allylic cyclization to the desired 
compounds characterized by the new  imidazole/oxazole ring system bearing an enone moiety. 
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3.3 Domino process on alkenes 
 
At last our attention has been directed to the transformation of unsaturated hydrocarbons 
through the action of oxidative Pd(II)-catalyzed alkene functionalization in order to build 
carbon-carbon and carbon-heteroatom bonds.
41
 
The classic pathway for this procedure typically requires the activation of the ethylenic bond 
induced by its coordination to the metal, which makes the bond susceptible to addition 
reactions, and the presence of a reoxidant agent in order to generate the suitable catalytic 
species. 
Following the interest shown so far towards transition metal-catalyzed reactions as well as 
towards the synthesis of heterocyclic structures containing in particular the isoxazolidine 
nucleus, we decided to focus on development of domino procedures for the regioselective 
cyclization of hydroxylamine derivatives bearing an ethylenic moiety. 
We considered the N-Boc O-but-3-enyl hydroxylamine (28) as a useful starting material for 
our studies.  
As a preliminary approach, we envisioned as suitable catalytic system PdCl2 (10% mol) and 
CuCl2 (3 equiv.), typically effective in domino reactions that rely upon a first carbon-carbon or 
carbon-heteroatom bond forming reaction.  
In agreement with this assumption, the use of this bimetallic couple in CH3CN at room 
temperature allowed the conversion of the hydroxylamine 28 to the chloro derivative 29 
arising from an amination/chlorination process (Scheme 10, Table 4, entry 1).  
 
                                                 
41
 a) S. S. Stahl, Angew. Chem. 2004, 116, 3480–3501; Angew. Chem. Int. Ed. 2004, 43, 3400–3420; b) E. M. 
Beccalli, G. Broggini, M. Martinelli, S. Sottocornola, Chem. Rev. 2007, 107, 5318–5365; c) V. Kotov, C. C. 
Scarborough, S. S. Stahl, Inorg. Chem. 2007, 46, 1910–1923; d) T. Jensen, P. Fristrup, Chem. Eur. J. 2009, 15¸ 
9632–9636; e) E. M. Beccalli, G. Broggini, A. Fasana, M. Rigamonti, J. Organomet. Chem. 2011, 696, 277–295; 
f) Le Bras, J.; Muzart, J. Chem. Rev. 2011, 111, 1170–1214; g) R. I. McDonald, G. Liu, S. S. Stahl, Chem. Rev. 
2011, 111, 2981–3019. 
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Scheme 10 
 
Table 4 
 
Catalytic system Oxidant Solvent Temp Time 
Product 
(%yield) 
1 PdCl2 10% mol CuCl2 3eq CH3CN RT 2h 29 (30) 
2 PdCl
2
(CH
3
CN)
2
 10% mol CuCl
2
 3eq THF 80°C 4h # 
3 PdCl2 10% mol CuCl2 3eq DMF 100°C 2h # 
4 
PdCl2(CH3CN)2 10% mol 
dppp 20% mol 
CuCl2 3eq DCM RT 1h 29 (43) 
5 PdCl2(CH3CN)2 10% mol CuCl2 3eq THF RT 2h 29 (48) 
6 PdCl2(CH3CN)2 10% mol CuBr2 3eq THF RT 5h 30 (17) 
7 PdCl2(CH3CN)2 10% mol CuBr2 3 eq DCM RT 4h 30 (43) 
 
By increasing the temperature, only degradation products were recovered, demonstrating the 
instability of the starting material to harsh conditions (entries 2 and 3). Better results were 
obtained when PdCl2(CH3CN)2 was used as catalyst in THF as solvent at room temperature 
(entry 5), while the use of 1,3-bis(diphenylphosphino)propane (dppp) as ligand did not 
produce great changes in the reaction outcomes. (entry 4) 
Finally the replacement of CuCl2 with CuBr2, afforded the bromo derivative 30 (entries 6 and 
7). 
Conversely, we found that the use of DMF as solvent triggers a competitive reaction pathway 
giving the formic ester 31, beside the chloro derivative 29. (Scheme 11) 
Scheme 11 
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Table 5 
 
This unusual domino pathway is based on an oxidative Pd(II)-catalyzed 
amination/esterification sequence that involves the DMF solvent.  
As a confirm to this unusual pathway the reaction was carried out in DMA as solvent, 
achieving the acetate derivative 32 (entry 4), along with the formation of the chloro derivative 
29.  
The mechanistic aspects of the above reactions can be elucidated as follow.  
The formation of the chloroamination product arises from a domino process in which CuCl2 
donates a chlorine to the reaction intermediate. This behavior is supported by precedents in 
literature,
42
 however, the formation of compounds 31 and 32 is quite unexpected. Only a 
recent example on indolyl allylamines can be found in the literature.
43
 This new domino 
amination/esterification reaction clearly involves the amidic solvent in determining the final 
structure. The mechanism may involve at first the formation of a -alkylpalladium complex 
that can be stabilized by the intervention of CuCl2, inhibiting palladium -hydride elimination. 
(Scheme 12).  
 
                                                 
42
 (a) Jiang, H.; Ma, S.; Zhu, G.; Lu, X. Tetrahedron 1996, 52, 10945;( b) Ji, J.; Lu, X. Synlett, 1993,745 
43
Broggini, G; Barbera, V.; Beccalli, E. M.; Borsini, E.; Galli, S.; Lanza, G.; Zecchi, G. Adv. Synth. Catal. 2012, 
354, 159 
 
Catalytic system Oxidant Solvent Temp Time 
29 
yield% 
Ester 
(%yield) 
1 PdCl2 10% mol CuCl2 3eq DMF RT 7h 20 31(22) 
2 PdCl2(CH3CN)2 10% mol CuCl2 3eq DMF RT 4h 31 31(35) 
3 PdCl2 10% mol Cu(OAc)2 3eq DMF RT 3h # # 
4 PdCl2 10% mol CuCl2 3eq DMA RT 18h 15 32(20) 
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Scheme 12 
 
Reductive metal elimination may result in the iminium intermediate, susceptible of hydrolysis 
to the final product 31 or 32.  
However, we cannot exclude that the iminium species arises from a direct nucleophilic attack 
by the solvent oxygen on the exocyclic carbon of the -palladium complex.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Studies towards the C1-C11 fragment of Stambomycin A 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following chapter is about the project I developed under the supervision of Dr. 
Edward A. Anderson during the six months term I spent at the University of Oxford. 
The project was directed to the design and synthesis of a fragment of Stambomycin A, a 51 
member macrolide isolated form Streptomices Ambofaciens. 
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4.1 Introduction 
 
Natural products have always played a crucial role in the discovery of new and improved 
drugs with a broad spectrum of applications in medicine and agriculture.
1
 
For this reason the recent development of genomics-guided approaches for novel natural 
product discovery has stimulated renewed interest in the search for natural product-based 
drugs. 
In the past decade, numerous secondary metabolites and their biosynthetic pathways has 
been uncovered thanks to this new technique and several strategies have been developed to 
identify the metabolic products of cryptic biosynthetic pathways.
2
 However, a relevant 
number of gene clusters appear to be expressed poorly, or even silent under laboratory 
growth conditions and a lot of them are not yet associated with the production of known 
metabolites,
3
 suggesting that the reservoir of bioactive natural products is far from 
exhausted.  
In these scenario Streptomices ambofaciens has revealed to be of high interest. 
Recent bioinformatic analysis of S. ambofaciens genome led to the identification of the 
biosynthetic gene clusters of two well known antibiotics: the macrolide spiramycin, an 
antibacterial agent used for the treatment of toxoplasmosis; and the pyrrole-amide 
congocidine.
4
 However, these analyses also revealed numerous cryptic putative secondary 
metabolite biosynthetic gene clusters. The metabolic products of three of these gene 
clusters have been identified as known antibiotics, none of which had been previously 
reported as product of S. ambofaciens,
5
 but other cryptic biosynthetic gene clusters 
remained unknown.  
In a recent work,
6
 Challis and coworkers achieved the identification of a family of four 
polyketides, named Stambomycins A–D, that are metabolic products of a large cryptic 
type I modular polyketide synthase (PKS) gene cluster located in the right arm of the S. 
ambofaciens chromosome.  
                                                 
1
  a) Bérdy J J Antibiot 2005, 58, 1–26. b) Newman, D. J.; Cragg, G. M.; J. Nat. Prod. 2007, 70, 461–477 
2
  Zerikly, M; Challis G. L. ChemBioChem 2009, 10, 625–633 
3
  Challis G. L. Microbiology 2008, 154, 1555–1569. 
4
  a) Pinnert-Sindico S. Ann Inst Pasteur 1954, 87, 702–707; b) Juguet M, et al. Chem Biol 2009, 16, 421–
431; c) Karray F, et al. Microbiology 2007, 153, 4111–4122. 
5
  a) Barona-Gómez F, et al. Microbiology 2006, 152, 3355–3366;  b) Pang X, et al. Antimicrob Agents 
Chemother 2004, 48, :575–588;  c) Bunet R, et al. J Bacteriol 2011, 193, 1142–1153. 
6
  Laureti,L; Song, L.; Huang, S.; Corre, C.; Leblond, P.; Challis, G. L.; Aiglea, B.,Pnas 2011, 108, 6258-
6263 
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Polyketides are of particular interest because they encompass several different chemical 
classes, including macrolides, polyenes, aromatics, and polyethers, which have found 
therapeutic applications as antibiotics, antitumor agents, immunosuppressants, and 
cholesterol-lowering drugs.
7
 
 
4.1.1 Stambomycins identification 
 
The Stambomycins constitute a unique family of 51-membered glycosylated macrolides 
with promising antiproliferative activity against human cell lines. Constitutive expression 
of a gene within the cryptic gene cluster encoding a putative pathway specific activator 
triggered the expression of the PKS genes (which are not expressed under laboratory 
growth conditions), providing the key to the identification of the Stambomycins. 
 
Figure 1. The Stambomycins family 
 
At first the structure of the fully assembled polyketide chain has been predicted as still 
attached to the Acyl Carrier Protein (ACP) domain in the last module of the PKS by 
sequence analyses of the biosynthetic enzymes, suggesting that the assembly of these 
remarkable macrolides involves unprecedented biosynthetic chemistry. However the 
structure of the side chain at C-26 could not be predicted in this manner. 
                                                 
7
  Hertweck C. Angew Chem Int Ed 2009, 48, 4688–4716 
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In Figure 2, the thus predicted polyketide chain is presented and atoms are colored 
according to the precursors from which they derive: malonyl-CoA (blue); methylmalonyl-
CoA (red).  
 
Figure 2. Predicted polyketide chain attached to the ACP domain 
 
 
Subsequent NMR experiments showed that stambomycins A and B consist of a common 
51- membered glycoslated macrolide core containing a tetrahydropyran resulting from the 
addition of the C-7 hydroxyl group to the C-3 keto group.  
Several structural features of the stambomycins were not predictable from sequence 
analyses of the biosynthetic enzymes, including the nature of the C-26 side chain, which is 
proposed to be a 4-methyl-n-hexyl derivative, and the sites of g1ycosylation, 
hydroxylation, and macrocycle formation.  
 
4.1.2 Aim of the work 
Among this class of compounds uncovered through genome mining we focused our 
attention to Stambomycin A (Figure 3) 
As largely commented before, its structure has been determined through NMR analysis. 
However its stereochemistry has been only partly assigned and the majority of the 
stereocentres contained within this intriguing molecule have been predicted solely through 
biosynthetic considerations,  remaining to be confirmed.  
With the aim to begin the stereochemical confirmation by the independent chemical 
synthesis of fragments of stambomycin which might be accessed through chemical 
degradation (such as exhaustive cross-metathesis), we focused our attention on C1–C11 
fragment A.  
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Figure 3. C1-C11 fragment of Stambomycin A 
 
 
In so doing, the project would deliver a validation of the largest-scale structural prediction 
of its kind and would revolutionize structural determination chemistry in the polyketide 
field. Furthermore, synthetic lessons learned en route to stambomycin could lay the basis 
for a total synthesis of the natural product, other family members, and/or unnatural 
analogues.  
 
4.2 Retrosynthetic approach to fragment A 
 
The analysis of the desired fragment A pointed the attention on the presence of six 
stereocenters on a twelve carbon alkyl chain, along with the presence of a pyran ring and a 
terminal alkene. 
By retrosynthetic analysis, the desired fragment A could be obtained by homologation and 
subsequent deprotection and cyclization of intermediate B.  
At the same time, a strategy for the formation of C-C bonds with the desired 
stereochemistry would be needed.  
With that in mind, we faced the transformation from C into B (by crotylation, alcohol 
protection and alkene cleavage) as well as the synthesis of the aldehyde C from 
commercially available starting materials.  
Scheme 1 
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Previous studies within the group towards the C1–C11 fragment of Stambomycin A led to 
the investigation of different strategies in order to install the requisite methyl 
stereochemistry at C4 and C8 of the aldehyde intermediate C. This followed two failed 
strategies: a vinylogous Mukaiyama aldol chemistry, and a reductive crotylation reaction 
developed by Morken.  
 
4.2.1 Failed attempts  
Mukaiyama aldol reaction 
Mukaiyama aldol reaction was first reported in 1975 as a vinilogous alkylation of a silyl 
dienol ether under activation of TiCl4.
8
 Since then, several methods for catalytic, 
enantioselective, vinilogous aldol reactions have appeared, and the addition of an O-silyl 
dienolate to aldehydes catalyzed by a chiral Ti (IV) complex was used to afford adducts in 
good yield and ee. 
Therefore, performing a vinilogous Mukaiyama reaction would allow to set two 
stereocentres in one step, linking an aldehyde and silyl dienol ether, precursors of the 
intermediate C (Scheme 2). 
Scheme 2. Synthetic route based on Mukaiyama aldol reaction 
 
 
This sequence is based on an asymmetric catalytic vinylogous Mukaiyama aldol reaction 
between the dioxenone silyl enol ether (prepared from Meldrum’s acid) and methacrolein, 
using TiCl4 and (S)-BINOL to form the chiral catalyst. 
Afterwards, deprotection, selective reduction of the ketone, acetonide protection and 
reduction would deliver to the corresponding aldehyde.  
However, although several attempts of Mukaiyama aldol reaction were carried out 
performing the reaction on both the enol ether and directly on the dioxenone derivative, 
                                                 
8
  a) Mukaiyama, T.; Ishida, A. Chem. Lett. 1972, 13, 4249. b) Denmark, S. E.; Heemstra, Jr.; Beutner, G. L. 
Angew. Chem. Int. Ed. 2005, 44, 4682. 
Studies towards the C1-C11 fragment of Stambomycin A 
_________________________________________________________________________ 
58 
unfortunately no successful results were obtained. Besides, several catalytic loads were 
tested, even the stoichiometric version, but no desired product was detected. 
A possible explanation for these results is the steric hindrance caused by the α-methyl 
group in methacrolein. Any of aldehydes tested in literature posses this functionality. The 
methyl group in the dioxenone dienolate derivative is also the cause of unreactivity.  
 
Morken’s reductive aldol reaction 
An alternative for the first step would be the use of Morken’s reductive aldol chemisty,9 a 
methodology that would allow to incorporate a propenyl side chain into a selected 
aldehyde. With this idea in mind the synthetic route would be designed as shown in 
Scheme 3. 
 
Scheme 3. Suggested synthesis based on Morken’s procedure. 
 
 
Therefore, asymmetric catalytic reductive aldol reactions between acrylate esters and 
aldehydes can be performed by the use of [(cod)RhCl]2 and BINAP, yielding good levels 
of enantioselectivity. 
However when Morken’s aldol chemistry was tested no desired compound was obtained, 
even by screening several reductive agents. 
                                                 
9
 a) Fuller, N. O.; Morken, J. P. Org. Lett. 2005, 7, 4867. b) Zhao, C.; Duffey, M. O.; Taylor, S. J.; Morken, 
J. P. Org. Lett. 2001, 3, 1829. c) Taylor, S. J.; Duffey, M. O.; Morken, J. P. J. Am. Chem. Soc. 2000, 122, 
4528. 
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4.2.2 New approach: enantioselective crotylation reactions 
 
Regarding the difficulties found in the routes described above, the attention was then 
focused on a more general procedure that allowed the settlement of the first two 
stereocentres of our molecule, developing a crotylation strategy. 
At first the recourse to Brown crotylation allowed the preparation of aldehyde C in very 
small quantities.  
Scheme 4 
 
By using methacrolein as starting material, the reaction carried out in the presence of (-)-
(Ipc)2B(OMe), obtained from (+)-α-pinene, afforded compound D with the desired 
stereoselectivity. A following metathesis reaction with methyl acrylate and a conjugate 
addition with benzaldehyde lead to compund D, precursor of the desired intermediate C  
However, the main drawbacks of this strategy are the formation of (Ipc)OH as a side 
product during Brown crotylation and non optimized reaction conditions for the following 
reactions (e.g. methatesis with acrolein) that led to compound C. 
 
With these promising results in hand as background, we then decided to refine this 
previous synthesis through: a) introduction of a synthetically useful iodide on the C10–C11 
alkene (avoiding the terminal alkene moiety); b) use of Leightonʼs crotylation chemistry,10 
which should avoid the tedious purification of the Brown crotylation product from the 
IpcOH byproduct associated with this reaction.  
 
In this vein, we then targeted C1–C11 fragment 1 (containing a vinyl iodide) rather than A, 
recognising that 1 could be converted to A though simple palladium-catalysed 
deiodination. 
                                                 
10
 a) Hackman, B. M.; Lombarda, P. J.; Leighton, J. L. Org. Lett. 2004, 23, 4375.; b) Kim, H.; Ho, S.; 
Leighton, J. L. J. Am. Chem Soc.2011, 133, 6517–6520 
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Scheme 5. New retrosynthetic approach 
 
 
Aldehyde 3 would be then prepared starting from a first Leighton crotylation to give 
adduct 5. Afterwards following the original strategy, although not yet perfectly optimised, 
a rapid chain extension would be accomplished yielding to the desired compound. (Scheme 
6) 
Scheme 6 
 
A second Leighton crotylation giving adduct 8 would deliver to the setting of all the 
required stereocentres. The synthesis of 1 should then be completed through alcohol 
protection, alkene cleavage (to the aldehyde 2), Roskamp homologation and finally acid 
mediated acetal cleavage / cyclisation / hydrolysis. (Scheme 7) 
Scheme 7. Final steps 
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4.3 Results and discussion 
 
Leighton and coworkers recently developed an asymmetric allylation and crotylation of 
aldehydes by using a new strained chiral reagent, which is practically an allyl or crotyl 
trichlorosilane tethered to a chiral 1,2-diamine (i.e. cyclohexyldiamine).
10
  
An important feature of these new reagents is that the reaction proceeds without need for 
any additional catalysts or reagents, yielding the addition to aldehydes on high yields and 
with excellent diastero- and enantioselectivities. 
 
In particular the use of the cis-crotyl-reagent afforded exclusively the syn-product, while 
the trans-derivative promoted an anti-selective crotylation. 
However, since this new methodology is not high performing with aromatic, unsaturated 
and sterically hindered aldehydes, the addition of a Lewis acid catalysis was found to be 
crucial to enhance the reactivity on these substrates and Sc(OTf)3 provided the best 
combination of high enantioselectivity and effective catalysis.
10b
  
Thus, the known aldehyde 2, obtained from oxidation of alcohol 1, underwent a Leighton 
crotylation to give adduct 3 in 96%yield and 92%ee. (Scheme 8) 
Scheme 8 
 
The following elongation of the alkyl chain was performed by a cross metathesis reaction. 
The presence of the vinyl iodide at one end of the chain let the reaction be regioselective 
towards the desired double bond. The challenging use of an electron deficient olefin to 
participate in the reaction is well supported by literature examples.
11
 Thus, compound 3 
undergoes a metathesis with methyl acrylate in the presence of Hoveyda-Grubbs II 
                                                 
11  a) Cossy, J.; BouzBouz, S.; Hoveyda, A. H. J. Organomet. Chem. 2001, 634, 216–221; b) Fuwa,H.; Noto, 
K.; Sasaki, M. Org Lett 2010, 12,.1636 
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catalyst. Although the reaction gave good results, different reaction conditions were tested 
in order to low the catalyst loading (Scheme 9, Table 1).  
 
Scheme 9 
 
Table 1 
 Catalytic System Solvent T (°C) Time 
%Yield 
(SM recovered) 
1 HG II  2.5% DCM RT 24h 78 
2 HG II  2.0% DCM 40 °C 16 h 78 
3 HG II  1.0% DCM RT 5 d 57 (20) 
4 
G II 2.0 %  
CuI 3.0% 
Et2O 40 °C 16 h 89 
 
However, the best results were obtained by using the less expensive 2
nd
 generation Grubbs 
catalyst in the presence of a catalytic amount of copper iodide. (entry 4) The presence of 
copper iodide salt is effective in cross metathesis reaction due to a catalyst stabilizing 
effect prompted by the iodide ion and a phosphine sequestering effect by Copper (I) from 
ruthenium
12
 
To insert the following oxygen functionality and set another sterocenter, a base catalyzed 
intramolecular conjugate Michael addition reaction on intermediate 4 was performed. 
(Scheme 10) 
Precedents for the synthesis of protected syn-1,3-diols from δ-hydroxy-α,β-unsaturated 
esters reported good yields and selectivities.
13
 In our case, the reaction of alcohol 4 with 
benzaldehyde in the presence of t-BuOK at low temperature furnished the corresponding 
benzaylidene acetal. To optimize the reaction several conditions were tested and best 
results were obtained using THF as solvent at -5 ºC, with excess of benzaldehyde and 
dropwise addition of t-BuOK in solution. As the acetalization is an equilibrium reaction, 
the slow addition of the base was found to be definitely crucial to avoid side reactions. 
                                                 
12
  Vigtritter, K.; Ghorai, S.; Lipshutz, B. H. J. Org. Chem. 2011, 76, 4697 
13
 Evans, D. A.; Gauchet-Prunet, J. A. J. Org. Chem. 1993, 58, 2446 
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However the yields were not great due to the steric hindrance performed by the methyl 
group on C4 in the emiacetal intermediate 
Scheme 10 
 
 
In order to confirm the absolute configuration of the stereocentres formed, we looked into 
NOE correlations. Figure 4 shows that there is NOE between H-7 and both H-3 and H-5, 
which places the three of them in the same face of the conformational chair. There is also 
NOE between H-4 and both H-3 and H-5, which confirms that the methyl on C4, which is 
also NOE coupled to H-6, is in axial position. 
 
Figure 4. NOE correlations 
 
 
The following one step reduction performed by using DIBAL-H in DCM at room 
temperature yield to the desired aldehyde 3. (Scheme 10). 
The further functionalization of the side chain followed a second Leighton crotylation. In 
this case the (S,S)-isomer of the crotylsilane reagent was used in order to install the right 
stereochemistry and the reaction was conducted in the absence of the Sc(OTf)3 to avoid a 
Lewis acid-promoted deacetalization. Thus, the desired compound 7 was obtained in good 
yield. (Scheme 11) The best results were obtained by prolonging the reaction times and 
performing the reaction at a higher concentration of the Leighton reagent. (Table 2) 
Studies towards the C1-C11 fragment of Stambomycin A 
_________________________________________________________________________ 
64 
Scheme 11 
 
Table 2 
 
(S,S)-Leighton 
reagent 
DCM Catalyst Time (h) Yield (%) 
1 1.2eq 0.1M Sc(OTf)3 10% 20 0 
2 1.2eq 0.1M -- 20 30 
3 2.4eq 0.25M -- 20 65 
4 2.4eq 0.25M -- 48 96 
 
Now that all the stereocenter required were successfully set, the further functionalization of 
the alkyl chain was performed by protection of the alcohol and subsequent alkene cleavage 
to achieve aldehyde 2. (Scheme 12) 
At first benzoylchloride was chosen as protecting agent, because of it can be easy removed 
under acidic conditions, thus the deprotection could have been accomplished in the last 
step of the designed synthesis along with the deacetalization/cyclization sequence. 
However we found out that the reaction carried out in pyridine was not high yielding and 
the product difficult to purify. Moreover some problems were detected during the 
subsequent reaction. (Table 3, entry 1)  
Scheme 12 
 
Table 3 
 PG A 10 (% yield) 2 (%yield ) 
1 Bz BzCl 1.2eq, Py 10a (50) 2a (30) 
2 PMB PMBCl, NaH, TBAI, THF/DMF 10b (72) 2b (53) 
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For these reasons, we decided to use p-methoxybenzyl as protecting group.  
Alcohol 9 was then treated with PMB-Cl in basic conditions (NaH) in THF/DMF as 
solvent in the presence of tetra-butyl-ammonium iodide to yield the protected product 10b 
in good yield. Compound 10b was then transformed into aldehyde 2b under oxidative 
conditions: catalytic amount of OsO4 and of NaIO4 in dioxane/water. The addition of 2,6-
lutidine was used to prevent the formation of oxidation by-products. 
 
At last a Roskamp omologation
14
 was performed by insertion of the carbine, generated 
from ethyl diazoacetate in the presence of SnCl2, into the aldehyde 2b, obtaining the 
desired -ketoester 11 in good yield (80%).  
At this point acidic conditions would deliver to the deprotection of the acetal, followed by 
intramolecular acetalization on the keto-group in order to obtain the cyclized compound 1. 
(Scheme 13). However, only small scale test reactions were performed on derivative 11. 
The catalytic use of p-toluensulfonic acid (PTSA) in methanol at 80 °C afforded only a 
mixture of degradation products, while when the reaction was performed with pyridinium 
p-toluensulfonate (PPTS) in methanol the formation of a small amount of the desired 
product was detected from both TLC analysis and 
1
H-NMR of the crude mixture.  
 
Scheme 13. Final steps 
 
 
 
                                                 
14
  Holmquist, C. R.; Roskamp, E. J. J. Org. Chem. 1989, 54, 3258. 
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4.4 Conclusions 
 
In summary a convenient route to fragment A of Sambomycin A has been developed and 
partially accomplished. The compound 1 was synthesized with high stereoselectivity and 
Leighton crotylation chemistry, cross-metathesis and conjugate additions were the 
synthesis key steps to construct the requisite stereocentres. However, the last step to the 
desired compound 1 has only been settled and remains to be scaled and the product 
recovered and purified.  
Since this synthesis proved to be successful, the attention can be turned to the C12–C25 
fragment F, which features two remote areas of stereochemistry (an anti-diol and a 
stereotriad) linked by a -(CH2)3- chain (Figure 5), recognizing that transformation from G 
to F could follow a sequence equivalent to the one settle in this early part of the project 
towards fragment A. 
 
Figure 5. C12-C25 fragment 
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In conclusion, during this research work we have developed transition metal catalyzed 
strategies resulting in the formation of new C-N bonds. 
The interest toward nitrogen containing heterocycles brought us to investigate new 
synthetic ways towards such structures exploiting Pd catalyzed reactions on unsaturated 
substrates, ending up with the formation of new two-heteroatom-containing cyclic systems 
such as imidazoindoles, oxazoles, imidazoles, benzoxazines, oxazepines and 
isoxazolidines.  
Hydroamination and carboamination reactions on different allenes let us to afford the 
formation of a new five-member ring system bearing a useful vinyl or styryl moiety. 
Conversely, the intramolecular hydroamination on alkynes resulted in different 
regioselectivity when platinum or palladium were used as catalysts. 
In the first case, seven-member ring heterocycles were obtained (e.g. benzoxazepines and 
benzodiazepines) through a 7-endo cyclization process, while by using palladium six-
member ring systems were formed. 
Finally, isoxazolidines were successfully synthesized performing a Pd(II) a 
halogenation/amination on alkenyl-hydroxylamines.  
 
At last, although not concerning within the project, the experience towards the synthesis of 
the first fragment of Stambomycin A accomplished at the University of Oxford has 
revealed to be a good challenge, resulting in the setting of the initial steps of the total 
synthesis of this macrolacton. 
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General details: All chemicals and solvents are commercially available and were used after 
distillation or treatment with drying agents. Silica gel F254 thin-layer plates were employed for 
thin layer chromatography (TLC). Silica gel 4063 micron/60 Å was employed for flash 
column chromatography. Melting points were measured with a Büchi B-540 heating unit and 
are uncorrected. Infrared spectra were recorded with a Perkin-Elmer FT-IR 16 PC 
spectrophotometer using KBr tablets for solids and NaCl disks for oils. 
1
H NMR spectra were 
recorded at room temperature in CDCl3, at 200, 300, 400, 500 MHz (with a Varian-Gemini 
200 or Brucker 300, 400 and 500 Avance spectrometers), with residual chloroform as the 
internal reference (δH = 7.27 ppm). 
13
C NMR spectra were recorded at room temperature in 
CDCl3 at 50.3, 75.45, 100 or 125.75 MHz, with the central peak of chloroform as the internal 
reference (δC = 77.3 ppm). The APT or DEPT sequences were used to distinguish the methine 
and methyl carbon signals from those due to methylene and quaternary carbons. Data for 
1
H 
NMR are reported as follows: s = singlet, d =doublet, t = triplet, q = quartet, qt = quintuplet, m 
= multiplet, br = broad. Coupling constants (J) are reported as values in hertz. All 
13
C NMR 
spectra were recorded with complete proton decoupling. Two-dimensional NMR experiments 
(COSY, NOESY and HMBC) were used, where appropriate, to aid in the assignment of 
signals in proton and carbon spectra. Low-resolution MS spectra were recorded with a 
Thermo-Finnigan LCQ advantage AP electrospray/ion trap equipped instrument using a 
syringe pump device to directly inject sample solutions. Microwave assisted reactions were 
performed in a MILESTONE microSYNT multimode labstation, using 12 mL sealed glass 
vessels. The internal temperature was detected with an optical fibre sensor.  
Column chromatography was performed on a Merck silica gel 60, (mesh size 63-200 µm). 
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Indole derivatives 
 
The allenamides of 2-indolcarboxylic acid were prepared in near quantitative yields, starting 
from indole-2-carboxylic acid easily conversted into the propargylamide and followed by 
prototropic isomerization promoted by t-BuOK.  
 
 
General procedure for the preparation of propargylamides  
 
A solution of indole-2-carboxylic acid (6.20 mmol), DMF (0.3 mL) and oxalyl chloride (18.60 
mmol) in anhydrous CH2Cl2 (40 mL) was stirred at rt for 1 h and refluxed for 1 h. The solvent 
was evaporated under reduced pressure, the crude residue was diluted with CH2Cl2 (40 mL) 
and a solution of propargylamine (8.24 mmol) and triethylamine (8.24 mmol) in CH2Cl2 was 
added at 0 °C. The solution was stirred at rt for 1 h, then the organic phase was washed with 
HCl 1M and dried over Na2SO4 then the solvent was evaporated under reduced pressure. The 
resulting crude was purified by flash chromatography to afford the desired product (PE/AcOEt 
7:3).  
 
N-Methyl-N-propargyl-1H-indole-2-carboxamide (Ia)  
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Yield: 96%. White solid. mp 145 °C (i-Pr2O). IR (νmax/cm
-1
): 3308, 3230, 2116, 1661; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.56 (1H, br s); 7.69 (1H, d, J = 8.0 Hz), 7.46 (1H, d, J = 8.2 
Hz), 7.30 (1H, dd, J = 8.2 Hz, 7.1 Hz), 7.15 (1H, dd, J = 8.0 Hz, 7.1 Hz), 7.00 (1H, s), 4.49 
(2H, s), 3.23 (3H, s), 2.37 (1H, s);
 13
C-NMR (100 MHz, CDCl3) δC: 163.6 (s), 136.3 (s), 129.0 
(s), 127.8 (s), 124.8 (d), 122.3 (d), 120.7 (d), 112.3 (d), 106.4 (d), 78.5 (s), 73.2 (d), 40.3 (t), 
35.8 (q). MS: m/z 212 [M]
+
. Anal. calcd for C13H12N2O: C, 73.57; H, 5.70; N, 13.20. Found C, 
73.41; H, 5.82; N, 13.34. 
 
5-Methoxy-N-methyl-N-propargyl-1H-indole-2-carboxamide (Ib) 
 
Yield: 94%. White solid. mp 143 °C (i-Pr2O). IR (νmax/cm
-1
): 3305, 3224, 2114, 1658; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.95 (1H, br s), 7.37 (1H, d, J = 8.9 Hz), 7.08 (1H, s), 6.96 (1H, 
d, J = 8.9 Hz), 6.91 (1H, s), 4.48 (2H, s), 3.85 (3H, s), 3.20 (3H, s), 2.38 (1H, s); 
13
C-NMR 
(100 MHz, CDCl3) δC: 163.2 (s), 154.5 (s), 131.4 (s), 129.3 (s), 127.9 (s), 116.0 (d), 112.9 (d), 
105.7 (d), 102.3 (d), 78.6 (s), 74.5 (d), 55.7 (q), 45.8 (t), 38.7 (q). MS: m/z 242 [M]
+
. 
 
N-5-Dimethyl-N-propargyl-1H-indole-2-carboxamide (Ic) 
 
Yield: 65%. White solid. mp 136 °C (i-Pr2O). IR (νmax/cm
-1
): 3312, 3220, 2118, 1664; 
1
H-
NMR (400 MHz, CDCl3) δH: 10.09 (1H, br s), 7.46 (1H, s), 7.39 (1H, d, J = 8.4 Hz), 7.14 (1H, 
d, J = 8.4 Hz), 6.93 (1H, s), 4.50 (2H, s), 3.41 (3H, s), 2.47 (3H, s), 2.39 (1H, s); 
13
C-NMR 
(100 MHz, CDCl3) δC: 163.3 (s), 134.5 (s), 129.7 (s), 128.9 (s), 127.9 (s), 126.5 (d), 121.3 (d), 
111.7 (d), 105.6 (d), 78.6 (s), 73.6 (d), 46.1 (t), 39.4 (q), 21.5 (q). MS: m/z 226 [M]
+
 
 
5-Chloro-N-methyl-N-propargyl-1H-indole-2-carboxamide (Id) 
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Yield: 65%. White solid. mp 152 °C (i-Pr2O). IR (νmax/cm
-1
): 3307, 3235, 2120, 1673; 
1
H- 
NMR (400 MHz, CDCl3) δH: 10.03 (1H, br s), 7.64 (1H, s), 7.40 (1H, d, J = 8.7 Hz), 7.24 (1H, 
d, J = 8.7 Hz), 6.92 (1H, s), 4.48 (2H, s), 3.43 (3H, s), 2.39 (1H, s); 
13
C-NMR (100 MHz, 
CDCl3) δC: 163.3 (s), 134.5 (s), 129.7 (s), 128.9 (s), 127.9 (s), 126.5 (d), 121.3 (d), 111.7 (d), 
105.5 (d), 78.3 (s), 72.8 (d), 47.8 (t), 33.4 (q). MS: m/z 246 [M]
+
. 
 
N-Methyl-7-nitro-N-propargyl-1H-indole-2-carboxamide (Ie) 
 
Yield: 74%. White solid. mp 161 °C (i-Pr2O). IR (νmax/cm
-1
): 3315, 3216, 2112, 1664; 
1
H-
NMR (400 MHz, CDCl3) δH: 10.5 (1H, br s), 8.25 (1H, d, J = 7.9 Hz), 8.02 (1H, d, J = 7.8 
Hz), 7.27 (1H, dd, J = 7.8 Hz, 7.9 Hz), 7.10 (1H, s), 4.45 (2H, s), 3.12 (3H, s), 2.39 (1H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 161.8 (s), 133.3 (s), 131.6 (s), 131.3 (s), 130.3 (d), 128.8 (s), 
121.6 (d), 120.0 (d), 106.5 (d), 78.1 (s), 72.4 (d), 45.8 (t), 38.7 (q). MS: m/z 257 [M]
+
. 
 
N-Benzyl-N-propargyl-1H-indole-2-carboxamide (If) 
 
Yield: 59%. White solid. mp 163 °C (i-Pr2O). IR (νmax/cm
-1
): 3313, 3220, 2116, 1668; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.35 (1H, br s), 7.63-7.66 (1H, m), 7.15-7.45 (8H, m), 7.09-7.14 
(1H, m), 5.05 (2H, s), 4.39 (2H, s), 2.37 (1H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 159.0 (s), 
30.9 (t), 136.0 (s), 135.8 (s), 128.8 (d), 128.6 (s), 127.8 (d), 127.7 (s), 124.6 (d), 122.4 (d), 
122.2 (d), 120.6 (d), 111.7 (d), 105.7 (d), 78.6 (s), 74.1 (d), 52.8 (t). MS: m/z 288 [M]
+
. 
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N-(4-Methoxybenzyl)-N-propargyl-1H-indole-2-carboxamide (Ig) 
 
Yield: 98%. White solid. mp 138 °C (i-Pr2O). IR (νmax/cm
-1
): 3321, 3218, 2108, 1667; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.53 (1H, br s), 7.62-7.65 (1H, m), 7.45 (2H, d, J = 8.2 Hz), 
7.12-7.33 (4H, m), 6.92 (2H, d, J = 8.2 Hz), 5.00 (2H, s), 4.37 (2H, s), 3.83 (3H, s), 2.37 (1H, 
s); 
13
C-NMR (100 MHz, CDCl3) δC: 163.3 (s), 159.3 (s), 135.9 (s), 128.7 (s), 127.9 (s), 127.7 
(s), 124.7 (d), 122.2 (d), 120.6 (d), 114.3 (d), 111.8 (d), 106.5 (d), 105.7 (d), 78.7 (s), 73.4 (d), 
55.3 (q), 53.4 (t), 30.9 (t). MS: m/z 318 [M]
+
.  
 
N-(4-Methylbenzyl)-N-propargyl-1H-indole-2-carboxamide (Ih) 
 
Yield: 98%. White solid. mp 138 °C (i-Pr2O). IR (νmax/cm
-1
): 3309, 3222, 2120, 1670; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.26 (1H, br s), 7.11-7.65 (9H, m), 5.01 (2H, s), 4.36 (2H, s), 
2.38 (4H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 163.4 (s), 137.6 (s), 135.9 (s), 132.9 (s), 129.6 
(d), 128.6 (s), 127.6 (s), 124.7 (d), 122.1 (d), 120.6 (d), 111.8 (d), 106.5 (d), 105.7 (d), 78.7 
(s), 72.8 (d), 49.1 (t), 33.9 (t), 21.1 (q). MS: m/z 302 [M]
+
.  
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N-(4-Chlorobenzyl)-N-propargyl-1H-indole-2-carboxamide (Ii) 
 
Yield: 58%. White solid. mp 166 °C (i-Pr2O). IR (νmax/cm
-1
): 3320, 3210, 2109, 1657; 
1
H-
NMR (400 MHz, CDCl3) δH: 10.06 (1H, br s), 7.12-7.65 (9H, m), 5.02 (2H, s), 4.42 (2H, s), 
2.41 (1H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 163.6 (s), 136.2 (s), 134.7 (s), 133.7 (s), 129.1 
(d), 128.3 (s), 127.5 (s), 124.8 (d), 122.1 (d), 120.6 (d), 112.0 (d), 105.9 (d), 105.8 (d), 78.5 
(s), 73.3 (d), 50.3 (t), 34.1 (t). MS: m/z 322 [M]
+
. 
 
N-Propargyl-N-(thiophen-2-ylmethyl)-1H-indole-2-carboxamide (Ij) 
 
Yield: 51%. White solid. mp 121 °C (i-Pr2O). IR (νmax/cm
-1
): 3312, 3220, 2114, 1676; 
1
H-
NMR (400 MHz, CDCl3) δH: 9.87 (1H, br s), 7.68 (1H, d, J = 8.0 Hz), 7.48 (1H, d, J = 8.3 
Hz), 7.27-7.32 (2H, m), 7.09-7.17 (3H, m), 7.00-7.03 (1H, m), 5.15 (2H, s), 4.46 (2H, s), 2.44 
(1H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 163.2 (s), 138.4 (s), 136.1 (s), 128.4 (s), 127.6 (s), 
127.1 (d), 127.0 (d), 126.9 (d), 126.1 (d), 124.8 (d), 122.2 (d), 112.0 (d), 105.8 (d), 78.6 (s), 
73.2 (d), 44.4 (t), 37.6 (t). MS: m/z 294 [M]
+
. 
 
General procedure for the synthesis of allenamides 
 
A solution of propargylamide (1 mmol) in THF (10 mL) was treated with t-BuOK (2.5 mmol). 
The resulting solution was stirred at rt for 1 min, then filtered on silica gel (AcOEt). The 
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solvent was evaporated under reduced pressure and the residue was used without further 
purification for the next step. 
 
N-Methyl-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1a)  
 
Yield 98%. White solid. mp 143 °C (i-Pr2O); IR (νmax/cm
-1
): 3306, 1940, 1668; 
1
H-NMR (400 
MHz, CDCl3) δH: 9.07 (1H, br s), 7.68 (1H, d, J = 8.8 Hz), 7.44 (1H, d, J = 8.2 Hz), 7.28 (1H, 
dd, J=8.8 Hz, 7.0 Hz), 7.27-7.72 (1H, m), 7.17 (1H, dd, J = 8.2 Hz, 7.0 Hz), 7.00 (1H, s), 4.49 
(2H, d, J = 6.6 Hz), 3.34 (3H, s); 
13
C-NMR (100MHz, CDCl3) δC: 202.4 (s) 161.7 (s), 136.1 
(s), 129.1 (s), 127.9 (s), 125.2 (d), 122.4 (d), 120.9 (d), 112.0 (d), 107.9 (d), 102.7 (d), 87.6 (t), 
33.7 (q). MS m/z 212 [M]
+
.  
 
5-Methoxy-N-methyl-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1b)  
 
Yield: 85%. White solid. mp 143 °C (i-Pr2O). IR (νmax/cm
-1
): 3310, 1935, 1672; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.22 (1H, br s), 7.57-7.88 (1H, m), 7.36 (1H, d, J = 8.9 Hz), 7.08 (1H, 
s), 6.99 (1H, d, J = 8.9 Hz), 6.92 (1H, s), 5.50 (2H, d, J = 6.3 Hz), 3.86 (3H, s), 3.35 (3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 201.9 (s) 161.6 (s), 154.6 (s), 131.6 (s), 129.3 (s), 127.9 (s), 
116.3 (d), 112.8 (d), 106.9 (d), 102.6 (d), 102.3 (d), 87.4 (t), 55.7 (q), 33.2 (q). MS: m/z 242 
[M]
+
.  
 
N,5-Dimethyl-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1c)  
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Yield: 88%. White solid. mp 135 °C (i-Pr2O). IR (νmax/cm
-1
): 3301, 1944, 1660; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.80 (1H, br s), 7.79-7.50 (1H, m), 7.45 (1H, s), 7.36 (1H, d, J = 8.4 
Hz), 7.13 (1H, d, J = 8.4 Hz), 6.92 (1H, s), 5.51 (2H, d, J = 6.3 Hz), 3.36 (3H, s), 2.46 (3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 202.5 (s), 162.0 (s), 134.6 (s), 129.9 (s), 128.9 (s), 127.8 (s), 
126.8 (d), 121.9 (d), 121.4 (d), 111.6 (d), 106.8 (d), 87.3 (t), 30.3 (q), 21.4 (q). MS: m/z 226 
[M]
+
.  
 
5-Chloro-N-methyl-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1d)  
 
Yield: 85%. White solid. mp 145 °C (i-Pr2O). IR (νmax/cm
-1
): 3313, 1937, 1655; 
1
H-NMR 
(400 MHz, CDCl3) δH: 10.16 (1H, br s), 7.23-7.82 (1H, m), 7.64 (1H, s), 7.39 (1H, d, J = 8.8 
Hz), 7.25 (1H, d, J = 8.8 Hz), 6.92 (1H, s), 5.52 (2H, d, J = 6.3 Hz), 3.31 (3H, s); 
13
C-NMR 
(100 MHz, CDCl3) δC: 201.8 (s), 161.4 (s), 134.5 (s), 130.1 (s), 128.4 (s), 126.2 (s), 125.3 (d), 
121.8 (d), 121.2 (d), 113.1 (d), 106.6 (d), 87.5 (t), 32.8 (q). MS: m/z 246 [M]
+
.  
 
N-Methyl-7-nitro-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1e)  
 
Yield: 80%. White solid. mp 128 °C (i-Pr2O). IR (νmax/cm
-1
): 3302, 1945, 1667; 
1
H-NMR 
(400 MHz, CDCl3) δH: 10.50 (1H, br s), 8.25 (1H, d, J= 7.4 Hz), 8.02 (1H, d, J= 7.8 Hz), 7.47-
7.32 (1H, m), 3.27 (3H, s), 7.27 (1H, dd, J= 7.8, 7.4 Hz), 6.97 (1H, s), 5.51 (2H, d, J= 6.3 Hz); 
13
C-NMR (100 MHz, CDCl3) δC: 202.0 (s), 160.1 (s), 133.3 (s), 131.6 (s), 131.1 (s), 130.3 (d), 
128.9 (s), 122.1 (d), 121.7 (d), 119.9 (d), 107.6 (d), 87.6 (t), 30.3 (q). MS: m/z 257 [M]
+
. 
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N-Benzyl-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1f)  
 
Yield: 69%. White solid. mp 145 °C (i-Pr2O). IR (νmax/cm
-1
): 3298, 1953, 1669; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.34 (1H, br s), 7.68-7.11 (11H, m), 5.36 (2H, s), 5.01 (2H, s); 
13
C-
NMR (100 MHz, CDCl3) δC: 202.8 (s), 161.6 (s), 137.2 (s), 136.0 (s), 128.6 (d), 128.4 (s), 
127.8 (s), 127.6 (d), 127.2 (d), 125.0 (d), 122.3 (d), 120.7 (d), 111.7 (d), 107.5 (d), 102.6 (d), 
87.5 (t), 49.8 (t). MS: m/z 288 [M]
+
.  
 
N-(4-Methylbenzyl)-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1g) 
 
Yield: 92%. White solid. mp 155 °C (i-Pr2O). IR (νmax/cm
-1
): 3310, 1933, 1655; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.62 (1H, br s), 7.77-7.03 (10H, m), 5.38 (2H, s), 4.90 (2H, s), 3.36 
(3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 202.4 (s), 161.5 (s), 158.8 (s), 136.0 (s), 130.0 (s), 
129.2 (s), 128.7 (d), 127.6 (s), 125.0 (d), 122.3 (d), 120.7 (d), 114.0 (d), 111.8 (d), 108.2 (d), 
102.1 (d), 87.4 (t), 55.3 (q), 47.4 (t). MS: m/z 302 [M]
+
.  
 
N-(4-Methoxybenzyl)-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1h)  
 
Yield: 84%. White solid. mp 136 °C (i-Pr2O). IR (νmax/cm
-1
): 3310, 1954, 1670; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.41 (1H, br s), 7.43-6.88 (10H, m), 5.39 (2H, s), 4.90 (2H, s), 3.81 
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(3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 202.4 (s), 161.5 (s), 158.8 (s), 136.0 (s), 130.0 (s), 
129.2 (s), 128.7 (d), 127.6 (s), 125.0 (d), 122.3 (d), 120.7 (d), 114.0 (d), 111.8 (d), 108.2 (d), 
102.1 (d), 87.4 (t), 55.3 (q), 47.4 (t). MS: m/z 318 [M]
+
.  
 
N-(4-Chlorobenzyl)-N-(propa-1,2-dienyl)-1H-indole-2-carboxamide (1i)  
 
Yield: 92%. White solid. mp 167 °C (i-Pr2O). IR (νmax/cm
-1
): 3295, 1938, 1652; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.28 (1H, br s), 7.64-6.85 (10H, m), 5.37 (2H, d, J = 5.9 Hz), 4.96 (2H, 
s); 
13
C-NMR (100 MHz, CDCl3) δC: 202.1 (s), 161.6 (s), 136.1 (s), 135.7 (s), 133.1 (s), 129.9 
(s), 128.8 (d), 127.5 (s), 127.5 (d), 125.1 (d), 122 (d), 120.8 (d), 111.8 (d), 108.0 (d), 101.9 (d), 
87.7 (t), 48.6 (t). MS: m/z 322 [M]
+
.  
 
N-(Propa-1,2-dienyl)-N-(thiophen-2-ylmethyl)-1H-indole-2-carboxamide (1j)  
 
Yield: 95%. White solid. mp 166 °C (i-Pr2O). IR (νmax/cm
-1
): 3321, 1952, 1654; 
1
H-NMR 
(400 MHz, CDCl3) δH: 9.47 (1H, br s), 7.67 (1H, d, J = 8.0 Hz), 7.43 (1H, d, J = 8.3 Hz), 7.31 
(1H, dd, J = 7.6 Hz, 7.7 Hz), 7.17-7.06 (3H, m), 7.24-7.27 (1H, m), 6.96-6.99 (1H, m), 6.95-
7.45 (1H, m), 5.54 (2H, d, J = 5.3 Hz), 5.10 (2H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 201.9 
(s), 161.2 (s), 139.8 (s), 136.1 (s), 130.3 (s), 128.5 (s), 127.5 (d), 126.5 (d), 125.5 (d), 125.1 
(d), 122.3 (d), 120.8 (d), 111.8 (d), 107.7 (d), 101.8 (d), 88.1 (t), 45.5 (t). MS: m/z 294 [M]
+
.  
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For the studies to dihydrobenzoxazoles and dihydrbenzoimidazoles the substrates were 
synthesized starting from 2-amino-phenol and 2-nitro-aniline following the scheme below: 
 
 
Aminophenol derivatives 
General procedure for the preparation of N-Boc 2-aminophenol derivatives 
 
 
To a stirred solution of the suitable 2-aminophenol (1 eq) in THF (6.5 mL / mmol), Boc2O (1.2 
eq) was added at room temperature and the reaction mixture was stirred at room temperature 
(heated when necessary) hor 16h. The solvent was then removed under reduce pressure, 10 
mL of H2O were added and the solution was extracted with AcOEt (3 x 20 mL). The layers 
were separated and the organic phases dried over Na2SO4, filtered and the solvent removed 
under reduced pressure. The crude product was purified by silica gel flash column 
chromatography. 
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N-(tert-butoxycarbonyl)-2-aminophenol (IIa)
44
 
 
Yield: 95% Colourless crystal solid. 
1
H-NMR (200 MHz, CDCl3) δH: 8.12 (1H, bs), 7.08-6.81 
(4H, m), 6.62 (1H, bs), 1.53 (9H, s). 
Data are consistent with literature. 
 
N-(tert-butoxycarbonyl)-5-nitro-2-aminophenol (IIb) 
 
Yield: 72% Orange solid. mp: 141 °C (Et2O) IR (νmax/cm
-1
): 3361, 3339, 1711, 1532, 1496. 
1
H-NMR (200 MHz, CDCl3) δH: 9.15 (1H, bs), 8.16 (1H, d, J = 2.9 Hz), 7.93 (1H, dd, J= 8.8, 
2.9 Hz), 6.86 (1H, bs), 6.99 (1H, d, J= 8.8 Hz), 1.55 (9H, s).
13
C-NMR (50 MHz, CDCl3) δC: 
155.1 (s), 153.2 (s), 141.4 (s), 126.3 (s), 121.4 (d), 118.4 (d), 117.0 (d), 83.6 (s), 28.4 (q). MS 
m/z 277.0 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)- 5-chloro-2-aminophenol (IIc) 
 
Yield: 97 % Orange oil. IR (νmax/cm
-1
): 3394, 3317, 2981, 1707, 1530. 
1
H-NMR (200 MHz, 
CDCl3) δH: 7.86 (1H, bs), 7.33 (1H, d, J = 2.2 Hz), 6.93 (1H, dd, J = 8.8, 2.9 Hz), 6.81 (1H, d, 
J = 8.8 Hz), 6.80 (1H, bs), 1.56 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 154.6 (s), 145.5 (s), 
131.9 (s), 127.1 (s), 124.8 (d), 120.8 (d), 119.0 (d), 82.5 (s), 28.5 (q). MS m/z 266.1 [M+Na]
+
. 
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 Buon, C.; Chacun-Lefèvre, L.; Rabot, R.; Bouyssou, P.; Coudert, G. Tetrahedron 2000, 56, 605. 
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N-(tert-butoxycarbonyl)-5-methy-2-aminophenol (IId)
 45
 
 
Yield: 99% Colourless solid. 
1
H-NMR (200 MHz, CDCl3) δH: 7.76 (1H, bs), 6.95 (1H, s), 6.65 
(1H, bs), 6.84-6.60 (2H, m), 2.23 (3H, s), 1.51 (9H, s). 
Data are consistent with literature. 
 
General procedure for the preparation of N-Boc O-propargyl ethers intermediates 
 
To a stirred solution of the suitable N-(tert-butoxycarbonyl)-2-aminophenol (1 eq) in 
THF/DMF (10 mL / 3 mL) at room temperature, under N2 atmosphere, was added K2CO3 (1.2 
eq). The mixture was cooled to 0 °C and a solution of propargyl bromide (80% in toluene, 1.2 
eq) was added dropwise. The resulting mixture was stirred at room temperature overnight. 
The solvent was removed under reduced pressure, brine (15 ml) was added and the mixture 
was extracted with Et2O (3 x 20 mL). The organic layers were dried over Na2SO4, filtered and 
the solvent was removed under vacuum. The crude was purified by crystallization or by silica 
gel flash chromatography. 
 
N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-2-aminophenol (14a) 
 
Yield: 97% Yellow oil. IR (νmax/cm
-1
): 3439, 3295, 2979, 2931, 2123, 1728, 1604, 1522, 1454. 
1
H-NMR (200 MHz, CDCl3) δH: 8.10-8.08 (1H, m), 7.06 (1H, bs), 6.99-6.96 (3H, m), 4.75 
(2H, d, J = 2.2 Hz), 2.54 (1H, t, J = 2.2 Hz), 1.53 (9H, s). 
13
C-NMR (75 MHz, CDCl3) δC: 
                                                 
45
 Sarkar, A.; Raha Roy, S.; Parikh, N.; Chakraborti, A. K. J. Org. Chem. 2011, 76, 7132. 
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152.9 (s), 145.8 (s), 128.9 (s), 122.5 (d), 122.2 (d), 118.9 (d), 112.2 (d), 80.6 (s), 76.6 (s), 76.4 
(d), 56.9 (t), 28.8 (q) MS m/z 270.0 [M+Na]
+ 
 
N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-4-nitro-2-aminophenol (14b) 
 
Yield: 80% Yellow solid. mp: 111-113 °C (Et2O) IR (νmax/cm
-1
): 3361, 3258, 2993, 2939, 
2120, 1706, 1594, 1535, 1345, 1278. 
1
H-NMR (200 MHz, CDCl3) δH: 9.03 (1H, d, J = 2.9 
Hz), 7.90 (1H, dd, J = 9.2, 2.9 Hz),7.10 (1H, bs), 7.04 (1H, d, J = 9.2 Hz), 4.86 (2H, d, J = 2.6 
Hz), 2.61 (1H, t, J = 2.6 Hz), 1.54 (9H, s).
13
C-NMR (50 MHz, CDCl3) δC:  152.3 (s), 149.9 (s), 
142.7 (s), 129.3 (s), 118.4 (d), 113.8 (d), 110.9 (d), 81.8 (s), 77.6 (s), 76.9 (d), 57.0 (t), 28.5 
(q). MS m/z 315.0 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-4-chloro-2-aminophenol (14c) 
 
 
Yield: 62% Dark yellow oil. IR (νmax/cm
-1
): 3436, 3299, 2980, 2933, 2125, 1729, 1598.
1
H-
NMR (200 MHz, CDCl3) δH 8.17 (1H, s),7.05 (1H, bs), 7.00-6.89 (3H, m), 4.73 (2H, d, J = 2.6 
Hz), 2.55 (1H, t, J = 2.6 Hz), 1.53 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 152.5 (s), 144.2 (s), 
129.9 (s), 127.6 (s), 121.8 (d), 118.6 (d), 112,9 (d), 82.9 (s), 81.1 (s), 76.3 (d), 57.0 (t), 28.5 
(q). MS m/z 304.0 [M+Na]
+ 
 
N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-4-methyl-2-aminophenol (14d) 
 
Yield: 76% Orange oil. IR (νmax/cm
-1
): 3408, 3276, 2980, 2930, 2129, 1731, 1532. 
1
H-NMR 
(200 MHz, CDCl3) δH: 7.95 (1H, s), 7.04 (1H, bs), 6.86 (1H, d, J = 8.1 Hz), 6.75 (1H, ddd, J = 
8.1, 2.0, 0.6 Hz), 4.71 (2H, d, J = 2.6 Hz), 2.53 (1H, t, J = 2.6 Hz), 2.30 (3H, s), 1.53 (9H, s). 
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13
C-NMR (50 MHz, CDCl3) δC: 153.0 (s), 144.7 (s), 132.0 (s), 128.6 (s), 122.7 (d), 119.4 (d), 
112.1 (d), 80.5 (s), 78.6 (s), 76.0 (d), 56.9 (t), 28.5 (q), 21.3 (q). MS m/z 284.1 [M+Na]
+ 
 
General procedure for the preparation of O-allenes 
 
A solution of the suitable tert-butyl (2-(prop-2-yn-1-yloxy)phenyl)carbamate (1 eq) in THF (10 
mL) was treated with t-BuOK (2.5 mmol). The resulting solution was stirred at rt for 1-3 min, 
then filtered on silica gel (AcOEt). The solvent was evaporated under reduced pressure and 
the residue was purified by silica gel flash chromatography. The products need to be stored at 
-18 °C. 
 
N-(tert-butoxycarbonyl)-O-(propa-1,2-dienyl)-2-aminophenol (4a) 
 
Yield: 84% Colourless oil. IR (νmax/cm
-1
): 3440, 2980, 2931, 1965, 1732, 1602, 1522. 
1
H-
NMR (200 MHz, CDCl3) δH: 8.11 (1H, d, J = 7.5 Hz), 7.09-6.94 (4H, m), 6.81 (1H, t, J = 5.9 
Hz), 5.48 (2H, d, J = 5.9 Hz), 1.52 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 202.7 (s), 152.8 
(s), 145.4 (s), 129.6 (s), 123.7 (d), 122.4 (d), 119.1 (d), 118.4 (d), 115.7 (d), 90.4 (t), 80.7 (s), 
28.6 (q). MS m/z 270.1 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-O-(propa-1,2-dienyl)-4-nitro-2-aminophenol tert-butyl (4b) 
 
Yield: 52% Orange solid. mp: 117-118 °C (Et2O) IR (νmax/cm
-1
): 3435, 2974, 2928, 2002, 
1733, 1541, 1343. 
1
H-NMR (200 MHz, CDCl3) δH: 9.06 (1H, d, J = 2.6 Hz),7.88 (1H, dd, J = 
9.0, 2.6 Hz), 7.13 (2H, d, J = 9.0), 6.84 (1H, t, J = 5.9 Hz), 5.56 (2H, d, J = 5.9 Hz),1.54 (9H, 
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s). 
13
C-NMR (50 MHz, CDCl3) δC: 202.7 (s),152.3 (s), 149.7 (s), 143.5 (s), 129.7 (s), 118.2 
(d), 116.7 (d), 114.2 (d), 113.8 (d), 91.2 (t), 81.9 (s), 28.5 (q). MS m/z 315.0 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-O-(propa-1,2-dien-1-yl)-4-chloro-2-aminophenol (4c) 
 
Yield: 66% Yellow oil. IR (νmax/cm
-1
): 3438, 2980, 2933, 1967, 1732, 1600, 1520. 
1
H-NMR 
(200 MHz, CDCl3) δH: 8.19 (1H, d, J = 2.0 Hz), 7.26 (1H, bs), 6.95–6.92 (2H, m), 6.78 (1H, t, 
J = 5.9 Hz), 5.48 (2H, d, J = 5.9 Hz), 1.53 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 202.4 (s), 
152.5 (s), 143.7 (s), 130.5 (s), 129.0 (s), 122.0 (d), 118.9 (d), 118.3 (d), 116.6 (d), 91.0 (t), 
81.3 (s), 28.5 (q). MS m/z 304.0 [M+Na]
+ 
 
N-(tert-butoxycarbonyl)-O-(propa-1,2-dien-1-yl)-4-methyl-2-aminophenol (4d) 
 
Yield: 70% Yellow oil. IR (νmax/cm
-1
): 3441, 2978, 2928,1965, 1730, 1602, 1530, 1467. 
1
H-
NMR (200 MHz, CDCl3) δH: 7.95 (1H, d, J = 1.3 Hz), 6.98 (1H, bs), 6.93 (1H, d, J = 8.1 Hz), 
6.79 (1H, t, J = 5.9 Hz), 6.75 (1H, dd, J = 8.1, 1.3 Hz), 5.45 (2H, d, J = 5.9 Hz), 2.30 (3H, s), 
1.53 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 202.6 (s), 152.9 (s), 143.2 (s), 133.6 (s), 129.2 
(s), 122.8 (d), 119.5 (d), 118.9 (d), 115.8 (d), 90.6 (t), 80.7 (s), 28.6 (q), 21.4 (q). MS m/z 
284.0 [M+Na]
+
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Aminoaniline derivatives 
N-(p-toluenesulfonyl)-2-nitro-aniline (III)
 46
 
 
To a stirred solution of 2-nitroaniline (8 g, 57.92 mmol, 1 eq) in dry pyridine (32 mL) p-
toluenesulfonylchloride (11 g, 57.92 mmol, 1 eq) was added over a 3 minute period at room 
temperature. The reaction mixture was stirred for 6 hours at 125 °C. The reaction mixture was 
concentrated under reduced pressure and the concentrate was poured into ice cold water (500 
mL). The resulting reddish brown solid precipitate was filtered, washed with water and dried. 
Crystallization from EtOH gave III (8.62 g, 29.49 mmol) as yellow needle shaped crystals. 
Yield: 51% mp: 112-113 °C (EtOH) 
1
H-NMR (200 MHz, CDCl3) δH: 9.85 (1H, s), 8.13-7.10 
(8H, m), 2.38 (3H, s). 
Data are consistent with literature. 
 
N-(p-toluenesulfonyl)-N-(prop-2-ynyl)-2-nitro-aniline (IV) 
 
N-(p-toluenesulfonyl)-2-nitro-aniline III (2.5 g, 8.56 mmol, 1 eq), prop-2-yn-1-ol (0.55 mL, 
9.42 mmol, 1.1 eq) and triphenylphosphine (3.368 g, 12.84 mmol, 1.5 eq) were suspended in 
anhydrous THF (50 mL) under inert atmosphere. The mixture was cooled to 0 °C and a 
solution of diisopropyl azodicarboxylate (2.49 mL, 12.84 mmol, 1.5 eq) in THF (10 mL) was 
added dropwise over a period of 30 minutes. The reaction mixture was allowed to warm to 
room temperature and stirred for 6 hours. After reaction completion, the solvent was removed 
under reduced pressure and the crude product was dissolved in CH2Cl2 (40 mL), washed 
sequentially with NaOH 2M (3 x 40 mL), HCl 1M (20 mL), saturated sodium bicarbonate 
                                                 
46
 Purushottamachar, P.; Khandelwal, A.; Vasaitis, T. S.; Bruno, R. D.; Gediyaa, L. K.; Njar, V. C. O. Bioorg. 
Med. Chem. 2008, 16, 3519. 
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solution (40 mL) and brine (3 x 40 mL). The organic phases were dried over anhydrous 
Na2SO4, filtered and the solvent was removed under reduced pressure. The crude product was 
purified by silica gel flash chromatography (CH2Cl2) to afford IV (2.68 g, 8.11 mmol) as 
yellow solid. 
Yield: 95% mp: 88 °C (Et2O) IR (νmax/cm
-1
): 3436, 3277, 2921, 2123, 1728, 1599, 1532. 
1
H-
NMR (200 MHz, CDCl3) δH: 7.89-7.85 (1H, m), 7.62-7.51 (4H, m), 7.38-7.34 (1H, m), 7.28-
7.24 (2H, m), 4.84-4.38 (2H, bs), 2.43 (3H, s), 2.26 (1H, t, J = 2.5 Hz). 
13
C-NMR (50 MHz, 
CDCl3) δC: 149.9 (s), 144.5 (s), 136.2 (s), 131.8 (s), 133.3 (d), 133.1 (d), 130.2 (d), 129.8 (d), 
128.1 (d), 125.4 (d), 78.3 (s), 74.6 (d), 41.3 (t), 21.8 (q). MS m/z 353.1 [M+Na]
+
 
 
N-(p-toluenesulfonyl)-N-(prop-2-ynyl)-2-amino-aniline (V) 
 
To a stirred suspension of N-(p-toluenesulfonyl)-N-(prop-2-ynyl)-2-nitro-aniline IV (2.68 g, 
8.11 mmol) in a mixture of glacial acetic acid (10 mL), ethanol (26 mL) and water (26 mL) 
was added reduced iron powder (1.81 g, 32.45 mmol). The resulting suspension was heated at 
reflux (85°C) for 3 hours. After reaction completion the mixture was filtered through a 
Celite® pad using AcOEt (400 mL) to remove the iron excess. The filtrate was washed with 
water (3 x 50 mL), dried over anhydrous Na2SO4, filtered and the solvent was removed under 
reduced pressure. The crude product was purified by silica gel flash chromatography (n-
hexane / AcOEt 4:1) to afford 8 (1.63 g, 5.43 mmol) as white crystal solid. 
Yield: 67% mp: 103 °C; IR (νmax/cm
-1
): 3446, 3362, 3303, 2921, 1911, 1617, 1498, 1335. 
1
H-
NMR (200 MHz, CDCl3) δH 7.66 (2H, d, J = 8.3 Hz, ArTs), 7.28 (2H, d, J = 8.3 Hz, ArTs), 
7.11 (1H, ddd, J = 8.2 Hz, 6.8 Hz, 1.4 Hz, Ar), 6.78 (1H, dd, J = 8.2 Hz, 1.4 Hz, Ar), 6.62-6.49 
(2H, m, Ar), 4.54 (1H, bd, J = 16.9 Hz, CH2), 4.23 (3H, m, CH2 and NH2), 2.44 (3H, s, CH3), 
2.16 (1H, t, J = 2.5 Hz, CH). 
13
C-NMR (50 MHz, CDCl3) δC: 146.5 (s), 144.1 (s), 135.8 (s), 
124.8 (s), 130.1 (d), 129.6 (d), 128.6 (d), 124.8 (d), 118.1 (d), 116.9 (d), 78.3 (s), 73.7 (d), 
41.0 (t), 21.8 (q).; MS m/z 301.0 [M]
+
 
 
N’-(p-toluenesulfonyl)-N’-(prop-3-ynyl)-2-amino-N-(tert-butoxycarbonyl)-aniline (15) 
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To a stirred solution of N-(p-toluenesulfonyl)-N-(prop-2-ynyl)-2-amino-aniline V (1.63 g, 5.43 
mmol, 1 eq) in THF (60 mL), 1.41 g of Boc2O (6.52 mmol, 1.2 eq) were added at room 
temperature. The reaction mixture was heated at reflux (90 °C) for 24 hours. Every 8 hours 
1.2 eq of Boc2O were added. After reaction completion the solvent was removed under 
reduced pressure, 20 mL of H2O were added to the residue and the solution was extracted with 
AcOEt (3 x 20 mL). The organic phases were dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure. The crude product was purified by silica gel flash 
chromatography (n-hexane/AcOEt 5:1) to afford 29 (2.16 g, 5.39 mmol) as white crystal solid. 
Yield: 67% mp: 127 °C (Et2O); IR (νmax/cm
-1
): 3395, 3266, 2999, 2968, 2930, 2120, 1722, 
1525, 1445, 1338. 
1
H-NMR (200 MHz, CDCl3) δH: 8.14 (1H, dd, J = 8.4, 1.3 Hz), 7.59 (2H, d, 
J = 8.3 Hz), 7.40 (1H, bs), 7.34-7.25 (3H, m, J = 8.3 Hz), 6.82 (1H, td, J = 7.7, 1.5 Hz), 6.66 
(1H, dd, J = 8.0, 1.5 Hz), 4.40 (1H, bs), 4.34 (1H, bs), 2.44 (3H, s), 2.17 (1H, t, J = 2.5 Hz), 
1.52 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 153.0 (s), 144.6 (s), 138.5 (s), 134.8 (s), 127.6 
(s), 130.1 (d), 130.0 (d), 128.8 (d), 128.7 (d), 122.6 (d), 120.8 (d), 80.9 (s), 77.6 (s), 73.4 (d), 
41.9 (t), 28.6 (q), 21.8 (q). MS m/z 423.2 [M+Na]
+
 
 
N’-(p-toluenesulfonyl)-N’-(propa-1,2-dienyl)-2-amino-N-(tert-butoxycarbonyl)-aniline (6) 
 
A stirred solution of N’-(p-toluenesulfonyl)-N’-(prop-3-ynyl)-2-amino-N-(tert-butoxycarbonyl) 
-aniline 15 (629 mg, 1.57 mmol, 1 eq) in THF (25 mL) was cooled to 0 °C with an ice bath. t-
BuOK (352 mg, 3.14 mmol, 2 eq) was added to the solution in one portion. The reaction 
mixture was stirred for 25 minutes. The crude mixture was filtered through a silica gel pad 
washing with AcOEt/MeOH (9:1) (150 ml). The solvent was removed under reduced pressure. 
The crude product was purified by silica gel flash chromatography (CH2Cl2) yelding 
compound 6 (414 mg, 1.07 mmol) as yellow solid. The product has to be stored in at -18 °C. 
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Yield: 68% mp: 125-126 °C (i-Pr2O). IR (νmax/cm
-1
): 3422, 2981, 1728, 1595, 1516, 1445, 
1355. 
1
H-NMR (200 MHz, CDCl3) δH: 8.17 (1H, dd, J = 8.4, 1.3 Hz), 7.60 (2H, d, J = 8.4 Hz), 
7.32-7.22 (3H, m), 7.18 (1H, bs), 7.10 (1H, t, J = 6.2 Hz), 6.75 (1H, td, J = 7.7, 1.5 Hz), 6.34 
(1H, dd, J = 8.0, 1.5 Hz), 5.02 (2H, d, J = 6.2 Hz), 2.46 (3H, s), 1.52 (9H, s). 
13
C-NMR (50 
MHz, CDCl3) δC: 201.2 (s), 152.8 (s), 144.7 (s), 138.0 (s), 134.6 (s), 125.4 (s), 130.1 (d), 129.5 
(d), 129.9 (d), 128.3 (d), 122.0 (d), 120.3 (d), 102.2 (d), 88.2 (t), 81.0 (s), 28.5 (q), 21.9 (q). 
MS m/z 423 [M+Na]
+
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Aliphatic derivatives 
 
For the studies to dihydroxazole, dihydroimidazole and isoxazolidine derivatives the 
precursors were synthetised following the scheme below. 
 
 
N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-1,2-amminoethanol (VI)
47
 
 
To a suspension of NaH (60% mineral oil, 1 eq) in THF at 0 °C was added a solution of N-
(tert-butyloxycarbonyl)-aminoethanol (3 g, 18.61 mmol, 1 eq) in 15 ml of DMF and stirred for 
30 minutes. Then a solution of propargylbromide (2 eq) in THF was added dropwise and the 
reaction was stirred overnight at room temprature. After reaction completion, 20 ml of water 
were added, extracted with CH2Cl2. The organic layers were then washed with brine, dried 
over Na2SO4, filtered and the solvent was removed under reduced pressure. The crude product 
was purified by silica gel flash chromatography (n-hexane / AcOEt 5:1) 
Yield: 85% Pale yellow oil. 
1
H-NMR (200 MHz, CDCl3) δH5.04 (1H, br s), 3.96 - 4.01 (2H, 
m), 3.43 (2H, t, J = 2.8 Hz), 3.17 (2H, br s), 2.35 (1H, s), 1.28 (9H, s); 
13
C-NMR (50 MHz, 
CDCl3): δC: 155.9 (s), 79.3 (s), 75.8 (s), 74.8 (d), 68.9 (t), 58.0 (t), 40.1 (t), 28.2 (q). MS (m/z): 
199 [M]
+ 
Data are consistent with literature. 
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 CTIBIO, Patent WO2009/113828 A2, 2009 
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N-(t-butoxycarbonyl)-O-(1,2-propadienyl)-aminoethanol (7) 
 
To a stirred solution of N-(tert-butoxycarbonyl)-O-(prop-2-ynyl)-1,2-amminoethanol VI (500 
mg, 2.53 mmol) in 40 mL of THF, t-BuOK (2 eq) was added and after 1 minute the mixture 
was filtered on a silica gel pad with AcOEt (250 ml) The solvent was removed under reduced 
pressure. The crude product was purified by silica gel flash chromatography (Petrol 
Ether/AcOEt 7:3) yelding compound 7 (382 mg, 1.92 mmol). 
Yield: 76% Colorless oil. IR (νmax/cm
-1
): 3287, 1956, 1704 
 1
H-NMR (200 MHz, CDCl3) δH 
6.66 (1H, t, J = 5.9 Hz), 5.37 (2H, d, J = 5.9 Hz), 4.98 (1H, br s), 3.55 (2H, dd, J = 10.2, 5.1 
Hz), 3.32 (2H, dd, J = 10.2, 5.1 Hz), 1.38 (9H, s); 
13
C-NMR (50MHz, CDCl3): δC: 200.9 (s), 
155.8 (s), 121.3 (d), 90.9 (t), 79.2 (s), 67.7 (t), 39.8 (t), 28.3 (q). MS (m/z): 199 [M]
+
 
 
N-(t-butoxycarbonyl)-N’-tosyl-propargylethylen-1,2-diamine (VII)
48
 
 
To a suspension of NaH (60% mineral oil, 178 mg, 2.72 mmol) in THF at 0 °C was added a 
solution of N-(tert-butyloxycarbonyl)-N-(p-toluenesulfonyl)-ethylendiamine (858 mg, 2.72 
mmol, 1 eq) in 7 ml of DMF and stirred for 30 minutes. Then a solution of propargylbromide 
(0.31 mL, 4.08 mmol, 2 eq) in THF (5 ml) was added dropwise and the reaction was stirred 
overnight at room temprature. After reaction completion, 5 ml of water were added and 
extracted with CH2Cl2. The organic layers were then washed with brine, dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. The crude product was purified 
by silica gel flash chromatography (Petrol Ether/AcOEt 8:2). 
Both the alkynyl (VII) and the allene (8) derivatives were formed. 
 
                                                 
48
 Li, H.; Widenhoefer, R. A. Org. Lett., 2009, 11, 2671 
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Yield: 31% Colorless oil. 
1
H-NMR (200 MHz, CDCl3) δH:7.71 (2H, d, J = 8.4 H) , 7.28 (2H, 
d, J = 8.4 Hz), 4.93 (1H, s), 4.14 (2H, d, J = 2.4 Hz,), 3.35-3.31 (4H, m), 2.41 (3H, s), 2.05 
(1H, t, J = 2.2 Hz), 1.44 (9H, s); 
13
C-NMR (50 MHz, CDCl3): δC: 156.2 (s), 143.9 (s), 137.9 
(s), 135.6 (d), 133.5 (d), 129.7 (d), 127.8 (d), 79.6 (s), 76.7 (s), 74.2 (d), 21.7 (q), 46.4 (t), 38.5 
(t), 37.3 (t), 28.5 (q). MS (m/z): 353 [M]
+
 
 
N-(t-butoxycarbonyl)-N’-tosyl-(1,2-propadienyl)-ethylendiamine (8) 
 
Yield: 63% Colorless oil. IR (νmax/ cm
-1
): 1950, 1634; 
1
H-NMR (200 MHz, CDCl3) δH 7.66 
(2H, d, J = 8.0 Hz), 7.30 (2H, d, J = 8.0 Hz), 6.83 (1H, t, J = 6.2 Hz), 5.34 (2H, dd, J = 12.6, 
6.2 Hz), 4.92 (1H, br s, 1H), 3.47 (2H, br s), 3.27 (2H, br s), 2.41 (3H, s), 1.45 (9H, s); 
13
C-
NMR (50 MHz, CDCl3) δC:  200.1(s), 154.6 (s), 143.9 (s), 134.5 (s), 129.8 (d), 129.2 (d), 
127.6 (d), 127.1 (d), 100.4 (d), 88.2 (t), 80.6 (s), 38.6 (t), 37.7 (t), 28.3 (q), 21.5 (q). MS (m/z): 
352 [M]
+
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Hydroxylamine derivatives 
 
For the studies to isoxazolidine derivatives the precursors were synthetised following the 
schemes below. 
 
 
 
 
2-(but-3-yn-1-yloxy) isoindoline-1,3-dione (VIII) 
 
To a stirred solution of 3-butyn-1-ol (1.5 g, 21.4 mmol) in THF (40 mL) under nitrogen 
atmosphere triphenylphosphine (6.74 g, 25.7 mmol) and N-hydroxyphtalimide (4.19 g, 25.7 
mmol) were added sequentially. The mixture was then cooled to 0 °C and a solution of 
diisopropyl azodicarboxylate (4.98 mL, 5.19 g, 25.7 mmol) in THF (5 mL) was added 
dropwise. After stirring the reaction at room temperature overnight, the solvent was removed 
under reduced pressure and the residue suspended with Et2O. The white precipitate was 
filtered off, the solvent removed and the crude mixture purified by silica gel chromatography 
(n-hexane/AcOEt 4:1) yielding the desired compound (4.45g, 20.66 mmol) as a white solid.  
Yield: 96.5%. White solid. mp 103 °C (Et2O); IR (νmax/cm
-1
): 3269, 2127, 1734;
 1
H-NMR 
(200 MHz, CDCl3) 7.90-7.68 (4H, m), 4.32-4.30 (2H, m), 2.73 (2H, td, J= 7.1, 2.7 Hz), 
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1.98 (1H, t, J= 2.7 Hz); 
13
C-NMR (50 MHz, CDCl3) δC: 163.9 (s), 134.9 (d), 129.3 (s), 124.0 
(d), 75.9 (t), 70.6 (d), 19.2 (t). MS (m/z): 215 [M]
+
 
 
O-(but-3-ynyl)-N-(tert-butoxycarbonyl)-hydroxylamine (IX) 
 
To a stirred solution of 2-(but-3-yn-1-yloxy)isoindoline-1,3-dione VIII (2.2 g, 10.6 mmol) in 
DCM (10 mL) 1.54 mL of hydrazine hydrate (1.59 g, 31.8 mmol) were added and the mixture 
was stirred at room temperature. After 1h30 the reaction mixture was filtered on a Celite® 
pad. 10 mL of water, solid NaOH (932 mg, 23.32 mmol) and Boc2O (2.77 g, 12.72 mmol) 
were then added to the filtrate and the mixture was stirred at room temperature overnight. 
After reaction completion, the layers were separated and extracted with AcOEt (3 x 20 mL). 
The combined organic phases were dried over anhydrous Na2SO4, filtered and the solvent 
removed under reduced pressure. The crude was then purified via silica gel chromatography 
(n-Hexane/AcOEt 5:1 the desired compound (1.62 g, 8.75 mmol) as a colorless oil. 
Yield: 82%; Colorless oil. IR (νmax/ cm
-1
): 3269, 2127, 1695; 
1
H-NMR (200 MHz, CDCl3) 
δH 7.18 (1H, br s),
 
3.97 (2H, t, J = 6.8 Hz), 2.56 (2H, t, J = 6.8 Hz), 1.99 (1H, t, J = 6.8 Hz), 
1.48 (9H, s); 
13
C-NMR (CDCl3) δC: 156.9 (s), 80.5 (s), 75.6 (d), 74.1 (t), 69.7 (t), 28.8 (q), 
18.3 (t). MS (m/z): 185 [M]
+
 
 
O-(penta-3,4-dien-1-yl)-N-(tert-butoxycarbonyl)-hydroxylamine (8) 
 
To a stirred solution of tert-butyl but-3-yn-1-yloxycarbamate (300 mg, 1.62 mmol) in dioxane 
(2 mL) under nitrogen atmosphere freshly distilled diisopropyl amine (0.46 mL, 328 mg, 3.24 
mmol) was added, followed by 97 g of paraformaldehyde (3.24 mmol) an 122 mg of CuI (0.81 
mmol). 
The mixture was then heated to 80 °C and stirred for 16h. The solvent was then removed and 
the residue purified by silica gel chromatography (n-Hexane/AcOEt 10:1) yielding the desired 
compound (93 mg, 0.45 mmol) as a pale yellow oil. 
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Yield 28%. Pale yellow oil. IR (νmax/ cm
-1
): 3315,1632,1564; 
1
H-NMR (200 MHz, CDCl3) δH 
7.30 (1H, br s), 5.14-5.07 (1H, m), 4.67 (2H, dt, J = 6.5, 3.1 Hz, 2H), 3.89 (2H, t, J = 6.7 Hz), 
2.35-2.28 (2H, m), 1.42 (9H, s); 
13
C-NMR (CDCl3) δC: 208.9 (s), 156.9 (s), 86.1 (d), 81.6 (s), 
75.6 (t), 75.1 (t), 28.2 (q), 27.1 (t). MS (m/z): 199 [M]
+
 
 
N-(tert-butoxycarbonyl)-O-(but-3-en-1-yl)-hydroxylamine 28
49
 
 
To a stirred suspension of NaH (60% on mineral oil, 71 mg, 1.8 mmol), in (THF 5 ml) under 
inert athmosphere at 0 °C, N-(tert-butoxycarbonyl)- hydroxylamine (200 mg, 1.5 mmol) was 
added. After 15 minutes a solution of 4-bromo-but-1-ene (0.17 ml, 227 mg, 1.65 mmol) was 
added dropwise and the reaction stirred at room temperature overnight. 
After reaction completion, the solvent was removed under reduced pressure, 10 ml NH4Cl 
solution added and exctracted with AcOEt (15 ml x 3).  
The combined organic phases were dried over anhydrous Na2SO4, filtered and the solvent 
removed under reduced pressure. The crude was then purified via silica gel chromatography 
(n-hexane/AcOEt :1) and the desired compound (112 mg, 0.61 mmol) was afforded as a 
colorless oil. 
Yield 40%. Colorless oil. 
1
H-NMR (200 MHz, CDCl3) δH 7.12 (1H, s), 5.83 (1H, ddt, J = 
16.9, 10.2, 6.7 Hz), 5.23–4.95 (2H, m), 3.91 (2H, t, J = 6.7 Hz), 2.40 (2H, qt, J = 6.7, 1.4 Hz), 
1.50 (9H, s).  
Data are consistent with literature. 
 
                                                 
49
 Lemen, G. S.; Giampietro, N. C.; Hay, M. B.; Wolfe, J. P. J. Org. Chem., 2009, 74, 2533–2540 
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Chapter 2: Hydroamination reactions 
General procedure for the hydroamination reactions on allene derivatives 
 
 
 
Catalyst Additive Solvent Temperature Time 
1 Pd(PPh
3
)
4  
8% mol --- Toluene 150 °C (MW) 60’ 
2 Pd(PPh3
)
4  
8% mol --- CH3
CN 120 °C (MW) 40’ 
3 Pd(PPh3
)
4  
8% mol --- THF 120 °C (MW) 40’ 
4 Pd(PPh3
)
4  
8% mol --- DMF 120 °C (MW) 40’ 
5 PdCl
2
(CH
3
CN)
2
 5% mol --- CH
3
CN 120 °C (MW) 40’ 
6 Pd2
(dba)
3  
5% mol --- THF 120 °C (MW) 40’ 
7 Pd(PPh3
)
4  
15% mol PPh
3
 10% mol Toluene 110°C 2-5h 
8 Pd(PPh3
)
4
  15% mol  PPh
3
 10% mol Toluene 90°C (MW) 40’ 
9 Pd(PPh
3
)
4
  8% mol PPh
3
 10% mol Toluene 90°C (MW) 40’ 
10 Pd(PPh3
)
4
  5% mol PPh
3
 5% mol Toluene 90°C (MW) 40’ 
 
Procedure with microwave irradiation 
A mixture of allene (0.4-1 mmol) and the suitable catalist dissolved in the suitable solvent 
(5 mL) were transferred in a microwave reactor and heated according to the data reported 
in the table above (temperature and time) under microwave irradiation maintaining the 
power between 400-500 W. The mixture was then filtered on a Celite® layer, the solvent 
was evaporated under reduced pressure and the crude residue was purified by flash 
chromatography.  
 
Procedure with conventional heating (entry 7) 
Pd(PPh3)4 (8% mol) and PPh3 (10% mol) were added to a solution of the suitable allene 
(0.4 mmol) in toluene (5 ml). The reaction mixture was stirred at reflux at 110 °C for 2-5h. 
The solvent was removed under reduced pressure and the crude product was purified by 
silica gel flash chromatography. 
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2-Methyl-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2a) 
 
Yield 71% (entry 1), Colorless oil; IR (νmax/cm
-1
):1645; 1H-NMR (400 MHz, CDCl3) δH: 
7.75 (1H, d, J=8.1Hz), 7.32-7.25 (2H, m), 7.10 (1H, dd, J = 7.8, 7.0 Hz), 6.92 (1H, s), 
5.96-5.88 (1H, m), 5.77-5.30 (3H, m), 3.07 (3H, s); 
13
C-NMR(100MHz,CDCl3) δC: 160.5 
(s), 133.5 (d), 133.0 (s), 131.9 (s), 131.4 (s), 124.4 (t), 123.8 (d), 123.6 (d), 121.0 (d), 110.1 
(d), 97.9 (d), 75.2 (d), 26.8 (q). MS (m/z) 212 [M]
+
. 
 
7-Methoxy-2-methyl-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2b)  
 
Yield: 67%. (entry 1). White solid. mp 138 °C (i-Pr2O). IR (νmax/cm
-1
): 1638; 
1
H-NMR 
(400 MHz, CDCl3) H: 7.16 (1H, d, J = 8.9 Hz), 7.13 (1H, d, J = 2.3 Hz), 6.91 (1H, dd, J = 
8.9, 2.3 Hz), 6.80 (1H, s), 5.89-5.85 (1H, m), 5.73-5.59 (3H, m), 3.83 (3H, s), 3.03 (3H, s); 
13
C-NMR (100 MHz, CDCl3) C 160.5 (s), 154.8 (s), 133.6 (d), 132.3 (s), 131.9 (s), 128.4 
(s), 124.3 (t), 115.1 (d), 110.8 (d), 103.9 (d), 97.3 (d), 75.1 (d), 55.7 (q), 26.7 (q). MS: 
(m/z) 242 [M]
+
.  
 
2,7-Dimethyl-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2c)  
  
Yield: 78%. (entry 1).White solid. mp 122 °C (i-Pr2O). IR (νmax/cm
-1
): 1655; 
1
H-NMR 
(400 MHz, CDCl3) : 7.51 (1H, s), 7.17 (1H, d, J = 8.5 Hz), 7.09 (1H, d, J = 8.5 Hz), 6.82 
(1H, s), 5.91-5.85 (1H, m), 5.74-5.60 (3H, m), 3.04 (3H, s), 2.44 (3H, s); 
13
C-NMR (100 
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MHz, CDCl3) C160.6 (s), 133.6 (d), 133.2 (s), 132.2 (s), 131.5 (s), 130.3 (s), 125.6 (d), 
124.2 (t), 122.9 (d), 109.7 (d), 97.2 (d), 75.1 (d), 26.7 (q), 21.4 (q). MS: (m/z) 226 [M]
+
.  
 
7-Chloro-2-methyl-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2d)  
 
Yield: 85% (entry 1). White solid. mp 144 °C (i-Pr2O). IR (νmax/cm
-1
): 1632; 
1
H-NMR 
(400 MHz, CDCl3) : 7.67 (1H, s), 7.17 (2H, s), 6.79 (1H, s), 5.93-5.60 (4H, m), 3.04 
(3H, s); 
13
C-NMR (100 MHz, CDCl3) C 160.0 (s), 133.1 (d), 132.7 (s), 132.6 (s), 131.2 
(s), 126.6 (s), 124.8 (t), 124.3 (d), 122.6 (d),  111.0 (d), 97.2 (d), 75.1 (d), 26.8 (q). MS: 
(m/z) 246 [M]
+
.  
 
2-Methyl-5-nitro-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2e) 
 
Yield: 58% (entry 1). White solid. mp 170 °C (i-Pr2O). IR (νmax/cm
-1
): 1652; 
1
H-NMR 
(400 MHz, CDCl3) : 8.11 (1H, d, J = 8.0 Hz), 8.06 (1H, d, J = 7.9 Hz), 7.27 (1H, dd, J = 
7.9, 8.0 Hz), 7.09 (1H, s), 6.37 (1H, d, J = 7.6 Hz), 5.61-5.51 (2H, m), 5.45-5.37 (1H, m), 
3.12 (3H, s); 
13
C-NMR (100 MHz, CDCl3) C 158.9 (s), 136.1 (s), 135.2 (s), 135.1 (s), 
133.3 (d), 130.7 (d), 125.1 (s), 124.1 (t), 121.6 (d), 120.3 (d), 99.3 (d), 76.8 (d), 27.0 (q). 
MS: (m/z) 257 [M]
+
. 
 
2-Benzyl-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2f)  
 
Yield: 63% (entry 1). White solid. mp 111 °C (i-Pr2O). IR: 1648 cm
-1
; 
1
H-NMR (400 
MHz, CDCl3) H: 7.75 (1H, d, J = 8.0 Hz), 7.36-7.17 (8H, m), 6.98 (1H, s), 5.77-5.64 (4H, 
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m), 5.35 (1H, d, J = 15.2 Hz), 4.14 (1H, d, J = 15.2 Hz); 
13
C-NMR (100 MHz, CDCl3) 
C160.3 (s), 136.2 (s), 133.4 (d), 133.0 (s), 131.9 (s), 131.1 (s), 128.9 (d),  128.3 (d), 
128.0 (d), 124.5 (t), 123.9 (d), 123.6 (d), 121.0 (d), 110.1 (d), 98.2 (d), 72.9 (d), 43.6 (t). 
MS: (m/z) 288 [M]
+
.  
 
2-(4-Methoxybenzyl)-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2g)  
 
Yield: 89% (entry 1).White solid. mp 113 °C (i-Pr2O). IR (νmax/cm
-1
): 1659; 
1
H-NMR 
(400 MHz, CDCl3) H: 7.74 (1H, d, J = 8.0 Hz), 7.26-7.22 (4H, m), 7.18-7.14 (1H, m), 
6.96 (1H, s), 6.89-6.87 (2H, m), 5.73-5.64 (4H, m), 5.27 (1H, d, J = 15.0 Hz), 4.08 (1H, d, 
J = 15.0 Hz), 3.79 (3H, s); 
13
C NMR (100 MHz, CDCl3) C 160.3 (s), 159.3 (s), 133.4 (d), 
133.0 (s), 131.8 (s), 131.3 (s), 129.7 (d), 128.3 (s), 124.5 (t), 123.9 (d), 123.5 (d), 121.0 (d), 
114.3 (d), 110.1 (d), 98.1 (d), 72.8 (d), 55.3 (q), 43.1 (t). MS: (m/z) 318 [M]
+
.  
 
2-(4-Methylbenzyl)-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2h)  
 
Yield: 69% (entry 1). White solid. mp 138 °C (i-Pr2O). IR (νmax/cm
-1
): 1648; 
1
H-NMR 
(400 MHz, CDCl3) H: 7.77-7.74 (1H, m), 7.27-7.15 (7H, m), 6.98 (1H, s), 5.82-5.63 (4H, 
m), 5.32 (1H, d, J = 15.1 Hz), 4.10 (1H, d, J = 15.1 Hz), 2.36 (3H, s); 
13
C-NMR (100 
MHz, CDCl3) C160.3 (s), 137.7 (s), 133.4 (d), 133.2 (s), 133.0 (s), 131.9 (s), 131.2 (s),  
129.7 (d), 128.3 (d), 124.5 (t), 123.9 (d), 123.5 (d), 121.0 (d), 110.1 (d), 98.1 (d), 72.8 (d), 
43.4 (t), 21.1 (q). MS: (m/z) 302 [M]
+
.  
 
2-(4-Chlororbenzyl)-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2i)  
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Yield: 85% (entry 1). White solid. mp 131 °C (i-Pr2O). IR (νmax/cm
-1
): 1650; 
1
H-NMR 
(400 MHz, CDCl3) H: 7.75 (1H, d, J = 8.0 Hz), 7.35-7.30 (2H, m), 7.27-7.24 (4H, m), 
7.20-7.16 (1H, m), 6.98 (1H, s), 5.82-5.63 (4H, m), 5.24 (1H, d, J = 15.4 Hz), 4.16 (1H, d, 
J = 15.4 Hz); 
13
C-NMR (100 MHz, CDCl3) C 160.3 (s), 134.8 (s), 133.9 (s), 133.3 (d), 
133.1 (s), 131.8 (s), 130.8 (s), 129.7 (d), 129.1 (d), 124.7 (t), 124.1 (d), 123.6 (d), 121.1 
(d), 110.1 (d), 98.4 (d), 73.0 (d), 43.0 (t). MS: (m/z) 322 [M]
+
.  
 
2-(Tiophen-2-ylmethyl)-3-vinyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2j)  
 
Yield: 72% (entry 1). White solid. mp 112 °C (i-Pr2O). IR (νmax/cm
-1
): 1656; 
1
H-NMR 
(400 MHz, CDCl3) : 7.74 (1H, d, J = 8.0 Hz), 7.27-7.23 (3H, m), 7.19-7.15 (1H, m), 
7.05-7.04 (1H, m), 6.99-6.97 (2H, m), 5.90-5.67 (1H, d, J = 16.4 Hz), 5.40 (1H, d, J = 15.7 
Hz), 4.38 (1H, d, J = 15.7 Hz); 
13
C-NMR (100 MHz, CDCl3) C: 159.9 (s), 138.5 (s), 
133.2 (d), 133.1 (s), 131.8 (s), 130.9 (s), 127.3 (d), 127.1 (d), 126.0 (d), 124.9 (t), 124.0 
(d), 123.6 (d), 121.1 (d), 110.1 (d), 98.4 (d), 72.8 (d), 38.0 (t). MS: (m/z) 294 [M]
+
.  
 
3-(1-Deutheriumvinyl)-2-methyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (2k)  
 
Yield: 68% (entry 1). Colorless oil. IR: 1639 cm
-1
; 
1
H-NMR (400 MHz, CDCl3) H: 7.76-
7.73 (1H, m), 7.30-7.19 (3H, m), 6.90 (1H, s), 5.92-5.89 (1H, m), 5.75-5.70 (2H, m), 3.07 
(3H, s); 
13
C-NMR (100 MHz, CDCl3) C: 158.5 (s), 133.5 (s), 132.9 (s), 131.7 (s), 124.3 
Experimental section 
_________________________________________________________________________ 
101 
 
(t), 123.8 (d), 123.6 (d), 123.2 (s), 121.0 (d), 110.3 (d), 97.9 (d), 75.1 (d), 26.8 (q). MS: 
(m/z) 213 [M]
+
.  
 
4-Hydroxy-2,4-dimethyl-3,4-dihydropyrazino-[1,2-a]indol-1(2H)-one (3). 
  
A mixture of allenamide 1 (1 mmol) in toluene (10 mL) was heated at 150 °C for 1 h under 
microwave irradiation, or refluxed for 24 h, then filtered on a Celite® layer. The solvent 
was evaporated under reduced pressure and the crude residue was purified by flash 
chromatography. 
Yield 41%. White solid, mp 134 °C (i-Pr2O); IR 3313, 1652 cm-1; 
1
H-NMR (400 MHz, 
CDCl3) δH: 7.83 (1H, d, J = 8.5 Hz), 7.52 (1H, d, J = 7.9 Hz), 7.22 (1H, dd, J = 7.9, 7.4 
Hz), 7.10 (1H, dd, J = 8.5, 7.4 Hz), 7.03 (1H, s), 4.92 (1H, br s), 3.67 (1H, d, J = 12.6 Hz), 
3.49 (1H, d, J = 12.6 Hz), 2.93 (3H, s), 1.78 (3H, s). 
13
C-NMR (100 MHz, CDCl3) δC: 
160.1 (s), 135.8 (s), 128.2 (s), 128.1 (s), 124.7 (d), 122.6 (d), 120.9 (d), 113.3 (d), 108.0 
(d), 82.9 (s), 60.7 (t), 34.1 (q), 24.7 (q). MS: (m/z) 230 [M]
+
.  
 
N-(tert-Butoxy carbonyl) 2-vinyl-2,3-dihydro-benzo[d]oxazole (5a) 
 
Yield 70% (entry 5). Colourless oil. IR (max/cm
-1
): 3417, 2978, 2103, 1711, 1490. 
1
H-
NMR (300 MHz, DMSO) H: 7.36 (1H, bs), 6.95-6.84 (3H, m), 6.47 (1H, d, J = 6.1 Hz), 
5.96 (1H, ddd, J = 16.9, 10.3 Hz, 6.1 Hz), 5.50 (1H, d, J = 16.9, Hz), 5.39 (1H, d, J = 10.3 
Hz), 1.49 (9H, s). 
13
C-NMR (75 MHz, DMSO) C: 150.5 (s), 150.2 (s), 133.8 (d), 129.7 
(s), 124.1 (d), 122.1 (d), 120.6 (t), 114.4 (d), 109.5 (d), 93.8 (d), 82.6 (s), 28.7 (q). MS 
(m/z) 270.1 [M+Na]
+
 
 
N-(tert-Butoxy carbonyl) 5-nitro-2-vinyl-2,3-dihydro-benzo[d]oxazole (5b) 
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Yield: 40% (entry 9). Colorless oil. IR (max/cm
-1
): 3413, 3131, 2980, 2931, 2853, 2425, 
2303, 1875, 1721, 1600, 1525, 1493. 
1
H-NMR (200 MHz, CDCl3) H: 8.30 (1H, br s), 7.92 
(1H, dd, J = 8.7, 2.4 Hz), 6.80 (1H, d, J = 8.7 Hz), 6.52 (1H, br d, J = 6.0 Hz), 5.96 (1H, 
ddd, J = 16.5, 10.2, 6.0 Hz), 5.57 (1H, d, J = 16.5, Hz), 5.44 (1H, d, J = 10.2 Hz), 1.57 
(9H, s). 
13
C-NMR (50 MHz, CDCl3) C: 155.5 (s), 149.8 (s), 142.9 (s), 132.1 (d), 130.8 
(s), 121.8 (d), 120.8 (t), 109.8 (d), 108.1 (d), 95.9 (d), 83.8 (s), 28.4 (q). 21b, MS (m/z) 
315.1 [M+Na]
+
 
 
N-(tert-Butoxy carbonyl) 5-chloro-2-vinyl-2,3-dihydro-benzo[d]oxazole (5c) 
 
Yield 91% (entry 7). Colourless oil. IR (max/cm
-1
): 2979, 2932, 1716, 1599, 1489, 1430, 
1383, 1297. 
1
H-NMR (200 MHz, CDCl3) H: 7.50 (1H, br s), 6.85 (1H, dd, J = 8.4, 2.2 
Hz), 6.66 (1H, d, J = 8.4 Hz), 6.38 (1H, br d, J = 6.4 Hz), 5.94 (1H, ddd, J = 17.0, 10.8, 6.4 
Hz), 5.52 (1H, d, J = 17.0 Hz), 5.38 (1H, d, J = 10.8 Hz), 1.55 (9H, s). 
13
C-NMR (50 
MHz, CDCl3) C: 150.1 (s), 149.2 (s), 130.6 (s), 126.4 (s), 132.7 (d), 119.9 (t), 122.9 (d), 
114.7 (d), 109.3 (d), 94.6 (d), 83.0 (s), 28.5 (q). MS (m/z) 304 [M+Na]
+
 
 
N-(tert-Butoxy carbonyl) 5-methyl-2-vinyl-2,3-dihydro-benzo[d]oxazole-3(2H) (5d) 
 
Yield 71% (entry 7). Yellow oil. IR (max/cm
-1
): 2977, 2930, 1713, 1645, 1498, 1388. 
1
H-
NMR (200 MHz, CDCl3) H: 7.65 (1H, br s), 6.72-6.63 (2H, m), 6.34 (1H, br d, J = 5.4 
Hz), 5.94 (1H, ddd, J = 17.0, 10.7, 6.0 Hz), 5.51 (1H, d, J = 17.0 Hz), 5.35 (1H, d, J= 10.7 
Hz), 2.28 (3H, s), 1.55 (9H, s). 
13
C-NMR (50 MHz, CDCl3) C: 150.4 (s), 148.3 (s), 131.1 
(s), 129.4 (s), 133.1 (d), 119.4 (t), 123.5 (d), 115.1 (d), 108.4 (d), 93.8 (d), 82.4 (s), 28.5 
(q), 21.4 (q). MS (m/z) 262 [M+H]
+
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N-(tert-Butoxy carbonyl)-N’-tosyl-2-vinyl-2,3-dihydro-1H-benzo[d]imidazole (9) 
 
Yield 79% (entry 7). Yellow oil. IR (max/cm
-1
): 3645, 3412, 3069, 2979, 2932, 1919, 
1714, 1598, 1486, 1385. 
1
H-NMR (200 MHz, CDCl3) H: 7.62-6.99 (8H, m), 6.22 (1H, 
m), 5.85 (1H, ddd, J = 17.0, 10.1, 4.7 Hz), 5.46 (1H, d, J = 17.0 Hz), 5.27 (1H, dt, J = 10.1, 
1.1 Hz), 2.32 (3H, s), 1.42 (9H, s). 
13
C-NMR (50 MHz, CDCl3) C: 150.2 (s), 144.7 (s), 
134.3 (s), 133.5 (s), 131.6 (s), 118.1 (t), 132.9 (d), 129.7 (d), 127.5 (d), 126.7 (d), 123.5 
(d), 119.1 (d), 115.5 (d), 77.3 (d), 82.3 (s), 28.4 (q), 21.6 (q). MS (m/z) 423 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)–2-vinyloxazolidine (10) 
 
Yield 76% (entry 5). Colorless oil- IR (νmax/cm
-1
): 1685. 
1
H-NMR (200 MHz, CDCl3) 
H 5.77-5.70 (1H, m), 5.40-5.29 (2H, m), 5.21 (1H, d, J = 10.3 Hz), 3.98-3.89 (2H, m), 
3.60-3.56 (1H, m), 3.35-3.30 (1H, m), 1.40 (9H, s) 
13
C-NMR (50 MHz, CDCl3) C: 
152.9 (s), 134.7 (d), 117.7 (t), 80.2 (s), 88.2 (d), 65.3 (t), 44.2 (t), 28.3 (q),MS (m/z): 
199 [M]
+
 
 
N-(tert-butoxycarbonyl)–N’-(p-toluenesulfonyl)-2-vinylimidazolidine (11) 
  
Yield 61% (entry 5) Colorless oil. IR (νmax/cm
-1
): 1689 
1
H-NMR (200 MHz, CDCl3) H 
7.31 (2H, d, J = 8.2 Hz), 7.28 (br s, 2H), 5.83-5.76 (2H, m), 5.33 (1H, d, J = 16.8 Hz), 
5.24 (1H, d, J = 9.8 H), 3.72 (1H, br s), 3.42-3.49 (1H, m), 3.15 (1H, t, J = 6.9 Hz),2.93 
(1H, br s), 2.42 (3H, s), 1.45 (9H, s). 
13
C-NMR (50 MHz, CDCl3) C: 152.2 (s), 144.4 
(s), 133.9 (s), 129.9 (d), 129.7 (d), 127.4 (d), 127.1 (d), 116.9 (t), 80.7 (s), 73.2 (d), 45.4 
(t), 43.3 (t), 28.3 (q), 21.6 (q). MS (m/z) 341 [M]
+
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N-(tert-butyl carbonyl) 3-vinylisoxazolidine (13) 
 
Yield 74% (entry 5). Colorless oil. IR (νmax/cm
-1
): 1689 
1
H-NMR (200 MHz, CDCl3) 
H 5.82 (1H, ddd, J= 16.9, 10.1, 6.5 Hz), 5.27 (1H, d, J = 16.9 Hz), 5.12 (1H, d, J = 10.1 
Hz), 4.59 (1H, dd, J = 13.8, 6.5 Hz), 4.06 (1H, td, J = 7.8, 4.2 Hz), 3.78 (1H, dd, J = 
15.3, 7.8 Hz), 2.56-2.37 (1H, m), 2.17-1.96 (1H, m), 1.50 (9H, s). 
13
C-NMR (50 MHz, 
CDCl3) C: 157.3 (s). 137.7 (d), 115.8 (t), 82.2 (s), 68.9 (t), 61.2 (d), 35.4 (t), 28.5 (q), 
MS (m/z): 199 [M]
+
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General procedure for the Pd-catalyzed hydroamination reactions on alkyne 
derivatives 
 
 
 
Pd(PPh3)4 (8% mol) and PPh3 (10% mol) were added to a solution of the suitable propargyl 
derivative (0.4 eq) in toluene (5 mL) under nitrogen atmosphere. The reaction mixture was 
stirred at reflux at 90 °C for 4h. The reaction mixture was filtered under reduced pressure 
through a Celite® pad washing with AcOEt. The solvent was removed under reduced 
pressure and the crude purify by silica gel chromatography. (n-hexane/AcOEt 10:1) 
 
N-(tert-butoxycarbolnyl)-3-methylene-3,4-dihydro-2H-benzo[b][1,4]oxazine (16a) 
 
Yield: 58%. Yellow oil. IR (νmax/cm
-1
): 3433, 3058, 2979, 2932, 2870, 1717, 1602, 1494. 
1
H-NMR (200 MHz, CDCl3) H: 7.01-6.76 (4H, m), 5.34 (1H, s), 5.13 (1H, s), 4.56 (2H, 
s), 1.53 (9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 152.0 (s), 147.2 (s), 133.7 (s), 131.6 (s), 
24.7 (d), 123.6 (d), 120.9 (d), 117.1 (d), 107.9 (t), 82.5 (s), 69.8 (t), 28.4 (q). MS (m/z) 
270.1 [M+Na]
+
, 249.0 [M]
+
 
 
N-(tert-buoxycarbonyl)-3-methylene-6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine 
(16b) 
 
Yield: 76%. Orange oil. IR (νmax/cm
-1
): 3436, 3128, 2986, 2923, 2851, 2626, 1926, 1721, 
1588, 1513; 
1
H-NMR (200 MHz, CDCl3) H: 8.76 (1H, d, J = 2.7 Hz), 7.89 (1H, dd, J = 
9.0, 2.7 Hz), 6.93 (1H, d, J = 9.0 Hz), 5.43 (1H, s), 5.35 (1H, s), 4.66 (2H, s), 1.57 (9H, s); 
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13
C-NMR (50 MHz, CDCl3) C: 152.4 (s), 151.6 (s), 143.0 (s), 134.0 (s), 129.6 (s), 120.3 
(d), 119.6 (d), 117.3 (d), 111.5 (t), 81.8 (s), 69.7 (t), 28.5 (q). MS m/z 315.0 [M+Na]
+
 
 
N-(tert-buoxycarbonyl)-3-methylene-6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine 
(16c) 
 
Yield: 45%. IR (νmax/cm
-1
): 3422, 3086, 2979, 2930, 2333, 1858, 1719, 1601; 
1
H-NMR 
(200 MHz, CDCl3) H: 7.79 (1H, m, d, J = 2.4 Hz), 6.94 (1H, dd, J = 8.7, 2.4 Hz), 6.79 
(1H, d, J = 8.7 Hz), 5.35 (1H, d, J = 0.5 Hz), 5.19 (1H, d, J = 0.5 Hz), 4.54 (2H, d, J = 0.5 
Hz), 1.54 (9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 151.5 (s), 145.5 (s), 135.7 (s), 127.7 (s), 
125.7 (s), 124.5 (d), 123.2 (d), 118.0 (d) 109.0 (t), 83.0 (s), 69.5 (t), 28.3 (q). MS (m/z) 
281.0 [M]
+
 
 
N-(tert-buoxycarbonyl)-3-methylene-6-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine 
(16d) 
 
Yield: 70%. IR (νmax/cm
-1
): 3432, 3056, 2977, 2928, 1715; 
1
H-NMR (200 MHz, CDCl3) 
H: 7.53 (1H, s), 6.95-6.67 (2H, m), 5.34 (1H, s), 5.15 (1H, s), 4.54 (2H, d, J = 0.6 Hz), 
2.30 (3H, s), 1.54 (9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 152.0 (s), 145.0 (s), 136.9 (s), 
133.8 (s), 126.8 (s), 125.3 (d), 123.8 (d), 116.7 (d), 107.6 (t), 82.4 (s), 69.8 (t), 28.4 (q), 
21.13 (q). MS (m/z) 279.0 [M+H2O]
+ 
 
tert-Butyl 2-methylene-4-tosyl-3,4-dihydroquinoxaline-1(2H)-carboxylate (17) 
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Yield: 83%. IR (νmax/cm
-1
): 3422, 2979, 2330, 1920, 1720; 
1
H-NMR (200 MHz, CDCl3) 
H: 7.71-7.38 (4H, m), 7.26-7.13 (4H, m), 5.14 (1H, d, J = 0.8 Hz), 4.53 (1H, d, J = 0.8 
Hz), 4.36 (2H, s), 2.30 (3H, s), 1.34 (9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 151.8 (s), 
143.7 (s), 138.5 (s), 134.7 (s), 133.8 (s), 131.7 (s), 129.6 (d), 127.7 (d), 127.4 (d), 126.6 
(d), 124.8 (d), 124.7 (d), 98.8 (t), 82.6 (s), 53.1 (t), 28.1 (q), 21.8 (q). MS m/z 423.0 
[M+Na]
+
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General procedure for the Pt-catalyzed hydroamination reactions on alkyne 
derivatives. 
 
 
PtCl2(CH3CN)2 (5% mol) and PPh3 (10% mol) were added to a solution of the suitable 
propargyl derivative (0.4 eq) in toluene (5 mL) under nitrogen atmosphere. The reaction 
mixture was stirred at reflux at 90 °C for 4-24h. The reaction mixture was filtered under 
reduced pressure through a Celite® pad washing with AcOEt. The solvent was removed 
under reduced pressure and the crude purify by silica gel chromatography. (n-
hexane/AcOEt 10:1) 
 
N-(tert-butoxycarbonyl)-2,5-dihydrobenzo[b][1,4]oxazepine (19a) 
(major isomer) 
 ab255 
Yield: 40%. Colorless oil. IR (νmax/cm
-1
): 3425, 2970, 1920, 1720; 
1
H-NMR (200 MHz, 
CDCl3) H: 7.91 (1H, d, J = 8.2 Hz), 6.93 (1H, br s), 6.84 (1H, t, J = 7.9 Hz), 6.64 (1H, dd, 
J = 7.5, 1.4 Hz), 6.41 (1H, dt, J = 9.9, 1.8 Hz), 5.76 (1H, dt, J = 9.9, 3.5 Hz), 4.83 (2H, dd, 
J = 3.5, 1.9 Hz), 1.54 (9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 152.9 (s), 141.8 (s), 127.1 
(s), 124.9 (d), 123.3 (d), 121.6 (d), 121.4 (d), 120.3 (d), 118.7 (d), 80.5 (s), 66.0 (t), 28.6 
(q). MS (m/z) 270.0 [M+Na]
+
  
 
N-(tert-butoxycarbonyl)-7-chloro-2,5-dihydrobenzo[b][1,4]oxazepine (19c)  
(major isomer)  
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Yield: 15% Colorless oil. IR (νmax/cm
-1
): 3432, 2979, 2930, 1728; 
1
H-NMR (200 MHz, 
CDCl3) H: 7.99 (1H, s), 6.94 (1H, s), 6.63 (1H, d, J = 2.5 Hz), 6.34 (1H, dt, J = 9.9, 1.9 
H), 5.81 (1H, dt, J = 9.9, 3.5 Hz), 4.84 (2H, dd, J = 3.5, 1.9 Hz), 1.54 (9H, s); 
13
C-NMR 
(50 MHz, CDCl3) C: 152.58 (s), 140.12 (s), 128.8 (d), 126.6 (s), 124.1 (d), 122.8 (d), 
122.6 (s), 119.7 (d), 118.2 (d), 81.1 (s), 66.1 (t), 28.52 (q). MS (m/z) 304.0 [M+Na]
+
  
 
N-(tert-butoxycarbonyl)-7-methy-2,5-dihydrobenzo[b][1,4]oxazepine (19d)  
(major isomer) 
 
Yield: 60%. Yellow oil. IR (νmax/cm
-1
): 3436, 2977, 2920, 1728; 
1
H-NMR (200 MHz, 
CDCl3) H: δ 7.72 (1H, d, J = 16.2 Hz), 7.00–6.76 (1H, m), 6.46 (1H, s), 6.37 (1H, dt, J = 
9.8, 1.7 Hz), 5.75 (1H, dt, J = 9.8, 3.5 Hz), 4.79 (2H, dd, J = 3.5, 1.8 Hz) 2.24 (3H, s), 1.53 
(9H, s); 
13
C-NMR (50 MHz, CDCl3) C: 153.0 (s), 139.7 (s), 130.9 (s), 130.0 (d), 126.7 
(s), 125.0 (d), 121.8 (d), 120.8 (d), 119.0 (d), 80.5 (s), 65.9 (t), 28.5 (q), 21.2 (q). MS (m/z) 
384.0 [M+Na]
+
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Chapter 3: Domino reactions 
 
General procedure for the carboamination reaction 
 
 
K2CO3 (4 mmol), aryl iodide (1.5 mmol), and Pd(PPh3)4 (5% mol) were added to a solution 
of allenamide (1 mmol) in acetonitrile (10 mL). The resulting solution was heated at reflux 
for 2-8 h. The solvent was evaporated under reduced pressure, then the resulting crude 
mixture was diluted with brine and extracted with AcOEt (3 x 20 mL). The organic phase 
was dried over Na2SO4 and the product was purified by flash chromatography. 
 
2-Methyl-3-(1-phenylvinyl)-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (21a) 
 
Yield 74%. White solid. mp 178 °C (i-Pr2O); IR (νmax/cm
-1
):1670; 
1
H-NMR (400 MHz, 
CDCl3) δH: 7.76 (1H, d, J = 8.0Hz), 7.34 (1H, d, J = 8.2 Hz), 7.27-7.24 (1H, m), 7.19-7.16 
(2H, m), 7.10 (2H, dd, J = 7.7 Hz, 7.2 Hz), 6.90 (1H, s), 6.73 (2H, d, J = 7.4 Hz), 6.01 
(1H, s), 5.86 (1H, s), 5.82 (1H, s), 2.99 (3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 161.0 
(s), 144.2 (s), 135.9 (s), 133.2 (s), 132.1 (s), 132.0 (s), 128.9 (d), 128.8 (d), 127.1 (d), 124.2 
(d), 123.8 (d), 123.6 (t), 121.3 (d), 110.5 (d), 98.3 (d), 77.5 (d), 27.1 (q). MS (m/z) 288 
[M]
+
. 
 
3-(1-(4-Methoxyphenyl)vinyl)-2-methyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one 
(21b) 
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Yield: 88%. White solid. mp 140 °C (i-Pr2O). IR (νmax/cm
-1
): 1666; 
1
H-NMR (400 MHz, 
CDCl3) H: 7.74 (1H, d, J = 8.0 Hz), 7.35 (1H, d, J = 8.2 Hz), 7.25 (1H, dd, J = 8.2 Hz, 7.6 
Hz), 7.17 (1H, dd, J = 8.0 Hz, 7.6 Hz), 6.91 (1H, s), 6.79-6.62 (4H, m), 6.03 (1H, s), 5.80 
(1H, s), 5.77 (1H, s), 3.68 (3H, s), 2.99 (3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 160.8 
(s), 159.8 (s), 143.3 (s), 133.0 (s), 131.8 (s), 128.6 (s), 128.0 (d), 127.8 (s), 123.9 (d), 123.6 
(d), 122.3 (t), 121.0 (d), 114.0 (d), 110.3 (d), 97.9 (d), 77.4 (d), 55.1(q), 26.8 (q). MS: (m/z) 
318 [M]
+
.  
 
2-Methyl-3-(1-(4-nitrophenyl)vinyl)-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (21c)  
 
Yield: 68%. White solid. mp 190 °C (i-Pr2O). IR (νmax/cm
-1
): 1654; 
1
H-NMR (400 MHz, 
CDCl3) H: 7.93 (2H, d, J = 8.7 Hz), 7.73 (1H, d, J = 8.0 Hz), 7.33 (1H, d, J = 8.1 Hz), 
7.27 (1H, dd, J = 8.2 Hz, 7.1 Hz), 7.18 (1H, dd, J = 8.0 Hz, 7.1 Hz), 6.89 (1H, s), 6.84 (2H, 
d, J = 8.7 Hz), 6.09 (1H, s), 6.07 (1H, s), 5.94 (1H, s), 3.03 (3H, s); 
13
C-NMR (100 MHz, 
CDCl3) δC: 160.6 (s), 147.8 (s), 142.5 (s), 142.0 (s), 132.8 (s), 131.9 (s), 131.3 (s), 127.9 
(d), 125.9 (t), 124.5 (d), 123.9 (d), 123.7 (d), 121.4 (d), 109.9 (d), 98.6 (d), 76.9 (d), 26.9 
(q). MS: (m/z) 333 [M]
+
. 
 
2-Methyl-3-(1-(4-ethoxycarbonylphenyl)vinyl)-2,3-dihydroimidazo[1,5-a]indol-1-one 
(21d)  
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Yield: 72%. Yellow oil. IR (νmax/ cm
-1
): 1659; 
1
H-NMR (400 MHz, CDCl3) H: 7.76 (2H, 
d, J = 8.5 Hz), 7.71 (1H, d, J = 8.0 Hz), 7.29 (1H, d, J = 8.2 Hz), 7.23 (1H, dd, J = 6.9 Hz, 
8.2 Hz), 7.16 (1H, dd, J = 6.9 Hz, 8.0 Hz), 6.87 (1H, s), 6.75 (2H, d, J = 8.5 Hz), 5.95 (1H, 
s), 5.92 (1H, s), 5.85 (1H, s), 4.27 (2H, q, J = 7.1 Hz), 2.97 (3H, s), 1.30 (3H, t, J = 7.1 
Hz); 
13
C-NMR (100 MHz, CDCl3) δC: 165.9 (s), 160.6 (s), 143.2 (s), 140.0 (s), 132.9 (s), 
131.8 (s), 131.6 (s), 130.5 (s), 129.7 (d), 126.9 (d), 124.7 (t), 124.2 (d), 123.6 (d), 121.2 
(d), 110.1 (d), 98.2 (d), 76.9 (d), 61.0 (t), 26.8 (q), 14.2 (q). MS: (m/z) 360 [M]
+
.  
 
3-(1-(4-Acetylphenyl)vinyl)-2-methyl-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one (21e) 
 
Yield: 76%. Yellow oil. IR (νmax/ cm
-1
): 1652; 
1
H-NMR (400 MHz, CDCl3) H: 7.71 (2H, 
d, J = 8.6 Hz), 7.71 (1H, d, J = 8.1 Hz), 7.29 (1H, d, J = 8.2 Hz), 7.23 (1H, dd, J = 6.9 Hz, 
8.2 Hz), 7.16 (1H, dd, J = 6.9 Hz, 8.1 Hz), 6.88 (1H, s), 6.76 (2H, d, J = 8.6 Hz), 5.99 (1H, 
s), 5.97 (1H, s), 5.88 (1H, s), 2.97 (3H, s), 2.44 (3H, s); 
13
C-NMR (100 MHz, CDCl3) δC: 
197.4 (s), 160.7 (s), 143.1 (s), 140.2 (s), 136.8 (s), 132.9 (s), 131.8 (s), 131.5 (s), 128.5 (d), 
127.1 (d), 124.9 (t), 124.2 (d), 123.7 (d), 121.3 (d), 110.1 (d), 98.3 (d), 76.8 (d), 26.9 (q), 
26.5 (q). MS: (m/z) 330 [M]
+
.  
 
N-(tert-butyloxycarbonyl)-2-(1-phenylvinyl)-2,3-dihydrobenzo[d]oxazole (22a) 
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Yield: 70%. Colorless oil. IR (νmax/cm
-1
): 3411, 2970, 2930, 1722, 1600, 1489, 1384. 
1
H-
NMR (300 MHz, DMSO) δH: 7.48-7.35 (6H, m), 6.95-6.87 (4H, m), 5.57 (1H, s), 5.50 
(1H, s), 1.48 (9H, s). 
13
C-NMR (75 MHz, DMSO) δC: 150.4 (s), 144.5 (s), 137.5 (s), 130.5 
(s), 129.2 (d), 129.0 (d), 127.7 (d), 124.2 (d), 122.1 (d), 114.1 (d), 113.9 (s), 109.5 (d), 
118.2 (t), 94.8 (d), 82.6 (s), 28.6 (q). MS (m/z) 346.4 [M+Na]
+
 
 
N-(tert-butyloxycarbonyl)-5-nitro-2-(1-phenylvinyl)-2,3-dihydrobenzo[d]oxazole (22b) 
 
Yield: 38%. Orange oil. IR (νmax/cm
-1
): 3423, 2978, 2933, 1721, 1524; 
1
H-NMR (200 
MHz, CDCl3) δH: 8.28 (1H, bs), 7.90 (1H, dd, J = 8.7, 2.4 Hz), 7.39-7.26 (5H, m), 6.87 
(1H, bs), 6.77 (1H, d, J = 8.7 Hz), 5.57 (1H, s), 5.53 (1H, s), 1.53 (9H, s); 
13
C-NMR (50 
MHz, CDCl3) δC: 155.5 (s), 149.8 (s), 144.2 (s), 142.9 (s), 
136.9 (s), 131.4 (s), 132.2 (d), 128.7 (d), 128.6 (d), 127.5 (d), 121.2 (d), 118.7 (t), 109.5 
(d), 108.1 (d), 97.2 (d), 83.9 (s), 28.3 (q). MS m/z 391.0 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-5-chloro-2-(1-phenylvinyl) 2,3-dihydrobenzo[d]oxazole (22c) 
 
Yield: 62%. Colorless oil. IR (νmax/cm
-1
): 3415, 2980, 2930, 1720, 1598. 
1
H-NMR (200 
MHz, CDCl3) δH: 7.65-7.26 (6H, m), 6.85 (1H, dd, J = 8.4, 2.2 Hz), 6.75 (1H, s), 6.65 (1H, 
d, J = 8.4 Hz), 5.53 (1H, s), 5.48 (1H, s), 1.49 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 
150.1 (s), 149.0 (s), 144.7 (s), 137.4 (s), 131.6 (s), 126.4 (s), 128.6 (d), 128.4 (d), 127.5 (d), 
123.0 (d), 114.4 (d), 109.3 (d), 117.7 (t), 95.8 (d), 83.1 (s), 28.4 (q). MS (m/z) 380 
[M+Na]
+
 
 
N-(tert-butoxycarbonyl)-5-methyl-2-(1-phenylvinyl) 2,3-dihydrobenzo[d]oxazole (22d) 
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Yield: 54%. Colourless oil. IR (νmax/cm
-1
): 3436, 2976, 2920, 1708, 1496. 
1
H-NMR (200 
MHz, CDCl3) δH: 7.46-7.26 (6H, m), 6.73-6.63 (3H, m), 5.52 (1H, d,), 5.48 (1H, d), 2.30 
(3H, s), 1.50 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.5 (s), 148.1(s), 145.0 (s), 137.8 
(s), 131.1 (s), 130.3 (s), 128.6 (d), 128.2 (d), 127.4 (d), 123.6 (d), 114.9 (d), 108.4 (d), 
117.1 (t), 94.9 (d), 82.4 (s), 28.4 (q), 21.4 (q). MS (m/z) 360 [M+Na]
+
, 338 [M]
+
 
 
N-(tert-butoxycarbonyl)-2-(1-(3-(trifluoromethyl)phenyl)vinyl)-2,3-dihydrobenzo[d] 
oxazole (22e) 
 
Yield: 68%. Yellow oil. IR (νmax/cm
-1
): 3400, 3000, 2940, 1720. 
1
H-NMR (200 MHz, 
CDCl3) δH: 7.97-7.87 (1H, m), 7.69-7.19 (5H, m), 6.95-6.75 (3H, m), 5.60 (1H, s), 5.56 
(1H, s), 1.51 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.1 (s), 148.1 (s), 143.9 (s), 138.5 
(s), 130.0 (s), 126.9 (s), 121.5 (s), 130.9 (d), 128.8 (d), 125.0 (d), 124.7 (d), 123.7 (d), 
121.7 (d), 114.1 (d), 109.0 (d), 119.0 (t), 94.7 (d), 82.8 (s), 28.4 (q). MS (m/z) 414 
[M+Na]
+
  
 
N-(tert-butoxycarbonyl)-2-(1-(4-(ethoxycarbonyl)phenyl)vinyl)-2,3-dihydrobenzo[d] 
oxazole (22f) 
 
Yield: 71%. Colorless oil. IR (νmax/cm
-1
): 3415, 3059, 2979, 1712, 1609, 1489. 
1
H-NMR 
(200 MHz, CDCl3) δH: 8.00-7.94 (2H, m), 7.50-7.44 (3H, m), 6.91-6.74 (4H, m), 5.59 (1H, 
s), 5.58 (1H, s), 4.36 (2H, q, J = 7.1 Hz), 1.50 (9H, s), 1.38 (3H, t, J = 7.1 Hz). 
13
C-NMR 
(50 MHz, CDCl3) δC: 166.5 (s), 150.5 (s), 150.1 (s), 144.3 (s), 142.2 (s), 130.2 (s), 130.1 
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(s), 129.8 (d), 127.5 (d), 123.6 (d), 121.6 (d), 114.1 (d), 109.0 (d), 118.9 (t), 94.7 (d), 82.7 
(s), 61.2 (t), 28.4 (q), 14.5 (q). MS (m/z) 418 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-2-(1-(4-nitrophenyl)vinyl) 2,3-dihydrobenzo[d]oxazole (22g)  
 
Yield: 78%. Orange oil. IR (νmax/cm
-1
): 3412, 3073, 2978, 2933, 1711, 1598. 
1
H-NMR 
(200 MHz, CDCl3) δH: 8.18-8.11 (2H, m), 7.59-7.53 (2H, m), 7.49-7.29 (1H, br s), 6.95-
6.74 (4H, m), 5.67 (1H, s), 5.63 (1H, s), 1.51 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 
150.5 (s), 149.9 (s), 147.8 (s), 144.3 (s), 143.5 (s), 129.9 (s), 128.5 (d), 123.8 (d), 123.7 (d), 
121.8 (d), 114.2 (d), 109.1 (d), 120.4 (t), 94.5 (d), 83.0 (s), 28.4 (q). MS (m/z) 391 
[M+Na]
+
  
 
N-(tert-butoxycarbonyl)-2-(1-(4-methoxyphenyl)vinyl) 2,3-dihydrobenzo[d]oxazole 
(22h) 
 
Yield: 65%. Colorless oil. IR (νmax/cm
-1
): 3414, 2977, 2933, 1713, 1608. 
1
H-NMR (200 
MHz, CDCl3) δH: 7.66-7.44 (1H, br s), 7.40-7.35 (2H, m), 6.95-6.75 (6H, m), 5.48 (1H, s), 
5.42 (1H, s), 3.79 (3H, s), 1.52 (9H). 
13
C-NMR (50 MHz, CDCl3) δC: 159.8 (s), 150.5 (s), 
150.3 (s), 144.3 (s), 130.4 (s), 130.2 (s), 128.6 (d), 123.5 (d), 121.4 (d), 114.1 (d), 114.0 
(d), 109.0 (d), 116.0 (t), 95.0 (d), 82.4 (s), 55.4 (q), 28.5 (q). MS (m/z) 376 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-2-(1-(thiophen-2-yl)vinyl) 2,3-dihydrobenzo[d]oxazole (22i) 
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Yield: 64%. Colorless oil. IR (νmax / cm-1): 3410, 3072, 2977, 2931, 1713, 1599, 1489, 
1393. 
1
H-NMR (200 MHz, CDCl3) δH: 7.66-7.37 (1H, br s), 7.20 (1H, dd, J = 5.1, 1.1 Hz), 
7.10 (1H, d, J = 3.2 Hz), 6.98-6.76 (4H, m), 6.72 (1H, br s), 5.65 (1H, s), 5.41 (1H, s), 1.50 
(9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.5 (s), 150.3 (s), 139.5 (s), 138.3 (s), 130.3 (s), 
127.6 (d), 25.5 (d), 125.4 (d), 123.6 (d), 121.6 (d), 114.1 (d), 109.1 (d), 116.3 (t), 94.8 (d), 
82.7 (s), 28.4 (q). MS (m/z) 352 [M+Na]
+ 
 
N-(tert-butoxycarbonyl)-2-(1-(1-(tert-butoxycarbonyl)-1H-imidazol-4-yl)vinyl) 2,3-
dihydrobenzo[d]oxazole (22j) 
 
Yield: 25%. Yellow oil. IR (νmax/cm-1): 3400, 2958, 2929, 1724, 1489. 
1
H-NMR (200 
MHz, CDCl3) δH: 8.40 (1H, d, J = 1.1 Hz), 7.71-7.41 (1H, br s), 7.17 (1H, br s), 6.98-6.74 
(4H, m), 6.10 (1H, s), 5.46 (1H, s), 1.56 (18H, br s). 
13
C-NMR (50 MHz, CDCl3) δC: 153.2 
(s), 150.3 (s), 147.0 (s), 138.6 (s), 136.3 (s), 131.2, (s), 123.7 (d), 121.6 (d), 117.5 (d), 
114.2 (d), 113.6 (d), 109.0 (d), 116.4 (t), 94.3 (d), 85.9 (s), 82.7 (s), 28.4 (q), 28.1 (q). MS 
(m/z) 414 [M+Na]
+
, 436 [M]
+
 
 
N-(tert-butoxycarbonyl)-2-(1-(1-(phenylsulfonyl)-1H-indol-3-yl)vinyl)-2,3-
dihydrobenzo[d] oxazole (22k) 
 
Yield: 67%. Orange oil. IR (νmax/cm
-1
): 3414, 2977, 2931, 1711. 
1
H-NMR (200 MHz, 
CDCl3) δH: 7.91 (1H, dd, J = 6.9, 1.8 Hz), 7.68-7.19 (10H, m), 7.00-6.80 (3H, m), 6.67 
(1H, bs), 5.78 (1H, s), 5.70 (1H, s), 1.47 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.5 (s), 
120.5 (s), 138.3 (s), 136.3 (s), 135.1 (s), 130.5 (s), 127.4 (s), 117.91 (s), 134.1 (d), 129.7 
(d), 127.2 (d), 125.3 (d), 124.5 (d), 123.9 (d), 123.8 (d), 121.7 (d), 120.8 (d), 114.2 (d), 
113.8 (d), 109.0 (d), 120.5 (t), 96.5 (d), 82.7 (s), 28.6 (q). MS (m/z) 525 [M+Na]
+
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N-(tert-butoxycarboyl)-2-(1-(pyridin-2-yl)vinyl) 2,3-dihydrobenzo[d]oxazole (22l) 
 
Yield: 30%. Colorless oil. IR (νmax/cm
-1
): 3434, 3058, 2978, 2292, 1716. 
1
H-NMR (200 
MHz, CDCl3) δH: 8.67-8.63 (1H, m), 7.73-7.54 (3H, m), 7.29-7.19 (2H, m), 6.92-6.74 (3H, 
m), 6.03 (1H, s), 5.63 (1H, s), 1.52 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 155.5 (s), 
150.3 (s), 149.4 (d), 144.4 (s), 136.7 (d), 130.9 (s), 123.6 (d), 122.9 (d), 121.38 (d), 121.0 
(d), 119.9 (s), 117.6 (t), 114.1 (d), 109.4 (d), 92.2 (d), 82.5 (s), 80.5 (s), 28.4 (q). MS (m/z) 
347.1 [M+Na]
+
 
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-phenylvinyl)-2,3-dihydro-1H-
benzo[d] imidazole (23a) 
 
Yield: 86%. Orange solid. mp: 99-101 °C (Et2O) IR (νmax/cm
-1
): 3402, 2973, 2928, 1709. 
1
H-NMR (200 MHz, CDCl3) δH: 7.53 (1H, dd, J = 7.1, 1.5 Hz), 7.49-7.26 (8H, m), 7.13-
6.95 (4H, m), 6.60 (1H, bs), 5.38 (1H, s), 5.24 (1H, s), 2.31 (3H, s), 1.35 (9H, s). 
13
C-
NMR (50 MHz, CDCl3) δC: 150.1 (s), 145.4 (s), 144.8 (s), 138.0 (s), 135.3 (s), 133.3 (s), 
131.9 (s), 29.7 (d), 128.4 (d), 128.2 (d), 128.1 (d), 127.8 (d), 127.6 (d), 127.0 (d), 123.5 
(d), 119.6 (t), 115.2 (d), 82.3 (s), 78.6 (d), 28.2 (q), 21.7 (q). MS (m/z) 499 [M+Na]
+
  
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-(3-(trifluoromethyl)phenyl) 
vinyl)-2,3-dihydro-1H-benzo[d]imidazole (23b) 
 
Yield: 65%. Yellow oil. IR (νmax/cm
-1
): 3436, 2980, 2930, 2359, 2342, 1716. 
1
H-NMR 
(200 MHz, CDCl3) δH: 7.55-7.37 (8H, m), 7.14-6.95 (4H, m), 6.57 (1H, br s), 5.49 (1H, s), 
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5.30 (1H, s), 2.31 (3H, s), 1.36 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.0 (s), 144.8 
(s), 144.5 (s), 138.7 (s), 135.0 (s), 132.3 (s), 130.9 (s), 130.2 (s), 121.5 (s), 131.8 (d), 129.7 
(d), 128.6 (d), 127.6 (d), 127.0 (d), 125.4 (d), 125.3 (d) 124.7 (d), 119.5 (d), 115.3 (d), 
118.7 (t), 82.6 (s), 78.6 (d), 28.2 (q), 21.6 (q). MS (m/z) 566.1 [M+Na]
+
 
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-1-(4-nitrophenyl)vinyl)-2,3-dihydro 
-1H-benzo[d]imidazole (23c) 
 
 
Yield: 86%. Orange oil. IR (νmax/cm
-1
): 3071, 2979, 2932, 2258, 1925, 1713. 
1
H-NMR 
(200 MHz, CDCl3) δH: 8.14 (2H, d, J = 8.4 Hz), 7.53-7.35 (5H, m), 7.4-6.98 (5H, m), 6.58 
(1H, br s), 5.67 (1H, s), 5.63 (1H, s), 2.32 (3H, s), 1.38 (9H, s). 
13
C-NMR (50 MHz, 
CDCl3) δC: 150.0 (s), 147.7 (s), 145.0 (s), 144.7 (s), 143.9 (s), 134.8 (s), 132.9 (s), 131.7 
(s), 129.8 (d), 129.4 (d), 127.6 (d), 127.2 (d), 123.8 (d), 123.4 (d), 119.7 (d), 115.3 (d), 
119.4 (t), 82.9 (s), 78.3 (d), 28.3 (q), 21.7 (q). MS (m/z) 544 [M+Na]
+
 
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-(4-methoxypheny)lvinyl)-2,3-
dihydro-1H-benzo[d]imidazole (23d) 
 
Yield: 65%. Orange oil. IR (νmax/cm
-1
): 3402, 2982, 2931, 1709, 1513. 
1
H-NMR (200 
MHz, CDCl3) δH: 7.55-7.25 (6H, m), 7.12-6.95 (4H, m), 6.80 (2H, d, J = 8.7 Hz). 6.58 
(1H, br s), 5.28 (1H, s), 5.19 (1H, s), 3.77 (3H, s), 2.31 (3H, s), 1.37 (9H, s). 
13
C-NMR (50 
MHz, CDCl3) δC: 159.6 (s), 150.0 (s), 144.7 (s), 135.4 (s), 133.3 (s), 132.0 (s), 130.3 (s), 
113.4 (s), 129.6 (d), 129.5 (d), 127.6 (d), 127.0 (d), 123.4 (d), 119.8 (d), 115.1 (d), 113.6 
(d), 116.4 (t), 82.3 (s), 78.7 (d), 55.4 (q), 28.3 (q), 21.7 (q). MS (m/z) 529 [M+Na]
+
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N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-(thiophen-2-yl)vinyl)-2,3-
dihydro-1H-benzo[d]imidazole (23e) 
 
Yield: 36%. Yellow solid. mp: 141-142 °C (Et2O) IR (νmax/cm
-1
): 3429, 2971, 2921, 1709, 
1593. 
1
H-NMR (200 MHz, CDCl3) δH: 7.57-6.93 (11H, m), 6.61 (1H, br s), 5.47 (1H, s), 
5.23 (1H, s), 2.33 (3H, s), 1.39 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 150.0 (s), 144.9 
(s), 139.3 (s), 138.6 (s), 135.5 (s), 133.1 (s), 132.0 (s), 129.7 (d), 127.7 (d), 127.6 (d), 127.0 
(d), 126.3 (d), 125.4 (d), 123.5 (d), 19.6 (d), 114.9 (d), 116.8 (t), 82.6 (s), 78.5 (d), 28.3 (q), 
21.8 (q). MS (m/z) 505 [M+Na]
+
 
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-(1-(tert-butoxycarbonyl)-1H-
imidazol-4-yl)vinyl)-2,3-dihydro-1H-benzo[d]imidazole (23f) 
 
Yield: 10% Colorless oil. 
1
H-NMR (200 MHz, CDCl3) δH: 8.17 (1H, dd, J = 8.4 Hz, 1.1 
Hz), 7.60 (2H, d, J = 8.3 Hz), 7.33-7.07 (6H, m), 6.75 (1H, td, J = 7.7, 1.4 Hz), 6.33 (1H, 
dd, J = 7.7, 1.4 Hz), 5.04 (1H, s), 5.01 (1H, s), 2.46 (3H, s), 1.52 (18H, s).
 
 
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-((1-(phenylsulfonyl)-1H-indol-3-
yl)vinyl)-2,3-dihydro-1H-benzo[d]imidazole (23g) 
 
Yield: 7% Colorless oil. IR (νmax/cm
-1
): 3436, 2975, 2929, 2336, 1714, 1635, 1598. 
1
H-
NMR (200 MHz, CDCl3) δH: 7.92-7.01 (18H, m), 6.55 (1H, br s), 5.56 (1H, s), 5.51 (1H, 
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s), 2.32 (3H, s), 1.37 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 144.8 (s), 143.9 (s), 138.3 
(s), 136.2 (s), 135.2 (s), 134.8 (s), 132.1 (s), 130.5 (s), 118.8 (s), 118.2 (s), 133.9 (d), 129.7 
(d), 129.5 (d), 127.6 (d), 127.3 (d), 126.9 (d), 126.1 (d), 124.9 (d), 123.6 (d), 120.7 (d), 
119.4 (t), 115.1 (d), 113.6 (d), 82.6 (s), 79.1 (d), 28.3 (q), 21.7 (q). MS m/z 803 [M+3Na]
+
  
 
N-(p-toluenesulfonyl)--N’-(tert-butoxycarbonyl)-2-(1-((1H-indol-3-yl)vinyl)-2,3-
dihydro-1H-benzo[d]imidazole (23g’) 
 
Yield: 12%. Colorless oil. IR (νmax/cm
-1
): 3411, 2976, 2926, 1712, 1622, 1598. 
1
H-NMR 
(200 MHz, CDCl3) δH: 8.17 (1H, br s), 7.70 (1H, m), 7.56-7.01 (12H, m) 6.61 (1H, bs), 
5.52 (1H, s), 5.40 (1H, s), 2.31 (3H, s, CH3), 1.35 (9H, s, t-Bu). MS (m/z) 538 [M+Na]
+
, 
514 [M]
-
 
 
N-(tert-butoxycarbonyl)-3-(1-phenylvinyl)isoxazolidine (24) 
 
Yield: 55%. Colorless oil. IR (νmax/cm
-1
): 1689. 
1
H-NMR (300 MHz, DMSO) δH: 7.49–
7.21 (5H, m), 5.44 (1H, s), 5.34 (1H, s), 5.15 (1H, dd, J = 8.7, 5.1 Hz), 4.06 (1H, td, J = 
7.6, 4.5 Hz), 3.97–3.74 (1H, m), 2.65–2.32 (1H, m), 2.21–1.89 (1H, m), 1.659 (9H, s); 13C-
NMR (50 MHz, CDCl3) δC: 
13
C NMR (50 MHz, cdcl3) δ 157.2 (s), 147.5 (s), 139.5 (s), 
128.6 (d), 128.0 (d), 127.0 (d), 112.9 (t), 82.2 (s), 69.1 (t), 61.8 (d), 35.6 (t), 28.48 (q).. MS 
m/z 298 [M+Na]
+
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Carbonilations 
 
General procedure for the carbonilation reaction 
 
Pd(PPh3)4 (8% mol), aryl iodide (1.5 mmol), and K2CO3 (4 mmol) were added to a solution 
of the suitable allene (1 mmol) in acetonitrile (10 mL) under CO atmosphere (balloon). 
The resulting suspension was stirred at rt for 48 h. The solvent was evaporated under 
reduced pressure, then the crude mixture was diluted with brine and extracted with AcOEt 
(3 x 20 mL). The organic phase was dried over Na2SO4 and the product was purified by 
flash chromatography. 
 
2-Methyl-3-(3-oxo-3-phenylprop-1-en-2-yl)-2,3-dihydro-1H-imidazo[1,5-a]indol-1-one 
(25a) 
 
Yield 45%. White solid, mp 133 °C (i-Pr2O); IR (νmax/cm
-1
): 1730, 1640; 
1
H-NMR (400 
MHz, CDCl3) δH: 7.81-7.74 (3H, m), 7.64-7.60 (1H, m), 7.51-7.45 (2H, m), 7.27-7.10 (3H, 
m), 6.97 (1H, s), 6.57 (1H, s), 6.10 (1H, s), 5.88 (1H, s), 3.10 (3H, s); 
13
C-NMR (100 
MHz, CDCl3) δC: 195.3 (s), 27.5 (q), 70.5 (d), 98.3 (d), 110.3 (d), 121.1 (d), 123.7 (d), 
124.2 (d), 128.7 (d), 129.6 (d), 160.7 (s), 142.0 (s), 136.1 (s), 133.5 (d), 132.5 (s), 132.0 
(s), 131.7 (s), 131.2 (t). MS m/z 316 [M]
+
.  
 
3-(3-(4-methoxyphenyl)-3-oxoprop-1-en-2-yl)-2-methyl-2,3-dihydro-1H-imidazo[1,5-
a]indol-1-one (25b)  
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Yield: 31%. White solid. mp 163 °C (i-Pr2O). IR (νmax/cm
-1
): 1724, 1633 cm
-1
; 
1
H-NMR 
(400 MHz, CDCl3) : 7.84 (2H, d, J = 9.0 Hz), 7.76 (1H, d, J = 7.8 Hz), 7.17-7.23 (3H, 
m), 6.97 (1H, s), 6.96 (2H, d, J = 9.0 Hz), 6.03 (1H, s), 6.56 (1H, s), 5.78 (1H, s), 3.89 (3H, 
s), 3.10 (3H, s); 
13
C-NMR (100 MHz, CDCl3) C206.9 (s), 193.7 (s), 164.1 (s), 142.2 (s), 
132.5 (s), 132.2 (d), 131.9 (s), 129.2 (t), 128.6 (s), 124.1 (d), 123.7 (d), 121.1 (d), 114.0 
(d), 110.4 (d), 110.0 (s), 98.3 (d), 70.8 (d), 55.6 (q), 27.5 (q). MS: m/z 346 (M
+
).  
 
3-(3-(4-acetylphenyl)-3-oxoprop-1-en-2-yl)-2-methyl-2,3-dihydro-1H-imidazo[1,5-
a]indol-1-one (25c)  
 
Yield: 28%. White solid. mp 145 °C (i-Pr2O). IR (νmax/cm
-1
): 1738, 1636; 
1
H-NMR (400 
MHz, CDCl3) H: 8.04 (2H, d, J = 8.4 Hz), 7.85 (2H, d, J = 8.4 Hz), 7.77 (1H, d, J = 8.0 
Hz), 7.27-7.18 (3H, m), 6.99 (1H, s), 6.60 (1H, s), 6.12 (1H, s), 5.96 (1H, s), 3.12 (3H, s), 
2.66 (3H, s); 
13
C-NMR (100 MHz, CDCl3) C197.1 (s), 194.7 (s), 160.6 (s), 142.1 (s), 
140.4 (s), 139.6 (s), 135.0 (s), 132.4 (s), 132.0 (t), 131.6 (s), 129.7 (d), 128.5 (d), 124.3 (d), 
123.8 (d), 121.2 (d), 110.1 (d), 98.5 (d), 70.4 (d), 27.5 (q), 26.8 (q). MS (m/z) 358 [M]
+
.  
 
3-(3-(4-ethoxycarbonylphenyl)-3-oxoprop-1-en-2-yl)-2-methyl-2,3-dihydro-1H-imidaz
o[1,5-a]indol-1-one (25d)  
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Yield: 33%. White solid. mp 121 °C (i-Pr2O). IR (νmax/cm
-1
): 1732, 1655; 
1
H-NMR (400 
MHz, CDCl3) H: 7.79 (2H, d, J = 8.4 Hz), 7.74 (1H, d, J = 8.1 Hz ), 7.35 (1H, d, J = 8.0 
Hz), 7.27 (1H, dd, J = 7.0 Hz, 8.1 Hz), 7.18 (1H, dd, J = 7.0 Hz, 8.0 Hz), 6.91 (1H, s), 6.80 
(2H, d, J = 8.4 Hz), 6.12 (1H, s), 5.99 (1H, s), 5.90 (1H, s), 4.30 (2H, q, J = 7.1 Hz), 3.03 
(3H, s),  1.33 (3H, t, J = 7.1 Hz); 
13
C-NMR (100 MHz, CDCl3) C 165.9 (s), 160.7 (s), 
143.4 (s), 140.0 (s), 132.9 (s), 131.9 (s), 131.6 (s), 130.6 (s), 129.8 (d), 129.7 (s), 126.9 (d), 
124.5 (t), 124.2 (d), 123.7 (d), 121.2 (d), 110.1 (d), 98.4 (d), 77.1 (d), 61.0 (t), 26.9 (q), 
14.2 (q). MS (m/z) 388 [M]
+
.  
 
N-(tert-butoxycarbonyl)-2-(3-oxo-3-phenylprop-1-en-2-yl)-2,3-dihydrobenzo[d] 
oxazole (26) 
 
Yield: 27%. Yellow oil. IR (νmax/cm
-1
): 3435, 3060, 2978, 2932, 2254, 1714, 1662.
1
H-
NMR (300 MHz, DMSO) δH: 7.83-7.78 (2H, m), 7.61-7.40 (4H, m), 6.98-6.77 (4H, m), 
5.84 (1H, s), 6.10 (1H, s), 1.49 (9H, s). 
13
C-NMR (75 MHz, DMSO) δC: 195.3 (s), 150.4 
(s), 144.1 (s), 137.2 (s), 129.7 (s), 133.1 (d), 129.9 (d), 128.6 (d), 128.4 (d), 126.4 (t), 123.8 
(d), 121.7 (d), 114.3 (d), 109.1 (d), 83.0 (s), 28.4 (q). MS (m/z) 374.0 [M+Na]
+
 
 
N-(p-toluenesulfonyl)-N-(tert-butoxycarbonyl)-2-(3-oxo-3-phenylprop-1-en-2-yl)-2,3-
dihydrobenzo[d] imidazole (27) 
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Yield: 20%. Yellow oil. IR (νmax/cm
-1
): 3413, 3066, 2980, 2930, 2592, 1919, 1715, 1668, 
1598. 
1
H-NMR (200 MHz, CDCl3) δH: 7.82-7.38 (9H, m), 7.18-7.01 (4H, m), 6.73 (1H, s), 
5.96 (1H, br s), 5.64 (1H, s), 2.33 (3H, s), 1.35 (9H, s). 
13
C-NMR (50 MHz, CDCl3) δC: 
194.5 (s), 151.2 (s), 144.9 (s), 144.6 (s), 137.2 (s), 134.5 (s), 133.2 (d), 132.7 (s), 131.9 (s), 
130.0 (d), 129.8 (d), 128.5 (d), 127.7 (d), 126.6 (d), 123.7 (d), 118.5 (d), 115.2 (d), 82.9 
(s), 75.8 (d), 28.3 (q), 21.7 (q). MS (m/z) 527.6 [M+Na]
+
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General procedure for the domino alkylation/halogenation reactions 
 
To a stirred solution of 28 (80 mg, 0.43 mmol) in a suitable solvent and in the presence of 
4Å molecular sieves under nitrogen atmosphere, were added sequentially PdCl2 (10% mol) 
or PdCl2(CH3CN)2 (10% mol) and the suitable oxidant copper salt (3eq) according to the 
Table 4 and 5 of Chapter 3. The reaction mixture was then stirred at room temperature for 
2-4h. After reaction completion, the solvent was removed under reduced pressure and, 
brine was added and the mixture extracted with Et2O. The organic layers were dried over 
Na2SO4, the solvent removed and the product purified by flash chromatography (n-
hexane/AcOEt 10:1) 
 
N-(tert-butoxycarbonyl)-3-(chloromethyl)isoxazolidine (29) 
 
Yield: 48%. Colorless oil. IR (νmax/ cm
-1
): 3386, 2982, 2938, 2875, 1701, 1430; 
1
H-NMR 
(200 MHz, CDCl3) H: 4.22 (1H, m), 4.08 (2H, m), 3.90 (1H, ddd, J = 11.8, 8.4, 3.3 Hz), 
3.63 (1H, dd, J = 14.4, 8.4 Hz), 2.27 (1H, m), 2.03 (1H, m), 1.50 (9H, s). 
13
C-NMR (100 
MHz, CDCl3) δC: 154.6 (s), 82.3 (s), 68.7 (t), 53.2 (t), 51.8 (d), 34.6 (t), 28.5 (q). MS (m/z): 
244 [M+Na]
+
 
 
N-(tert-butoxycarbonyl)-3-(bromomethyl)isoxazolidine (30) 
 
Yield: 43%. Yellow oil. IR (νmax/ cm
-1
): 3292, 2981, 2935, 1783, 1754, 1478; 
1
H-NMR 
(200 MHz, CDCl3) H 4.17 (1H, m), 3.92 (1H, ddd, J = 11.9, 8.6, 3.3 Hz,), 3.69 (1H, dd, J 
= 14.5, 9.0 Hz), 2.44–2.05 (2H, m), 1.50 (9H, s); 13C-NMR (50 MHz, CDCl3) δC: 153.8 
(s), 83.4 (d), 82.3 (s), 70.0 (d), 53.5, 42.8, 35.4, 28.2. MS (m/z): 288.0 [M+Na]
+
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N-(tert-butoxycarbonyl)- isoxazolidin-3-ylmethyl formate (31) 
 
Yield: 35%. Colorless oil. IR (νmax/ cm
-1
) 3435, 2978, 2933, 1724; 
1
H-NMR (200 MHz, 
CDCl3) H: 8.04 (1H, s), 5.15–4.93 (1H, m), 4.21 (1H, ddd, J = 12.1, 9.0, 3.3 Hz), 4.02–
3.81 (2H, m), 3.74 (1H, dd, J = 14.1, 3.0 Hz), 2.21-2.09 (1H, m), 1.99–1.78 (m, 1H), 1.48 
(9H, s).
 
 
13
C-NMR (50 MHz, CDCl3) δC: 160.2 (d), 155.1 (s), 82.1 (s), 67.0 (t), 65.2 (d), 
49.5 (t), 29.6 (t), 28.4 (q). MS (m/z): 254.0 [M+Na]
+
. 
 
N-(tert-butoxycarbonyl)- isoxazolidin-3-ylmethyl acetate (32) 
 
Yield: 20%. Colorless oil. IR (νmax/ cm
-1
): 3430, 2988, 2930, 1725; 
1
H-NMR (200 MHz, 
CDCl3) H: 4.96–4.78 (1H, m), 4.28–4.10 (2H, m), 3.92-3.82 (1H, m), 3.70 (1H, dd, J = 
14.2, 2.9 Hz), 2.24–2.09 (1H, m), 2.07 (3H, s), 1.93–1.72 (1H, m), 1.49 (9H, s).MS (m/z): 
268 [M+Na]
+
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Chapter 4: Studies towards the C1-C11 fragment of Stambomycin A 
 
General details 
NMR Spectra: 
1
H Nuclear magnetic resonance (NMR) spectra were recorded using an 
interna deuterium lock for the residual protons in CDCl3 (δ 7.26), C6D6 (δ 7.16), d8-
toluene (δ 2.31) and CD3OD (δ 3.31) at ambient probe temperatures on the following 
instruments: Bruker AV400 (400 
MHz), Varian Inova Unity 400 (400 MHz), Bruker AMX 500 (500 MHz), Bruker 
AVANCE III 500 (500 MHz), Bruker DRX500 (500 MHz) or Varian Inova 600 (600 
MHz). Data are presented as follows: chemical shift, peak multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants and 
interpretations. Chemical shifts are expressed in ppm on a δ scale relative to δTMS (δ = 0 
ppm) and coupling constants, J, are given in Hz. Assignments were determined either on 
the basis of unambiguous chemical shift or coupling patterns, by analysis of 2D NMR 
(COSY, HSQC, HMBC, NOESY) and irradiation of protons in nOe experiments, or by 
analogy to fully interpreted spectra for structurally related compounds. 
13
C NMR Spectra 
were recorded using an internal deuterium lock using solvents CDCl3 (δ 77.0), C6D6 (δ 
128.6) and d8-toluene (δ 21.4) at ambient probe temperatures on the following 
instruments: Bruker AV400 (101 MHz), Varian Inova Unity 400 (101 MHz), Bruker AMX 
500 (126 MHz), Bruker AVANCE III 500 (126 MHz), Bruker DRX500 (126 MHz) or 
Varian Inova 600 (151 MHz).  
Infra-red spectra: Recorded on a Perkin Elmer Paragon 1000 spectrometer or a Perkin 
Elmer Spectrum One spectrometer, with the sample prepared as a thin film between NaCl 
plates, or using a PIKE-Miracle Diamond /Universal ZnSe ATR module  
Mass spectra: Low resolution mass spectra (m/z) were recorded on a Micromass LCT 
Premier Open Access. Accurate mass (HRMS) data was determined under the conditions 
of ESI on a Bruker MicroTOF (resolution = 5000 FWHM) using tetraoctylammonium 
bromide as a lock-mass in both positive and negative ion modes, or under the conditions of 
CI on a Micromass GCT (resolution = 7000 FWHM) using isoamyl acetate as a lock-mass. 
High resolution values are calculated to 4 decimal places from the molecular formula, and 
all values are within a tolerance of 5 ppm.  
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Reactions were monitored by thin layer chromatography (TLC). TLC was conducted on 
pre-coated aluminium-backed plates (Merck Kieselgel 60 with fluorescent indicator 
UV254) or on pre-coated glass-backed plates (Macherey-Nagel SIL G-25 with fluorescent 
indicator UV254). Spots were visualized either by quenching of UV fluorescence or by 
staining with potassium permanganate or vanillin.  
Flash chromatography was performed manually with silica gel 60 (0.040-0.063 mm) (MN 
Kieselgel 60M) applying head pressure by means of nitrogen.  
Materials: All reagents, obtained from Acros, Aldrich, Fluka, Lancaster, Strem and 
Fluorochem fine chemicals suppliers were used directly as supplied or purified by the 
methods described by Amerago and Chai. All non-aqueous reactions were performed in 
oven dried apparatus under argon or nitrogen atmospheres, using anhydrous solvents, at 
room temperature unless otherwise indicated. 
The anhydrous solvents were purchased as sure-seal bottles from Aldrich or dried by pre-
storing over activated 3Å molecular sieves and then passing through an activated alumina 
column on a solvent tower. 
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Procedure for the preparation of the Leighton reagent 
(Z)-Crotyltrichlorosilane
1
 
 
In a sealed tube, equipped with a side-arm and magnetic stirring bar, was condensed 1,3-
butadiene (1.99 0g, 36.91 mmol, 1 eq) at –78 °C, under argon. To this tube were 
sequentially added Pd(PPh3)4 (106 mg, 0.0925 mmol, 0.025 eq) and HSiCl3 (3.72 ml, 36.91 
mmol, 1.0 equiv) at –78 °C. The side arm was then removed, the tube sealed, and the 
reaction mixture was allowed to warm at room temperature and stirred overnight. The 
solution was purified by distillation at atmospheric pressure under argon. The title 
compound was isolated as a colorless oil. bp: 142-144°C (142°C lit.) 
1
H-NMR (500 MHz, 
C6D6) δH 5.83-5.63 (1H, m, H-3), 5.51-5.35 (1H, m, H-2), 2.36 (2H, dq, J= 8.1, 0.8 Hz, 
CH2), 1.67 (3H, ddt, J= 6.8, 1.7, 0.8 Hz). Data are consistent with literature.
 
 
(1R,2R)-N1,N2-bis(4-bromobenzyl)cyclohexane-1,2-diamine
2
 
 
To a stirred suspension of (1R,2R)-cyclohexane-1,2diamine.L-tartrate (13.92 g, 52.7 
mmol, 1 eq) in water (250 ml) was added K2CO3 (14.56 g, 105.3 mmol, 2 eq). To this 
mixture was added EtOH (125 ml) and a solution of 4-bromobenzaldehyde (19.48 ml, 
105.3 mmol, 2 eq) and methanesulfonic acid (0.428 ml, 6.324 mmol, 0.12 eq) in DCM 
(250 ml). The biphasic mixture was stirred overnight at room temperature then heated at 
reflux for 1 hour. The reaction was concentrated in vacuo and the residue diluited with 
water. The mixture was filtered and the solid residue dissolved in MeOH (150 ml). The 
solution was cooled to 0 °C and NaBH4 (4.48 g, 118.5 mmol, 2.25 eq) added. After 
gaseous evolution had ceased the reaction was heated to reflux for 1 hour. The reaction 
was allowed to cool, concentrated in vacuo and 1N NaOH (70 ml), EtOAc (50 ml) and 
petrol ether (50 ml) added. The layers were separated and the aqueous layer extracted with 
AcOEt/petrol ether (1:1, 2 x 50 ml). The combined organic layers were washed with brine 
                                                 
1
 Kira, M.; Hino, T.; Sakurai, H. Tetrahedron Lett. 1989, 30, 1099 
2
 B. M. Hackman, P. J. Lombardi, J. L. Leighton, Org Lett, 2004, 6, 4375-4377  
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(50 ml), dried over MgSO4 and the solvent removed in vacuo. The crude product was 
purified by flash chromatography on silica gel (4:1 petrol ether/AcOEt to 1:1:01 petrol 
ether/AcOEt/Et3N) to leave pure diamine (18.16 g, 40.16 mmol, 76%) as a colorless oil.  
1
H-NMR (500 MHz, C6D6) δH 7.4 (4H, dt, J= 8.5, 2.0 Hz), 7.04 (4H, dt, J= 8.5, 2.0 Hz), 
3.63 (2H, d, J= 14.0 Hz), 3.43 (2H, d, J= 14.0 Hz), 2.19-2.12 (2H, m), 2.01-1.95 (2H, m), 
1.70-1.62 (2H, m), 1.47 (2H, bs, NH), 1.21-1.11 (2H, m), 0.98-0.88 (2H, m); 
13
C-NMR 
(125 MHz, C6D6) δC 140.9, 131.6, 130.0, 120.8, 61.2, 50.4, 31.6, 25.2. Data are consistent 
with literature.
b
 
 
(3aR,7aR)-1,3-bis(4-bromobenzyl)-2-((Z)-but-2-en-1-yl)-2-chlorooctahydro-1H-
benzo[d][1,3,2] diazasilole  
 
To a stirred solution of (Z)-crotyltrichlorosilane (1.8 g, 9.5 mmol, 1.2 eq) and freshly 
distilled 1,8-diazabicyclo[5,4,0]undec-7-ene (2.83 ml, 18.98 mmol, 2.4 eq) in anhydrous 
DCM (40 ml) at 0 °C under argon was added a solution of the above diamine (3.55 g, 7.90 
mmol, 1 eq) in DCM (10 ml) via syringe pump over 45 minutes. The reaction was allowed 
to warm to room temperature and stirred overnight. The reaction mixture was concentrated 
by vacuum distillation. The residue was diluted with pentane (50 mL) and vigorously 
stirred for 3 h to ensure complete precipitation of all DBU salts. The suspension was 
filtered under argon and the solvent removed in vacuo yielding 4 (4.42 g, 7.7 mmol, 82%) 
as a pale yellow oil. 
1
H-NMR (500 MHz, C6D6) δH 7.42-7.44 (4H, dd, J= 8.3, 3.2, Ar-H), 
7.17-7.20 (4H, dd, J= 8.3, 4.5, Ar-H), 5.48-5.50 (2H, m, SiCH2CH=CHMe), 3.99-3.92 
(2H, m, two of ArCH2N), 3.64-3.52 (m, 2H, two of ArCH2N), 2.73-2.69 (2H, m, two 
CHN), 1.79-1.31 (9H, m, SiCH2, CH=CHCH3, and 2 x CH2), 0.96-0.84 (4H, m, 2 xCH2); 
13
C-NMR (125 MHz, C6D6) δC 141.5, 140.7, 131.6, 130.1, 129.3, 125.1, 122.3, 66.5, 65.7, 
48.2, 31.0, 30.7, 24.8, 22.7.0, 18.7, 13.1. Data are consistent with literature. 
 
The same procedure was applied for the synthesis of the S,S enantiomer using (1S,2S)-
cyclohexane-1,2-diamine-D-tartrate as starting material. 
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(E)- 3-iodo-2-methyl-prop-2-en-1-ol (1)
 3
 
 
To a stirred suspension of ZrCp2Cl2 (913 mg, 3.125 mmol, 0.25 eq) in DCM (40 ml) at 
room temperature under argon was added trimethyl alluminium (18.75 ml 2.0M solution in 
n-Hexane, 37.5 mmol, 3 eq) and the mixture was then cooled to 0°C. A solution of 
propynol (0.738 ml, 12.5 mmol, 1 eq) in DCM (40 ml) was added via cannula and the 
mixture was allowed to warm at room temperature and stirred for 15h. 
The mixture was cooled to -30°C, a solution of iodine (4.75g, 18.75 mmol, 1.5 eq) in Et2O 
(10 ml) was added and, after stirring for 30 minutes at -30°C, the mixture was allowed to 
warm at 0°C. The reaction was quenched by transfer of the solution in a mixture of 
saturated Na K Tartrate (50 ml) and pentane (300 ml). The mixture was stirred vigorously 
for 10 minutes, the layers were separated, and the aqueous layer extracted with Et2O. The 
organic phases were washed with brine and dried on MgSO4. The solvent was removed 
and the crude purified by chromatography to afford 1 (1.48 g, 7.48 mmol, 60%). Rf 0.41 
(Petrol Ether/AcOEt (7:3)); 
1
H-NMR (500 MHz, CDCl3) δH 6.29 (1H, q, J= 1.1, H-1), 
4.14 (2H, s, CH2-3), 1.85 (3H, s, CH3); 
13
C-NMR (125 MHz, CDCl3) δC 147.2, 77.4, 67.8, 
21.36. Data are consistent with Literature. 
 
(E)-3-iodo-2-methylpropenal (2)
3
 
 
To a solution of 1 (950 mg, 4.8 mmol, 1 eq ) in Et2O is added MnO2 (4.17 g, 48.0 mmol, 
10 eq) and the mixture stirred for 45 minutes at room temperature. Celite® is then added 
and the mixture is stirred for other 30 minutes before filtration on Celite to remove MnO2. 
The solution is concentrated in vacuo yielding 2 (835 mg, 4.26 mmol, 89%) that is used for 
the next step without further purification. Rf 0.55 (Petrol Ether / AcOEt (4:1)); 
1
H-NMR 
(500 MHz, CDCl3) δH  9.53(1H,s, CHO), 7.82 (1H, q, J= 1.1, H-1), 1.92 (3H, d, J= 1.1 
Hz, CH3); 
13
C-NMR (125 MHz, CDCl3) δC 189.6, 150.8, 109.8, 16.4. Data are consistent 
with literature. 
                                                 
3
 J. D. White, P. R. Blakemore, N. J. Green, E. B. Hauser, M. A. Holoboski, L. E. Keown, C. S. Nylund 
Kolz, B. W. Phillips J. Org. Chem., 2002, 67, 7750–7760 
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(3S,4R,E)-1-iodo-2,4-dimethylhexa-1,5-dien-3-ol (3) 
 
A solution of aldehyde 2 (713 mg, 3.64 mmol, 1 eq) in DCM (25 ml) was cooled, under 
argon, to 0 °C. A solution of (3aR,7aR)-1,3-bis(4-bromobenzyl)-2-((Z)-but-2-en-1-yl)-2-
chlorooctahydro-1H-benzo[d][1,3,2] diazasilole (2.45 g, 4.3 mmol, 1.2 eq) in DCM was 
added, followed by Sc(OTf)3 (89 mg, 0.182 mmol, 0.05 eq). The mixture was stirred at 0 
°C for 1 hour, then at room temperature overnight. 
Solid TBAF 3H2O (1.15 g, 3.64 mmol, 1 eq) was added and the mixture stirred for 1 hour. 
The  solvent was removed and the crude purified on silica gel chromatography (10:1 petrol 
ether/AcOEt  to1:1:0.1 petrol ether/AcOEt/Et3N to recover the diamine), yielding 3 as a 
pale yellow oil (880 mg, 3.49 mmol, 96%). Rf 0.46 (Petrol / AcOEt (5:1)); [a]D
25
  –15.29° 
(c=1.02, CHCl3), IR (thin film, νmax / cm
-1
) 3413, 3077, 2975, 2917, 1725,1639, 1454, 
1376, 1266, 1009, 916; 
1
H-NMR (500 MHz, CDCl3) δH 6.267 (1H,t, J= 1.05 Hz, H-1), 
5.73 (1H, ddd, J = 17.3, 10.5, 7.1 Hz, H-5), 5.10 (1H, dt, J = 9.5, 1.4 Hz, HA-6), 5.07 (1H, 
m, HB-6), 4.04 (1H, dd, J = 5.9, 3.5 Hz, H-3), 2.45 (1H, q, J = 6.8 Hz, H-4), 2.05 (3H, s, 
Me-2), 1.80 (1H, d, J= 1.03 Hz, OH) 1.02 (3H, d, J = 6.8 Hz, Me-4); 
13
C-NMR (125 
MHz, CDCl3) δC 148.2, 139.96, 115.4, 79.63, 78.92, 40.97, 20.59, 13.88; HRMS (FI
+
) 
calc. for C8H13IO [M+1]
+ 
252.0011, found 252.0006 
 
Methyl (3S,4R) 5-hydroxy-7-iodo-4,6-dimethylhepta-2,6-dienoate (4) 
 
Compound 3 (1.01 g, 4.03 mmol) and methyl acrylate (2.17 mL, 24.18 mmol) were 
dissolved in DCM (12 mL) and the solution was degassed for 15 min. Then Hoveyda-
Grubbs catalyst II (50 mg, 0.08 mmol) was added and the reaction mixture was stirred at 
40º C until full conversion by TLC. The solvent was removed under pressure and the crude 
purified on silica gel chromatography yielding compound 4 (1.04 g, 3.35 mmol, 78%). Rf 
0.27 (Petrol ether/AcOEt (5:1)); [a]
D
25
  –10.69° (c=1.02, CHCl3),  IR (thin film, νmax / cm
-1
) 
3459, 3056, 2951, 2874, 2357, 1703, 1654, 1436, 1229, 1145, 943, 686; 
1
H-NMR (500 
MHz, CDCl3) δH 6.87 (1H, dd, J = 15.7, 7.6 Hz, H-3), 6.32 (1H, s, H-7), 5.84 (1H, dd, J = 
15.7, 1.1 Hz, H-2), 4.13 (1H, dd, J = 5.6, 3.9 Hz, H-5), 3.73 (1H, s, Me-1), 2.58 (1H, m, 
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H-4), 1.96 (1H, d, J= 3.8 Hz, OH), 1.79 (3H, s, Me-6), 1.07 (3H, d, J = 6.8 Hz, Me-4); 
13
C-NMR (125 MHz, CDCl3) δC 166.9, 150.3, 147.8, 121.2, 79.6, 79.0 51.6, 40.0, 20.6, 
13.8; HRMS (ES
+
) calc. for C10H15IO3 [M+Na]
+ 
 332.9958, found 332.9956 
 
Methyl 2-((4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-4-
yl)acetate (5) 
 
Compound 4 (330 mg, 1.06 mmol, 1 eq) was dissolved in THF (5 mL) under argon  and 
the solution was cooled to -5 ºC. Then freshly distilled benzaldehyde (0.27 mL, 2.66  
mmol, 2.5 eq) was added, followed by tBuOK/THF 0.5M (0.21 mL, 0.106 mmol, 0.1 eq). 
The addition of the solution tBuOK/THF was dropwise and it was repeated three times 
every 20 minutes. The resulting red solution was quenched with pH 7 phosphate buffer. 
The layers were separated and the aqueous layer was extracted with Et2O. The combined 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo. Purification by chromatography on silica gel (petrol ether/AcOEt 10:1) afforded 5 
(130 mg, 0.31 mmol, 30%) as a colourless oil. Rf 0.42 (Petrol / AcOEt (5:1)); [a]D
25
  –
18.89° (c=0.99, CHCl3), IR (thin film, νmax / cm
-1
) 3468, 3091, 3034, 2974, 2874, 2358, 
1737, 1624, 1347, 1101, 1028, 758, 699; 
1
H-NMR (500 MHz, CDCl3) δH 7.48-7.59 (2H, 
m, Ph), 7.34-7.40 (3H, m, Ph), 6.35 (1H, s, H-1), 5.63 (1H, s, CHPh), 4.48 (1H,ddd, J=7.8, 
5.8, 2.2 Hz, H-5), 4.13 (1H, s, H-3), 3.72 (1H, s, Me-7), 2.74 (1H, dd, J= 7.8, 15.9 Hz, H-
6A), 2.52 (1H, dd, J= 15.9, 5.8 Hz, H-6B), 1.87-1.91 (1H, m, H-4), 1.81 (1H, s, Me-2), 
0.87 (3H, d, J = 6.9 Hz, Me-4); 
13
C-NMR (125 MHz, CDCl3) δC 171.1, 143.7, 138.5, 
128.9, 128.3, 128.2, 126.2, 101.35, 83.4, 78.2, 51.9, 37.8, 33.1, 21.4, 6.2; HRMS (ES
+
) 
calc. for C17H21IO4 [M+Na]
+ 
 439.0377, found 439.0374 
 
2-((4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-4-
yl)acetaldehyde (6) 
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To a solution of 5 (174 mg, 0.432 mmol, 1 eq) in DCM (4 mL), cooled to -78 ºC and under 
inert atmosphere, was added DIBAL-H 1.0M Hex (0.475 mL, 0.475 mmol, 1.1 eq). The 
solution was stirred at low temperature for 2 hours. Then, MeOH was added and the 
solution was poured in a flask containing a mixture of saturated Na  K Tartrate and ethyl 
acetate. After stirring for 1 hour the layers were separated, the aqueous extracted with ethyl 
acetate and the combined organic layers were washed with brine, dried over MgSO4 and 
filtered. The solvent was evaporated to afford a crude that was purified by chromatography 
on silica gel (petrol/AcOEt 5:1) yielding 6 (110 mg, 0.285 mmol, 66%) as a colourless oil. 
Rf 0.24 (Petrol / AcOEt (5:1)); [a]D
25
  –40.24° (c=0.83, CHCl3), IR (thin film, νmax / cm
-1
) 
3429, 3034, 2974, 2848, 2733, 2365, 1726, 1624, 1454, 1346, 1133, 1028, 769, 699; 
1
H-
NMR (500 MHz, CDCl3) δH 9.85 (1H, t, J= 1.6 Hz, CHO), 7.48-7.50 (2H, m, Ph), 7.36-
7.40 (3H, m, Ph), 6.36 (1H, t, J = 1.6 Hz, H-1), 5.65 (1H, s, CH-Ph), 4.57 (1H, ddd, J = 
7.1, 4.7, 2.3 Hz, H-5), 4.45 (1H, s, H-3), 2.88 (1H, ddd, J= 17.3, 8.4, 1.6, H-6A), 2.55 (1H, 
ddd, J= 17.3, 4.7, 1.6, H-6B), 1.85-1.90 (1H, m, H-4), 1.81 (3H, s, Me-2), 0.88 (3H, d, J = 
6.9 Hz, Me-4); 
13
C-NMR (125 MHz, CDCl3) δC 200.0, 143.5, 137.9, 129.1, 128.3, 126.2, 
101.4, 83.4, 78.3, 75.2, 46.7, 33.3, 21.4, 6.3; HRMS (ES
+
) calc. for C16H20IO3 
[M+Na+MeOH]
+ 
441.0533, found 441.0544 
 
(2S,3S)-1-((4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-4-
yl)-3-methylpent-4-en-2-ol (7) 
 
A solution of 6 (100 mg, 0.259 mmol, 1 eq) in DCM (2.5 ml) under inert atmosphere was 
cooled to 0 °C and a solution of (3S,7S)-1,3-bis(4-bromobenzyl)-2-((Z)-but-2-en-1-yl)-2-
chlorooctahydro-1H-benzo[d][1,3,2] diazasilole (176 mg, 0.1 mmol, 1.2 eq) in DCM was 
added. The mixture was allowed to warm at room temperature and stirred for 48h. The 
reaction was then quenched adding solid TBAF 3H2O (82 mg, 0.259 mmol, 1 eq) and after 
stirring for 1h, the solvent was removed and the crude purified on silica gel 
cromatograpphy yielding an inseparable mixture of starting material and product 7 (35 mg, 
product/SM 3:1). Rf 0.22 (Petrol / DCM (1:1)); [a]D
25
  –35.5° (c=1.00, CHCl3),  
1
H-NMR 
(500 MHz, CDCl3) δH 7.48-7.52 (2H, m, Ph), 7.36-7.41 (3H, m, Ph), 6.33 (1H, s, H-1), 
5.80 (1H, ddd, J = 17.5, 10.2, 7.3 Hz, H-9), 5.62 (1H, s, CH-Ph), 5.12 (2H, d, J = 14.1 Hz, 
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H-10), 4.41 (1H, s, H-3), 4.27 (1H, dt, J= 10.1, 2.1 Hz, H-5), 3.82 (1H, t, J= 4.2 Hz, H-7), 
2.32 (1H, m, H-8), 1.87 (1H, ddd, J= 14.3, 9.7, 2.3 Hz, H-6A), 1.79 (3H, s, Me-2), 1.76 
(1H, dt, J= 6.9, 2.3 Hz, H-4), 1.43 (1H, ddd, J= 14.3, 9.9, 2.2 Hz, H-6B), 1.06 (3H, d, J= 
6.9 Hz, Me-8), 0.86 (3H, d, J = 6.9 Hz, Me-4); 
13
C-NMR (125 MHz, CDCl3) δC 144.0, 
140.6, 129.1, 128.9, 128.3, 126.2, 115.7, 101.3, 83.8, 77.9, 77.2, 70.8, 43.7, 37.4, 34.5, 
21.4, 14.0, 6.4. HRMS (ES
+
) calc. for C20H27IO3 [M+Na]
+ 
465.0897, found 465.0886 
 
(2S,3S)-1-((2S,4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-
4-yl)-3-methylpent-4-en-2-yl benzoate (10a) 
 
To a solution of 7 (35 mg, 0.08 mmol, 1 eq) in pyridine (0.2 ml) under inert atmosphere 
was added benzoyl chloride (11microL, 13 mg, 0.09 mmol, 1.2 eq). The mixture was 
stirred at room temperature for 16h. The reaction was then quenched adding water and 
extracting with DCM. The organic layers were then washed with HCl 1M, dried over 
MgSO4, filtered, the solvent removed and the crude purified on silica gel cromatography 
yielding product 7 (22 mg, 0.04 mmol, 50%). Rf 0.31 (Petrol / AcOEt (20:1)) 
1
H-NMR 
(500 MHz, CDCl3) δH 8.09 (2H, m, Ph), 7.36-7.61 (8H, m, Ph), 6.35 (1H, t, J = 1.2 Hz, H-
1), 5.85 (1H, ddd, J = 17.5, 10.4, 7.3 Hz, H-9), 5.51 (1H, s, CH-Ph), 5.48 (1H, ddd, J = 
9.9, 5.4, 2.5 Hz, H-7 ), 5.09 (2H, m, H-10), 4.30 (1H, s, H-3), 3.98 (1H, dt, J= 10.1, 2.1 
Hz, H-5), 2.60 (1H, dq, J= 13.6, 6.9 Hz, H-8), 2.06 (1H, ddd, J= 14.7, 9.8, 2.6 Hz, H-6A), 
1.80-1.64 (2H, m, H-6B, H-4), 1.72 (3H, s, H-2), 1.12 (3H, d, J= 6.9 Hz, Me-8), 0.85 (3H, 
d, J = 6.9 Hz, Me-4); 
13
C-NMR (125 MHz, CDCl3) δ 166.1, 143.9, 139.5, 138.3, 133.0, 
130.4, 129.6, 128.7, 128.4, 128.1, 126.1, 115.7, 101.0, 83.5, 77.9, 77.1, 74.2, 41.9, 35.2, 
34.2, 21.3, 15.0, 6.3.HRMS (ES
+
) calc. for C27H31IO3 [M+Na]
+ 
569.1159, found 569.1163 
 
(2S,3R)-1-((2S,4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-
4-yl)-3-methyl-4-oxobutan-2-yl benzoate (2a) 
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6 l of 2,6-lutidine (5.8 mg, 0.054mmol, 2eq), 5.48 mg of a OsO4 (2.5% solution in t-
BuOH, 5.4·10
-4
mmol, 0.02 eq) and 23 mg of NaIO4 (0.108 mmol, 4 eq) were added 
sequentially to a solution of 10a (15 mg, 0.027 mmol, 1 eq) in dioxane/H2O (0.2 ml/ 0.06 
ml). The mixture was stirred at room temperature for 2h30. The reaction was then 
quenched adding H2O and extraceted with Et2O. The organic layers were then dried over 
MgSO4, filtered, the solvent removed and the crude purified on silica gel cromatography 
yielding product 2a (9 mg, 0.016 mmol, 61%). Rf 0.41 (Petrol / AcOEt (5:1)), 
1
H-NMR 
(500 MHz, CDCl3) δH 9.8 (1H, s, H-9), 8.03 (2H, d, J = 7.0 Hz, Ph), 7.60 (2H, t, J = 7.4 
Hz, Ph), 7.53 (2H, dd, J = 7.9, 1.4 Hz, Ph), 7.47 (2H, t, J = 7.9 Hz, Ph), 7.43 – 7.34 (2H, 
m, Ph), 6.36 (1H, s, H-5), 5.90 (1H, dt, J = 8.9, 3.4 Hz, H-7), 5.53 (1H, s, CHPh), 4.35 
(1H, s, H-3), 4.06 (1H, dt, J = 10.0, 2.3 Hz, H-5), 2.78 (1H, dq, J = 7.0, 3.4 Hz, H-8), 2.6 
(1H, ddd, J= 14.6, 10.0, 4.0 Hz, H-6A), 1.93 (1H, ddd, J = 14.6, 8.9, 2.3 Hz, H-6B), 1.82 – 
1.71 (4H, m, H-4, Me-2), 1.24 (3H, d, J = 7.0 Hz, Me-8), 0.87 (3H, d, J=6.9Hz, Me-4). 
13
C-NMR (125 MHz, CDCl3) δC 201.9, 165.8, 143.7, 138.1, 133.3, 129.7, 128.9, 128.5, 
128.4, 128.2, 126.1, 101.1, 83.5, 78.1, 76.9 70.3, 50.7, 36.0, 34.1, 21.3, 8.0, 6.3. HRMS 
(ES
+
) calc. for C27H33IO6 [M+Na+MeOH]
+ 
603.1214, found 603.1209 
 
(2S,4S,5R,6S)-4-((E)-1-iodoprop-1-en-2-yl)-6-((2S,3S)-2-((4-methoxybenzyl)oxy)-3-
methylpent-4-en-1-yl)-5-methyl-2-phenyl-1,3-dioxane (10b) 
 
32 mg of NaH (60% mineral oil, 0.81 mmol, 3 eq) were suspend in THF (4 ml)/DMF (0.2 
mml) under inert atmosphere. A solution of 7 (120 mg, 0.27 mmol, 1 eq) in THF (2.5 ml) 
was added dropwise followed by tetrabutylamonium iodide (20 mg, 0.054 mmol, 0.2 eq) 
and 110 l of p-methoxy-benzyl chloride (127 mg, 0.81 mmol, 3 eq) The reaction was 
stirred at room temperature for 16h. Methanol was then added and the mixture stirred for 
15 minutes, diluted with water and extracted with Et2O. The organic layers were then 
washed with brine., dried over MgSO4, filtered, the solvent removed and the crude purified 
by on silica gel cromatography yielding product 10b (110 mg, 0.19 mmol, 72%). Rf 0.34 
(Petrol / AcOEt (9:1)); 
1
H-NMR (500 MHz, CDCl3) δH 7.45 (2H, dd, J = 7.8, 1.6 Hz, Ph), 
7.41 – 7.34 (3H, m, Ph), 7.30 – 7.27 (2H, d, J = 8.7 Hz, PMB), 6.89 (2H, d, J = 8.7 Hz, 
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PMB), 6.31 (1H, s, H-1), 5.93 (1H, ddt, J = 13.0, 10.0, 7.6 Hz, H-9), 5.36 (1H, s CHPh,), 
5.13 – 5.03 (2H, m, H-10), 4.66 (1H, d, J = 11.0 Hz, CH2 p-MeOPh), 4.41 (1H, d, , J = 
11.0 Hz, CH2 p-MeOPh), 4.29 (1H, s, H-3), 4.06 (1H, dt, J = 10.3, 2.0 Hz, H-5), 3.74 (3H, 
s, OCH3), 3.68 – 3.60 (1H, m, H-7), 2.58 (1H, td, J = 13.6, 6.8 Hz, H-8), 1.82 – 1.71 (4H, 
m, Me-2, H-6A), 1.72 – 1.65 (1H, m, H-4), 1.47 – 1.30 (1H, m, H-6B), 1.05 (3H, d, J = 6.9 
Hz, Me-8), 0.80 (3H, d, J = 6.9 Hz, Me-4). 
13
C-NMR (125 MHz, CDCl3) δC: 159.2, 144.1, 
140.3, 138.6, 130.8, 129.70, 128.1, 126.1, 114.8, 113.8, 113.7, 100.9, 83.9, 78.2, 77.8, 
72.0, 55.2, 40.3, 35.1, 34.2, 21.3, 15.1, 6.3.HRMS (ES
+
) calc. for C28H35IO4 [M+Na]
+ 
585.1472, found 585.1467 
 
(2R,3S)-4-((2S,4S,5R,6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-dioxan-
4-yl)-3-((4-methoxybenzyl)oxy)-2-methylbutanal (2b) 
 
33 l of 2,6-lutidine (31 mg, 0.284 mmol, 2eq), 29 mg of OsO4 (2.5% solution in t-BuOH, 
0.028 mmol, 0.02 eq) and 121 mg of NaIO4 (0.568 mmol, 4 eq) were added sequentially to 
a solution of 10b (80 mg, 0.142 mmol, 1 eq) in dioxane/H2O (1 ml/ 0.4 ml). The mixture 
was stirred at room temperature for 2 hours. The reaction was then quenched adding H2O 
and extraceted with Et2O. The organic layers were then dried over MgSO4, filtered, the 
solvent removed and the crude purified on silica gel cromatography yielding product 2b 
(41 mg, 0.075 mmol, 53%). Rf 0.42 (Petrol / AcOEt (5:1)); 
1
H-NMR (500 MHz, CDCl3) 
δH 9.85 (1H, s, CHO), 7.52 – 7.34 (4H, m, Ph), 7.30 – 7.21 (2H, m, PMB), 6.89 – 6.82 
(2H, m, PMB), 6.32 (1H, s, H-1), 5.39 (1H, s, CHPh), 4.58 (1H, d, J = 11.3 Hz, CH2 p-
MeOPh), 4.40 (1H, d, J = 11.3 Hz, CH2 p-MeOPh), 4.32 (1H, s, H-3), 4.17 – 4.12 (1H, m, 
H-7), 4.08 (1H, dt, J = 10.3, 2.0 Hz, H-5), 3.75 (3H, s, OMe), 2.71 – 2.61 (1H, m, H-8), 
1.84 – 1.78 (1H, m, H-6A), 1.77 (3H, s, Me-2), 1.74 – 1.66 (1H, m, H-4), 1.63 – 1.58 (1H, 
m, H-6B), 1.14 (3H, d, J = 6.9 Hz, Me-8), 0.82 (3H, d, J = 6.9 Hz, Me-4); 
13
C-NMR (125 
MHz, CDCl3) δC 204.5, 159.4, 143.8, 138.3, 129.7, 128.8, 128.2, 126.1, 113.9, 101.0, 83.8, 
78.0, 76.5, 74.5, 67.1, 60.4, 55.2, 50.2, 36.4, 34.1, 21.3, 8.4, 6.3. HRMS (ES
+
) calc. for 
C28H37IO6 [M+Na+MeOH]
+ 
619.1527, found 619.1519 
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(4R, 5S)-ethyl 6-((2S, 4S, 5R, 6S)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyl-2-phenyl-1,3-
dioxan-4-yl)-5-((4-methoxybenzyl)oxy)-4-methyl-3-oxohexanoate (11) 
 
To a stirred solution of ethyldiazoacetate (34 l, 0.054 mmol, 2 eq) and of SnCl2 (0.5 mg 
0.0027 mmol, 0.1 eq) in DCM (0.5 ml) under inert atmosphere a solution of 15 mg of 
aldehyde 2b (0.027 mmol, 1 eq) in DCM was slowly added over 5 minutes, observing the 
evolution of N2 and then the mixture was stirred overnigh.t 
The reaction was then washed with brine and extracted with Et2O (x3) The organic layers 
were then dried over MgSO4, filtered, the solvent removed and the crude purified on silica 
gel cromatography yielding product 11 (15 mg, 0.023 mmol, 42%).  Rf 0.37 (Petrol / 
AcOEt (5:1)); 
1
H-NMR (500 MHz, CDCl3) δH 7.54-7.17 (6H, m, Ph), 6.95-6.76 (2H, m, 
PMB),  6.30 (1H, s, H-1), 5.32 (1H, s, CH-Ph), 4.63 (1H, d, J = 11.2 Hz, CH2 p-MeOPh), 
4.43 (1H, d, J = 11.2 Hz, CH2 p-MeOPh), 4.29 (1H, s, H-3), 4.19 (2H, q, J= 7.14 Hz, 
CH2(Et)), 4.04-3.95 (1H, m, H-7), 3.95-3.84 (1H, m, H-5), 3.73 (3H, s, OMe), 3.60 (2H, s, 
H-10), 3.14 (1H, dd, J= 7.0, 3.8 Hz, H-8), 1.87-1.60 (4H, m, H-6A, Me-2), 133-1.24 (4H, 
m, CH3(Et), H-4), 1.10 (3H, d, J= 6.9 Hz, Me-8), 0.79 (3H, d, J = 6.9 Hz, Me-4). 
 
 
